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SUMMARY 
RbpA is a RNA polymerase-binding protein that was identified in Streptomyces 
coelicolor. It is found in all Actinobacteria, including the pathogenic agent 
Mycobacterium tuberculosis. Streptomyces strains that have an rbpA mutation 
grow at a slower rate than the wild-type and are more sensitive to the RNAP-
targeting antibiotic, rifampicin. RbpA binds to and activates HrdB, the principal 
sigma factor that directs transcription of most housekeeping genes in S. 
coelicolor. Using bacterial two-hybrid analysis and in vitro pull down assays, 
RbpA was shown to interact with region 1.2-2.4 of HrdB. This region forms part 
of a major interface with core RNA polymerase and is involved in the recognition 
of, and binding to, the -10 promoter element. Rv2050, the homologue of RbpA in 
M. tuberculosis, was also shown to interact with the principal sigma factor of this 
organism, A. Structural studies on RbpA and Rv2050 revealed that it is 
composed of two regions, a structured N-terminal -fold region and an flexible or 
unstable C-terminal region, which interacts with sigma. Alanine-scanning site-
directed mutagenesis on the C-terminal region of RbpA identified important 
residues involved in HrdB interaction as well as residues that might be involved 
in transcriptional activation.  
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ECF: Extra-Cytoplasmic function 
ETZ: ET12567 cells containing pUZ8002 plasmid 
HtH: Helix-turn-helix 
ICP-MS: Inductively coupled plasma mass spectrometry 
IPTG: Isopropyl-β-D-thiogalactopyranoside  
LA: Lennox agar 
LB: Lennox broth 
MCS: Multiple cloning site 
MS: Mannitol soya flour medium 
Mg: Magnesium 
Mn: Manganese 
NMR: Nuclear magnetic resonance 
NCR: Non-conserved region 
PMSF: Phenylmethylsulfonyl Fluoride 
ppGpp: Guanosine 5’-diphosphate 3’-diphosphate  
Rif: Rifampicin 
RNAP: RNA polymerase 
RT: Room temperature 
tsr: Thiostepton resistance gene 
X-gal: 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside  
YEME: Yeast extract-malt extract medium  
ZAS: Zinc-binding anti-sigma factor 
Zn: Zinc 
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1.0 Overview 
Streptomyces coelicolor, a Gram-positive bacterium, is the most studied 
representative of the Streptomyces genus. Streptomycetes are soil-living 
microorganisms that belong to the large phylum of Actinobacteria and this 
includes pathogenic agents such as Mycobacterium tuberculosis and 
Mycobacterium leprae. There are many cases where fundamental biological 
mechanisms are shared between all Actinobacteria and so discoveries made in 
the non-pathogenic streptomycetes can often have important implications for the 
understanding of pathogenic strains. The streptomycetes are medically 
important in their own right because they produce the majority of antibiotics in 
use today and are a potential source of novel antimicrobials. This project 
focuses on RNA polymerase (RNAP), the transcription machinery. Basic RNAP 
function is conserved in all bacteria and is a target for antibiotics, including 
rifamycins. However, recent discoveries suggest that the Actinobacteria possess 
some unique RNAP regulatory features that might be novel targets for 
antimicrobials.  
 
1.1 The Actinobacteria phylum 
The Actinobacteria formerly known as the “Actinomycetes” are a large group of 
microorganisms that were discovered in the late 19th century. However, the 
name Actinomycete was first used in the late 18th century to describe a disease 
that affected cattle, “lumpy jaw”. Carl Otto Harz, a German botanist, saw that the 
structure of this new organism was similar to fungus and grew in the absence of 
oxygen. Therefore, he concluded that it was a fungus and he called it 
“Actinomyces bovis”. Actinomyces means “ray fungus” (Hopwood, 2007).  
 
Selman Abraham Waksman discovered that these microbes produce 
antimicrobial agents and put forward the name ‘antibiotic’ (Kresge et al., 2004). 
An antibiotic is a natural compound produced by one bacterium that inhibits the 
growth of another bacterium. The first antibiotic discovered by Waksman was 
Actinomycin, from Actinomyces antibioticus. Actinomycin has two components: 
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A and B. Actinomycin A has an orange-red colour and has bacteriostatic and 
bactericidal characteristics, whilst Actinomycin B is colourless and has only 
bactericidal properties (Kresge et al., 2004). However, this antibiotic was very 
toxic and hence, was not useful at that time (Hopwood, 2007). Nowadays, it is 
used as a therapeutic agent in chemotherapy.  
 
However, Waksman then discovered Streptomycin in 1943 from Streptomyces 
griseus, which was the first effective antibiotic for the treatment of tuberculosis. 
He was awarded the Nobel Prize for Physiology or Medicine in 1952. Interest in 
these microorganisms thereafter greatly increased (Kresge et al., 2004) and 
currently these bacteria make over two-thirds of the world’s antibiotics that we 
use for treatment of bacterial infections and fungal diseases, as well as several 
key anticancer and anti-parasitic therapies (Bentley et al., 2002). 
 
1.1.1 Streptomyces coelicolor A3 (2) 
Streptomyces are ubiquitous soil bacteria that produce antibiotics as a result of 
complex secondary metabolic pathways. Antibiotics are produced to aid them in 
competition with other soil bacteria for basic nutrients and also for space so they 
can multiply freely. Streptomycetes are also involved in carbon and nitrogen 
recycling as they degrade insoluble remains (e.g. chitin) of organisms in the soil 
(Bentley et al., 2002). Streptomyces coelicolor A3 (2) is the model organism 
used in research to study and understand the streptomycetes. It is an obligate 
aerobe but has been shown to stay viable and undergo microaerobic growth 
during periods of anaerobiosis (van Keulen et al., 2007). 
  
1.1.1.1 The genome  
S. coelicolor A3 (2) has a single linear chromosome with a high guanine and 
cytosine (G+C) content of 72.1%. DNA replication proceeds bi-directionally from 
the origin of replication (oriC) that is positioned centrally. The essential genes 
including genes coding for DNA replication, transcription, translation are located 
close to the oriC between 1.5 to 6.4 Mb (known as the ‘core’ region). However, 
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non-essential genes such as those coding for secondary metabolites enzymes, 
hydrolytic enzymes, are located on the ‘arms’ of the chromosome (Bentley et al., 
2002). 
 
The chromosome of S. coelicolor has 8,667,507 bp and 7,825 predicted genes 
(Bentley et al., 2002). It is larger and encodes about two-fold more genes than 
that of M. tuberculosis. The ‘core’ region of S. coelicolor and the whole 
chromosome of M. tuberculosis have evolved from a common ancestor, and so 
they have a large number of similar gene sequences and gene clusters. The 
most highly conserved gene clusters code for respiratory chain NADH 
dehydrogenase subunits. Others include genes coding for origin of replication, 
pyrimidine synthesis, cell division, arginine biosynthesis and ribosomal proteins. 
However, S. coelicolor has gained extra DNA at the ‘arm’ regions (Bentley et al., 
2002). 
 
The S. coelicolor genome has expanded protein families involved in regulatory 
functions, transport, and the utilisation of extracellular nutrients. With regard to 
gene regulation, S. coelicolor has 965 regulators, of which 65 are sigma factors, 
and has many genes that encode sensor kinases and response regulators 
involved in two-component regulatory systems. In transport, it encodes 614 
proteins, most of which are ABC transporter type, including permeases and 
ATP-binding proteins involved in transporting sugars, amino acids, peptides, 
metals and ions. It also encodes 819 proteins involved in degradation of 
nutrients, an example of which includes the secreted hydrolases that are 
comprised of 60 proteases/peptidase, thirteen chitinases/chitosanases, eight 
cellulases/endogluconases, three amylases and two pectate lyases (Bentley et 
al., 2002). 
 
1.1.1.2 Life cycle and regulation  
S. coelicolor and other streptomycetes are distinguished from other bacteria by 
their complex multi-cellular development. They form a highly branched 
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vegetative mycelium growing horizontally on a surface. The mycelium then 
differentiates into aerial hyphae that project up from the mycelium giving rise to 
spores (Bentley et al., 2002, Hopwood, 2007).  
 
When a spore of S. coelicolor lands on a suitable environment with nutrients, it 
starts germination by forming one or two “germ tubes” (Fig. 1.1A & B) (Flardh & 
Buttner, 2009). These germ tubes grow to produce a vegetative branching mass 
of mycelium (Fig. 1.1C). The growth of S. coelicolor is distinct from the other 
Actinobacteria in that they extend at the tip. The protein, DivIVA is crucial for tip 
extension and cell shape, recruiting cell wall biosynthesis machinery during 
branching (Flardh & Buttner, 2009). During nutrient limitation, aerial hyphae 
projects from the vegetative mycelium and grows into the air (Fig. 1.1D). This 
requires the aerial hyphae to be coated in a hydrophobic sheath and to produce 
SapB, a surfactant peptide. SapB, however, is only activated on rich media and 
reduces the surface tension allowing the aerial hyphae to protrude into the air. 
The hydrophobic sheath is made up of the chaplin and rodlin proteins. The 
chaplins assemble at the surface, lowering the surface tension, whilst the rodlins 
organise the chaplins into well-ordered structures (Flardh & Buttner, 2009).  
 
The aerial hyphae continue growing by tip extension, carrying DivIVA foci, and 
can form hyphal cross-walls. This forms a sporagenic cell, which has no 
septation and contains more than 50 copies of the genome (Fig. 1.1E). Growth 
is arrested before multiple cell divisions are initiated. Septation is directed by 
FtsZ, which is recruited by SsgB (van Wezel & McDowall, 2011). The 
segregation and arrangement of the chromosomes require ParAB and FtsK 
systems during sporulation. This forms the prespore compartments each of 
which contains a single chromosome (Fig. 1.1G). MreB then ensures accurate 
assembly of the spore wall (Fig. 1.1H) (Flardh & Buttner, 2009). 
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Figure 1.1: The life cycle of Streptomyces coelicolor. 
A: Spore, B: spore germination and formation of germ-tube, C: vegetative 
growth, D to F: aerial growth, G: aerial hyphae with septation and uni-genomic 
pre-spore compartments, and H: spore maturation. Copyright license No.: 
2937570798152 (Newton & Fahey, 2008).  
 
Regulation of these different stages of the life cycle is controlled to some extent 
by sigma factors belonging to both groups III and IV (Section 1.2.2.1). BldN and 
N are involved in the formation of aerial hyphae (Bibb et al., 2000, Dalton et al., 
2007) whereas WhiG, the sporulation sigma factor, commences the formation of 
spores (Chater et al., 1989). The bld mutants lack the ability to form aerial 
mycelium whilst the whi mutants do not produce normal mature spores or the 
grey pigment (Chater, 2001). BldD is a repressor of bldN and whiG. When aerial 
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hyphae growth starts, BldD no longer represses bldN and hence, RNAP-BldN 
transcribes BldM, which is required for aerial growth (Chater, 2001).  
 
The early sporulation genes include: whi A, B, G, H, I and J. WhiA, WhiB and 
possibly WhiI are involved in initiating septum formation (Flardh & Buttner, 
2009), whilst WhiD is involved in later stages of sporulation. Both WhiB and 
WhiD contain iron-sulphur cluster, co-ordinated by four conserved cysteine 
residues, which possibly responds to redox stress causing the dissociation of 
the cluster (Chater, 2001, Crack et al., 2009). F is involved in later stages of 
sporulation and is only expressed when sporulation has initiated and therefore is 
reliant on WhiG and other early sporulation genes (Kelemen et al., 1996). 
Another late sporulation gene is whiE, which produces the grey polyketide spore 
pigment (Flardh & Buttner, 2009). 
 
1.1.1.3 Regulation of antibiotic production 
S. coelicolor has 22 gene clusters that encode enzymes involved in the 
synthesis of secondary products that can function as antibiotics, siderophores, 
pigments, lipids and other molecules. Of particular interest is the production of 
antibiotics. There are four gene clusters that encode enzymes that produce 
characterised antibiotics: Actinorhodin - an aromatic polyketide antibiotic (Wright 
& Hopwood, 1976a), Red - red complex of undecylprodigiosin antibiotic (Rudd & 
Hopwood, 1980), the non-ribosomal peptide CDA - calcium-dependent antibiotic 
(Lakey et al., 1983), and methylenomycin (Wright & Hopwood, 1976b), which is 
located on the giant linear plasmid SCP1.  
 
Antibiotic clusters are each regulated by a specific regulatory protein (ActII-
ORF4, RedD and CdaR) that initiates a pathway specific signalling cascade, 
which leads to the production of the antibiotic. The transcription factors that 
regulate the synthesis of antibiotics also undergo regulation to either stimulate or 
inhibit their transcription. The antibiotic clusters are also regulated by global 
regulators of the cell in response to nutrient starvation and environmental stress, 
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which also control the development of S. coelicolor (van Wezel & McDowall, 
2011).   
 
Regulation of the actinorhodin (ACT) production has been widely studied. The 
major transcription factor that activates the act cluster of S. coelicolor is ActII-
ORF4 and the regulation of its promoter involves several mechanisms (van 
Wezel & McDowall, 2011). One of the main regulators is AbsA2, which is a 
repressor of actII-ORF4. AbsA2 is phosphorylated by AbsA1 and this 
phosphorylated AbsA2 can now bind to the promoter and inhibit its transcription 
(Sheeler et al., 2005). Another repressor of the actII-ORF4 promoter is DasR, 
which binds directly to the promoter. It has a dual function as it senses a 
nutrient, glucosamine-6-phosphate, which decreases its affinity for the actII-
ORF4 promoter and hence, ACT production is enhanced (Rigali et al., 2008). 
AtrA is the main activator of actII-ORF4 promoter by inducing its transcription 
(Uguru et al., 2005). 
 
The red and cda clusters are regulated by the RedD and CdaR transcription 
factors, respectively. AbsA2 is also the protein that binds to these promoters and 
represses their activity. Another system that was shown to affect ACT and RED 
production is the AfsKRS system. AfsK phosphorylates AfsR, which then binds 
to afsS promoter and stimulates its transcription. The precise mechanism of 
action of AfsS has not been resolved yet; however, it has been shown that 
increasing the induction of afsS enhances antibiotic production. The 
biosynthesis of methylenomycin is regulated by MmyB, which is a transcriptional 
activator. It has been shown that the level of phosphate, nitrogen, carbon, and 
metals such as Zn and iron all play key roles on antibiotic production (van Wezel 
& McDowall, 2011). 
 
In conditions of low nutrients, S. coelicolor switches on the production of 
antibiotics. The highly phosphorylated guanine nucleotide ppGpp has been 
shown to have a major role in the stringent response in E. coli (Section 1.2.5.1). 
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In S. coelicolor, ppGpp production decreases rRNA synthesis, ribosomal 
production, carbon metabolism, fatty acid biosynthesis, and amino acid 
biosynthesis (Hesketh et al., 2007), and is additionally thought to play a major 
role in development and secondary metabolism. S. coelicolor has two 
homologues of the E. coli RelA/SpoT that synthesise ppGpp (Section 1.2.5.1). 
The first one is called RelA and it synthesises ppGpp when there is a depletion 
of amino acids or glucose. The second homologue of RelA/SpoT is RshA (Sun 
et al., 2001). RshA produces ppGpp when the level of phosphate is reduced 
(Ryu et al., 2007). Both RelA and RshA are similar to E. coli SpoT in that they 
both contain (p)ppGpp hydrolase and synthetase activity. ppGpp synthesis leads 
to the induction of redD and actII-ORF4 transcription and therefore, the 
stimulation of ACT and RED production (van Wezel & McDowall, 2011).  
 
1.1.2 Mycobacterium tuberculosis 
M. tuberculosis was identified by Robert Koch in 1882. He was awarded the 
Nobel Prize in Physiology or Medicine for this discovery in 1905 (Hopwood, 
2007). The tubercle is a slender, straight or slightly curved bacillus. It is non-
motile and non-encapsulated and, unlike S. coelicolor, does not form spores. 
Mycobacteria are obligate aerobes and cannot grow in the absence of oxygen. 
However, M. tuberculosis can survive long periods, months to years, of oxygen 
limitation in their inactive state (Wayne & Sohaskey, 2001). Unlike S. coelicolor, 
M. tuberculosis cannot survive sudden anaerobiosis and it is thought that they 
reduce nitrate by nitrate reductase to provide enough energy to adjust to this 
anaerobic condition (Wayne & Hayes, 1996). 
 
1.1.2.1 The genome  
M. tuberculosisis is a Gram-positive bacterium with a high G+C content of 
65.6%. It has a circular genome of 4,411,529 bp and about 4,000 genes (Cole et 
al., 1998). The genome has 50 genes that encode stable RNA of which 45 are 
transfer RNAs. It has pathways involved in amino acid biosynthesis, vitamins, 
and enzyme co-factors with extensive metabolic pathways for carbohydrates 
26 
 
and lipids. It has more than 100 regulatory proteins of which thirteen are sigma 
factors (Cole et al., 1998). Unlike other bacteria, M. tuberculosis has a large part 
of its genome dedicated to enzymes involved in lipogenesis and lipolysis to 
produce a complex cell envelope that is involved in its pathogenicity. Also, about 
10% of its genome codes for two newly discovered large families of glycine-rich 
proteins (PE and PPE protein families), which might be essential in immunology 
(Cole et al., 1998). Additionally, it encodes proteins involved in responses to 
oxidative-stress, heat shock, carbon starvation and other environmental stresses 
(Rodrigue et al., 2006).  
 
1.1.2.2 Pathogenicity 
Tuberculosis is an airborne disease that continues to claim millions of lives 
around the world. There has been a rise in tuberculosis occurrence in people 
with immunodeficiency virus (HIV) or poor immune response, where it can be 
fatal (Cole et al., 1998). Since M. tuberculosis can mutate into antibiotic-resistant 
strains, developing a cure for this disease is proving to be difficult (Cole et al., 
1998, Mukherjee & Chatterji, 2008). It is essential to try to understand these 
bacteria better so as to help develop new therapeutic interventions to treat and if 
possible to wipe out this disease.  
 
M. tuberculosis is a slow growing bacterium that takes approximately 24 hours 
to reproduce. When it infects a human, the immune response controls the 
infection but does not destroy it. This bacterium then goes into a dormant state, 
rapidly decreasing rRNA and ribosome synthesis (Stallings et al., 2009) and the 
immune system can no longer recognise it. Thus, later in life when the immune 
system is compromised, it can then attack the host and potentially cause death 
(Cole et al., 1998). The tubercle has a complex cell envelope made up of 
peptidoglycan and a further layer rich in lipids (mycolic and mycocerosic acid), 
glycolipids (lipoarabinomannan) and polysaccharides, which might cause the 
inflammatory response by the host and play a role in pathogenesis (Cole et al., 
1998). 
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1.1.2.3 Therapeutics and importance of Rifampicin 
M. tuberculosis has natural resistance to antibiotics, due in part, to the nature of 
the cell envelope, as well as resistance genes (Cole et al., 1998). All these 
factors contribute to the persistency of this bacterium. Therefore, treatment of 
tuberculosis involves a combination of multi-drug therapy including Rifampicin 
(Rif), isoniazid, pyrazinamide, ethambutol and streptomycin (WHO) (Villain-
Guillot et al., 2007). As M. tuberculosis is an intracellular pathogen, the drug 
needs to diffuse into the tissues, the cells and bacteria to exert its effect. Rif has 
this property and is nowadays one of the most effective drugs against 
tuberculosis (Villain-Guillot et al., 2007).  
 
Rifamycins are naturally occurring antibiotics that were first discovered to belong 
to the ansamycin family. Ansamycin was isolated from the strain Amycolatopsis 
mediteranei by Sensi et al., in 1959. It contains an aromatic naphthoquinone 
moiety and a “tail” on C3 and/or C4 position that can be altered (Fig. 1.2) 
(Artsimovitch et al., 2005). Rif is a synthetic derivative of the rifamycins and is 
effective against Gram-positive and some Gram-negative bacteria (Tupin et al., 
2010). It binds to the -subunit of RNAP in the DNA binding pocket deep within 
the DNA/RNA channel. However, it is separated from the Mg2+ in the RNAP 
active site by about 12.1 Å (Campbell et al., 2001). There are 23 residues 
situated around the DNA binding pocket of RNAP that have been shown to 
interact with Rif. The bonds are mainly van der Waal’s forces interacting with the 
napthol ring of Rif and some hydrogen bonding with polar groups of Rif. 
However, only twelve of these residues directly interact with Rif (Campbell et al., 
2001, Villain-Guillot et al., 2007).  
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Figure 1.2: The overall structure of the Rifamycins. 
On the left is the naphthoquinone moiety and on the right are the various tails 
that can be attached on C3 and/or C4 position. The red tails are attached to C3 
(RIF: Rifampicin and RPN: rifapentin) and the blue tails are attached on C3/C4 
(RFB: rifabutin and RMX: rifamexyl). Copyright license No.: 2937590289248 
(Artsimovitch et al., 2005).  
 
The mechanism by which Rif inhibits RNAP is proposed to be by steric 
hindrance. Rif binds to the DNA channel within RNAP and directly blocks the 
path of a 2 to 3 nt long RNA transcript using its napthol ring (Campbell et al., 
2001). However, as Rif activity is altered by different sigma factors, this 
proposed model was reviewed. It was proposed that Rif binds to sigma region 3 
and causes an allosteric signal that dissociates the Mg2+ ion from the active 
centre of RNAP (Artsimovitch et al., 2005), which diminishes the catalytic activity 
of the active site leading to the short unstable RNA/DNA hybrid to dissociate 
from the RNAP (Artsimovitch et al., 2005, Villain-Guillot et al., 2007). Recently, 
the allosteric model for Rif action proposed by Artsimovitch et al., has been 
called into question (Feklistov et al., 2008). Rif does not have any effect on the 
elongating RNAP (Campbell et al., 2001). 
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The sequence homology is not extensive between bacterial RNAP and 
eukaryotic RNAP. This makes Rif a good drug to combat tuberculosis and to be 
used for long periods (Villain-Guillot et al., 2007). However, RNAP can acquire 
mutations, which render the RNAP resistant to Rif. Most of the mutations 
isolated so far in RNAP appear to be around the active site and are present in a 
short 81 nt stretch of the -subunit known as the “rifampicin resistance-
determining region” (Jin & Gross, 1988, Malshetty et al., 2010). These mutants 
can become insensitive to Rif but might decrease their “fitness”. However, if 
these mutants survive they may later obtain other mutations that might restore 
their “fitness” level and allow these mutants to persist leading to Rif resistance 
(Malshetty et al., 2010).  
 
Rif resistance can also be imposed by RNAP binding proteins e.g. DnaA and 
RbpA. In E. coli, DnaA, which is a key initiator of DNA replication, was also 
forund to interact with RNAP at the -subunit and influence Rif resistance. 
Nevertheless, it is not known whether DnaA prevents Rif binding, or whether the 
presence of DnaA stabilises the Mg2+ and keeps RNAP active (Flatten et al., 
2009). RbpA is the subject of this thesis, but the mechanism by which it affects 
Rif resistance in S. coelicolor is not known (Newell et al., 2006). Bacteria can 
also modify Rif making it inactive by phosphorylation, ribosylation and 
glucosylation (Tupin et al., 2010). Therefore, due to the growing problem with Rif 
resistance, it is mostly used selectively in treatments of tuberculosis, meningitis 
and brucellosis. It is also used in a combination therapy with other drugs to 
reduce its resistance (Villain-Guillot et al., 2007). 
 
 
1.2 Bacterial gene regulation 
Transcription is the process of transferring genetic information from DNA to 
RNA. This process of RNA synthesis is catalysed by the enzyme DNA-
dependent RNA polymerase (RNAP) and is the first step in the production of 
protein from DNA (Murakami & Darst, 2003). RNAP activity is controlled by 
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factors that bind to it and exert their effect, either positively or negatively 
(Section 1.2.5-1.2.9). mRNA is then translated to protein, which can then exert 
its function in the cell. 
 
1.2.1 Bacterial DNA-dependent RNA polymerase 
Bacteria have only one form of RNAP, which is a multi-subunit enzyme. The 
core RNAP is composed of five subunits; two alpha subunits (α), one beta 
subunit (β), one beta prime subunit (β’), and an omega (ω) subunit (α2ββ’ω) 
(Young et al., 2002). It has a molecular mass of approximately 400 kDa, and the 
overall structure is well conserved in bacteria, archaea and eukaryotes. 
However, the mechanism for promoter recognition is distinct, as are the factors 
that bind to RNAP to modulate its activity (Zhang et al., 1999). Addition of the 
bacterial sigma factor, , to RNAP forms the RNAP holoenzyme, which is the 
fully functional enzyme that can recognise promoter DNA and initiate 
transcription.  
 
Obtaining pure RNAP crystals for X-ray crystallography proved difficult, 
therefore, the three dimensional structure of E. coli RNAP holoenzyme was first 
determined using electron microscopy (Darst et al., 1989). The first crystal 
structure of the core bacterial RNAP was determined at 3.3 Å resolution by 
Zhang, G., and colleagues and it was that of Thermus aquaticus (Zhang et al., 
1999). It was shown from this structure that RNAP looks like a ‘crab-claw’ with 
one jaw composed mainly of the β subunit and the other of the β’ subunit (Zhang 
et al., 1999, Young et al., 2002). The RNAP molecule is 150 Å long, 115 Å tall 
and 110 Å wide with a channel width of ~27 Å (Zhang et al., 1999).  
 
The subunits dimerise and are situated at the interface of the  and ’ jaws. 
The subunit is composed of two domains: the -N terminal domain (-NTD), 
which is ~26 kDa and is flexibly linked to the-C terminal domain (-CTD) that 
is ~9 kDa. The -NTD forms a dimer and acts as a scaffold for the assembly of 
the  and ’ subunits. The -CTD however, interacts with transcriptional 
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regulator proteins and binds non-specifically with sequences of the promoter 
DNA (Blatter et al., 1994). The subunit interacts extensively with the C-
terminal tail of the ’ subunit and this subunit is thought to have a function in the 
finishing stages of the assembly of the core RNAP (Zhang et al., 1999).  
 
The active site of RNAP is found at the back of the channel where the  and ’ 
subunits form a major contact. It has a chelated Mg2+ ion co-ordinated by three 
Aspartate (Asp - D) residues found in the ’ subunit conserved motif - 
NADFDGD. This active centre is vital for the catalytic activity of RNAP (Zhang et 
al., 1999). 
 
The and ’ subunits are together composed of five mobile modules; β-
upstream lobe, - downstream lobe, the β flap, the ’ jaw and the ’ clamp, 
which all surround the active site of the enzyme (Ghosh et al., 2010). These 
mobile domains allow the binding of the sigma factor and the promoter DNA. In 
transcription initiation, the clamp swings open the channel so DNA can enter the 
active site but during elongation, the clamp closes. This helps in the outstanding 
processivity of transcription (Murakami & Darst, 2003). The base of the ’ 
subunit has a Zn (II) ion that is complexed by four cysteine residues and plays 
an important structural role in the folding of the ’ subunit (Zhang et al., 1999). 
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Figure 1.3: The crystal structure of Thermus thermophilus RNAP 
holoenzyme at 2.6 Å resolution. 
The subunits are coloured:  (white), ’ (tan), ’ non-conserved domain (blue), 
1 (purple), 2 (yellow),  (pink), and  (red). The figure shows two catalytic 
Mg2+ ions as red spheres (active site) and Zn (II) ion as a blue sphere (at the 
base of ’). Copyright license No.: 2942490346046 (Vassylyev et al., 2002). 
 
1.2.2 Sigma factors 
Sigma factors are the sixth subunit of the bacterial RNAP and are essential for 
transcription initiation. The sigma factor recruits RNAP to the promoter DNA, 
and aids in DNA melting and thus, the formation of the open complex (Section 
1.2.4.1). It is also involved in promoter escape and clearance (Section 1.2.4.1). 
Sigma factors are specific to particular promoters and hence, are involved in the 
regulation of gene expression.  
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1.2.2.1 The different groups of the 70-related family  
There are two families of sigma factors; the 70-related family and the 54 family. 
In E. coli, the principal sigma factor is σ70, which is homologous to the vast 
majority of sigma factors and acts as a model for the 70 family (Wilson & 
Dombroski, 1997). Members of the 54 family are structurally and 
mechanistically distinct and activate the transcription of genes that are involved 
in the metabolism of nitrogen, pathogenicity and cytotoxicity (Ghosh et al., 
2010). The 54 family appears to be absent from the Actinobacteria and so these 
are not discussed further here (Sachdeva et al., 2010). 

70-related sigma factors recognise specific sequences on the promoter DNA: 
the -10 element, with a consensus sequence of TATAAT, which is centred at 
position -10 from the transcription start site and the -35 element, with a 
consensus sequence of TTGACA, starts at position -35 from the transcription 
start site. Some promoter regions have an “extended -10 element”, 
TGnTATAAT, that is sufficient to direct transcription without the need for the -35 
element (Barne et al., 1997). rRNA promoters have a “discriminator region”, a 
rich GC region, downstream of the -10 element that affects the strength and 
regulation of the promoter (Haugen et al., 2008). An “UP element”, which is an 
AT-rich region positioned between 60 and 40 bp upstream of the transcriptional 
start point, is bound by the RNAP -CTD and stimulates the activity of the 
promoter (Ross et al., 1993).  
 
There are four groups of σ70-related factors. Group I (primary) sigma factors are 
essential for survival and direct the transcription of the house-keeping genes. 
Most bacteria have only one primary sigma factor, which comprise four main 
domains, σ1.1, σ2, σ3 and σ4, that are flexibly linked. These domains contain 
conserved sub-regions 1.1, 1.2-2.4, 3.0-3.1 and 4.1-4.2, respectively (Section 
1.2.2.2) (Murakami & Darst, 2003).  
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Figure 1.4: Schematic diagram of the 70 principal sigma factor. 
It is showing the four distinct domains: 1.1, 2, 3 and 4 along with its regions 
1.1, 1.2-2.4, 3.0-3.1 and 4.1-4.2, respectively. The diagram also shows the 
domains connected by linkers, 3-4 linker and the NCR between 1.2 and 2.1 
(Adapted from Murakami & Darst, 2003). 
 
Group II sigma factors are similar to those of Group I, although they lack most of 
region 1.1. They are non-essential for bacterial growth and survival 
nevertheless, they normally control the transcription of genes involved in 
universal stress responses and genes expressed during stationary phase (e.g. 
S in E. coli) (Loewen & Hengge-Aronis, 1994). They also recognise the -10 
element, the -35 element and the “extended -10 element”. The only difference is 
that in the “extended -10 promoters”, domain 3 contacts a C nucleotide at 
position -13 (Paget & Helmann, 2003).  
 
The third group of sigma factors, Group III, are more diverse structurally and 
functionally. They lack region 1.1, however they consist of domains 2-4. They 
are involved in controlling clusters of genes involved in heat shock, sporulation 
and flagellar biosynthesis. Their primary promoter elements are different from 
Group I and Group II sigma factors, although they have some conserved 
nucleotides in the -10 element (Paget & Helmann, 2003, Rodrigue et al., 2006).  
 
The largest numbers of sigma factors belong to Group IV and they are also 
known as the Extra-Cytoplasmic Function (ECF) sigma factors (Lonetto et al., 
1994). As the name implies, they respond mainly to extra-cellular signals from 
the environment and might transcribe genes involved in stress responses or cell-
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wall homeostasis. They only have conserved regions 2 and 4 and lack domain 
1.1 and 3. An example of an ECF sigma factor is σR of S. coelicolor that controls 
the thiol-disulphide balance in the hyphae (Paget et al., 2001b, Paget et al., 
2002, Paget & Helmann, 2003). 
 
1.2.2.2 The domains of the principal sigma factors 
1.1 
Region 1.1 has a poorly conserved sequence, but examples tend to retain their 
acidic property (Murakami et al., 2002b). The main function of region 1.1 is to 
auto-inhibit free sigma factor from recognising promoter sequences. However, 
when sigma binds to RNAP this auto-inhibition is lost (Murakami & Darst, 2003). 
Region 1.1 is also thought to enhance the rate of transition from closed complex 
to open complex at some promoters (Wilson & Dombroski, 1997, Murakami et 
al., 2002b). In T. aquaticus A, region 1.1 is buried in the active site of RNAP 
(Murakami et al., 2002a). The acidic region of 1.1 is located N-terminally of the 
-helix and is thought to interact with the walls of the channel and thus possibly 
assist in the widening of the channel to allow DNA entry into the active site. This 
leads to an increase in the rate of open complex formation (Murakami & Darst, 
2003). 
 
2 
The 2.6 Å resolution crystal structure of region 1.2-2.4 was first solved in 
isolation (Malhotra et al., 1996). It showed that this region is composed mainly of 
helices interconnected by loops forming four helix-turn-helix (HtH) motifs: HtH1, 
HtH2, HtH3 and HtH4 (Fig. 1.5) (Vassylyev et al., 2002). The sigma domain 2 
containing conserved regions 1.2, 2.1, 2.2, 2.3 and 2.4 extensively binds to 
every nucleotide between -12 to -6 of the melted -10 element, with most 
interactions occurring in region 2.3 (Feklistov & Darst, 2011). 
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Figure 1.5: A ribbon diagram of the principal sigma factor, 70.  
It is composed mainly of helices connected by turns or loops. 2 is composed of 
four HtH with region 1.2 (purple), non-coserved region (grey), 2.1 (tan), 2.2 
(yellow), 2.3 (orange), 2.4 (red). 3 is composed of region 3.0 (dark red) and 3.1 
(light green), 3-4 linker composed of region 3.2 (dark green), and 4 is 
composed of two HtH with region 4.1 (light blue) and 4.2 (dark blue). Copyright 
license No.: 2942490346046 (Vassylyev et al., 2002).  
 
 
Region 1.2 interacts with residues in the ’ coiled-coil domain of RNAP and is 
thought to aid region 2.3 in forming contacts with the -10 element and so cause 
DNA melting (Fig. 1.5). Region 1.2 also affects the recognition of the -10 
element by region 2.4 (Baldwin & Dombroski, 2001, Zenkin et al., 2007). In 
rRNA and tRNA promoters, region 1.2 contacts the non-template strand at the 
“discriminator” region and this affects the prolonged existence of the open 
complex (Haugen et al., 2008). The “discriminator” region is located two base 
pairs downstream of the -10 element and at this position the nucleotide can be a 
cytosine or a guanine, depending on the extent of regulation. In the E. coli rrn P1 
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promoter, it was observed that if the nucleotide at this position is a cytosine, 
which is common in rRNA promoters, then the interaction of region 1.2 with the 
discriminator element is weak and hence, short-lived open complexes are 
formed with RNAP. Most promoters, however, appear to have a guanine at the 
“discriminator” region forming longer-lived complexes with RNAP. Methionine 
(Met) 102 was the candidate amino acid in sigma region 1.2, which is thought to 
interact with guanine at this position, thereby enhancing the existence of the 
open complex (Haugen et al., 2008). The stability of the open complex can have 
a crucial role on the response of the promoter to the global effector, ppGpp 
(Section 1.2.5.1). 
 
Some residues in region 2.1 are involved in binding to the ’ coiled-coil domain 
of RNAP. Region 2.1 is comprised of two -helices: the C-terminal part of helix 
12a and helix 12b have approximately 45º kink between them (Fig. 1.5). Most of 
the conserved residues in this region are located close to the kink and are 
involved in strong interactions with RNAP (Malhotra et al., 1996). Residues in 
region 2.1 also make up 23% of the interactions between sigma domain 2 and 
the -10 element (Feklistov & Darst, 2011).  
 
Region 2.2 is composed almost entirely of helix 13 (Fig. 1.5) and has most of the 
hydrophobic residues that are involved in the interaction with the clamp-helix 
region of the ’ subunit of RNAP, which is one of the major interactions between 
sigma and RNAP (Campbell et al., 2002, Yang & Lewis, 2010). These residues 
are conserved in 97% of all sigma factors and thus, region 2.2 is the most highly 
conserved region of the sigma factor (Malhotra et al., 1996). Conserved basic 
residues in region 2.2 also interact with the non-template strand of the 
negatively charged DNA (Murakami et al., 2002a). In T. aquaticus A, R237 
forms hydrogen bonds with the O4 atom of T-12 in the -10 element, making T-12 a 
very highly conserved nucleotide of the -10 element (Feklistov & Darst, 2011).  
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There are six conserved aromatic residues in region 2.3 that are thought to be 
crucial for promoter melting leading to open complex formation: two tyrosines 
(Y), two tryptophans (W) and two phenylalanines (F). In E. coli, four aromatic 
residues Y425, Y430, W433 and W434 are solvent exposed and located on 
helix 14 causing promoter melting. The two phenylalanine residues have an 
important function in the formation of the hydrophobic core to ensure appropriate 
folding of the protein (Malhotra et al., 1996).  
 
Region 2.4 has an amphipathic helix with hydrophobic residues contributing to 
the hydrophobic core interaction with RNAP and hydrophilic residues directly 
interacting with bases of the -10 element promoter. In T. aquaticus A, Q260 
contacts A-12 on the template strand only when strand separation is achieved at 
-11 (Feklistov & Darst, 2011). In E. coli, Arg-441 contacts the -13 base of the -10 
element (Malhotra et al., 1996, Murakami & Darst, 2003). 
 
3 
Some promoters have an “extended -10 element”, which is recognised by amino 
acids in region 3 and removes the need for a -35 element (Campbell et al., 
2002). Domain 3 is composed of three helices (Fig. 1.5); the first helix is of 
particular importance as it interacts with DNA sequences upstream from the -10 
element in the “extended -10 promoter” (Murakami & Darst, 2003). In E. coli 
region 3.0, Q485 recognises the extended -10 sequence whilst the H455 non-
specifically binds to the phosphate backbone of the non-template strand 
(Murakami et al., 2002a). This interaction stabilises the open complex formation 
(Murakami & Darst, 2003). 
 
4 
4 is composed of four helices forming two HtH motifs: HtH5 and HtH6 (Fig. 1.5) 
(Vassylyev et al., 2002). It has a concave pocket containing the hydrophobic 
residues of region 4.1 and these residues interact with the -flap of RNAP. This 
interaction is important to help position region 4 in relation to region 2 and 
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hence, allow the simultaneous contact with the -35 and -10 elements, 
respectively (Dove et al., 2003). Region 4.2 recognises and binds to the -35 
element inducing a bend in the DNA which brings the upstream DNA closer to 
RNAP. This kink enhances interaction between the -CTD of RNAP with DNA 
upstream from the -35 element and with activators present upstream of the -35 
element (Murakami & Darst, 2003).  
 
3-4 linker 
Connecting domain 3 and 4 is the 33-residue linker (Fig. 1.5). This linker starts 
at domain 3, runs near the active site of RNAP, through the RNA exit channel 
and connects to domain 4 of the sigma factor. This linker is thought to be 
involved in maintaining the stability of the incoming nucleotide during 
transcription initiation as it is present near the active site of RNAP. Also, it is 
thought to help in sigma dissociation from the core RNAP after transcription 
initiation as it gets displaced by the nascent RNA from the RNA exit channel 
causing weakening of the 4 domain and finally the rest of the sigma factor 
(Section 1.2.4.1- promoter escape and clearance) (Paget & Helmann, 2003).  
 
1.2.3 The sigma factors of Actinobacteria 
 
1.2.3.1 S. coelicolor 
The S. coelicolor genome was found to encode 65 sigma factors, all of which 
belong to the 70 family (Bentley et al., 2002). Prior to this, initial studies found 
that RNAP is heterogenous and exists in numerous forms containing S. 
coelicolor σ49, σ35 and σ28 (Westpheling & Brawner, 1989). An rpoD probe 
derived from ten conserved amino acids in the principal sigma factor from 
Myxococcus xanthus was used to search the S. coelicolor genome for sigma 
factors (Buttner et al., 1990). This probe helped in the identification of four genes 
that encode sigma factors: HrdA, HrdB, HrdC and HrdD (hrd =homologue of rpoD 
gene) (Buttner et al., 1990).  
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Three of these genes, hrdA, hrdC, and hrdD, are non-essential and strains 
comprising deletion mutants of all three genes are viable and are unaffected in 
terms of morphology, differentiation and antibiotic production (Buttner et al., 
1990, Tanaka et al., 1991). However, it proved impossible to delete the hrdB 
gene, which suggested that σHrdB is the principal sigma factor in S. coelicolor 
(Buttner et al., 1990). The complete nucleotide sequence of HrdB was 
determined by Shiina and colleagues (Shiina et al., 1991). HrdB has 511 amino 
acids and a molecular weight (Mw) of 55,902 (StrepDB).  
 
Apart from the principal (HrdB) and principal-like sigma factors (HrdA, HrdC and 
HrdD), S. coelicolor encodes ten sigma factors that are related to the stress 
response sigma factor in Bacillus subtilis, B (Paget & Helmann, 2003). These 
include: B, which has a role in osmoprotection and morphological development 
(Cho et al., 2001) and F, which is involved in spore maturation (Kelemen et al., 
1996). WhiG resembles the flagella-related sigma factors such as FliA 
(Helmann, 1991) and is essential for sporulation (Kelemen et al., 1996). The 
remaining 51 sigma factors belong to the ECF family (Paget et al., 2002), most 
with unknown function. Of those that have been investigated, E is involved in 
maintaining the integrity of the cell envelope (Lonetto et al., 1994), R responds 
to disulphide stress (Paget et al., 1998) and BldN has a role in the formation of 
the aerial mycelium (Bibb et al., 2000). 
 
1.2.3.2 M. tuberculosis 
M. tuberculosis has thirteen sigma factors and all are members of the σ70 family. 
A is the principal sigma factor (Group I) and has all the four conserved regions. 
It is particularly stable and its mRNA has a half-life of more than 40 min (Hu & 
Coates, 1999). It controls the majority of genes and is essential for the viability 
of this bacterium. It also modulates expression of virulence genes, which are 
thought to aid resistance to superoxide and improve intracellular growth 
(Rodrigue et al., 2006) . 
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Another important sigma factor in M. tuberculosis is B, which is the sole Group 
II member. B mRNA has a much shorter half-life of 2.4 min, suggesting that it is 
involved in adaptive responses (Hu & Coates, 1999). The sigB gene is 
positioned at approximately 3 kb downstream from sigA. The sigma domains 2, 
3 and 4 are well conserved between A and B. B is auto-regulated and its 
expression can also be induced by E in response to surface stress and by H in 
response to heat shock or oxidative stress (Sachdeva et al., 2010). Hence, B 
seems to be involved in transcription of genes expressed as a result of stress or 
carbon starvation, and stationary phase survival genes (Rodrigue et al., 2006).  
 
σF belongs to Group III and is induced by cold shock, oxidative stress, depletion 
of nutrients, presence of a number of antibiotics, and during stationary phase. It 
controls genes involved in maintaining the cell envelope and in stationary phase 
(Rodrigue et al., 2006). The remaining ten sigma factors belong to Group IV, 
e.g. H, an orthologue of S. coelicolor R, that is required for survival at elevated 
temperatures and in oxidative conditions (Rodrigue et al., 2006). 
 
1.2.4 Transcription in bacteria 
The transcription cycle is divided into three main stages; initiation, elongation 
and termination (Canals & Coll, 2009). During transcription, core RNAP binds to 
a sigma factor and DNA, undergoes various conformational changes, initiates de 
novo RNA synthesis, loses the sigma factor at some point during the cycle, and 
binds to other regulatory factors to aid in transcription elongation and/or 
termination. 
 
1.2.4.1 Initiation 
Initiation is the first stage of transcription and is a major point at which gene 
expression is regulated. Regulation can be brought about by proteins that bind 
to DNA and either positively or negatively affect transcription together with the 
use of alternative sigma factors that recognise different promoters (Paget et al., 
2002). Core RNAP interacts with a sigma factor to form the holoenzyme that can 
42 
 
recognise the promoter in the double-stranded DNA and binds to it forming a 
closed complex. The RNAP melts the double-stranded DNA, around the 
initiation start site, into single-stranded DNA forming the open complex 
(transcription bubble) (Zhang et al., 1999). De novo RNA synthesis is initiated 
using mononucleotides in the 5’ to 3’ direction (Young et al., 2002). The nascent 
RNA follows the template for ~9 nt and leaves the RNAP via the RNA exit 
channel. RNA synthesis can be abortive until ~12 nt (See below). However, 
when the RNA finally escapes abortive initiation it proceeds into elongation 
(Murakami & Darst, 2003). 
 
Holoenzyme formation 
Core RNAP can bind to DNA non-specifically. However, it requires a sigma 
factor to recognise specific promoter sequences. The different domains of the 
sigma factor, together with the linkers, all interact with the core RNAP. This high 
affinity of sigma to the core RNAP provides stability to the holoenzyme 
(Murakami & Darst, 2003).  
 
Formation of the closed complex 
In the RNAP holoenzyme the DNA binding domains, 2 and 4, are solvent-
exposed and together with the mobile modules of the holoenzyme can aid in 
altering the spacing between the sigma regions to allow them to bind to their 
respective elements on the DNA (Young et al., 2002). The closed complex is 
formed when the RNAP holoenzyme contacts the promoter DNA at the -35 and -
10 elements using region 4.2 and 2.4, respectively (Fig. 1.6A). The DNA lies 
across the outside of one face of the RNAP (Murakami et al., 2002a). The 3-4 
linker sits close to the active centre and passes through the RNA exit channel. 
The 1.1 domain interacts with the RNAP active site channel by electrostatic 
charges (Murakami & Darst, 2003).  
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Figure 1.6: A cross-section view of RNAP during transcription initiation.  
The whole RNAP (grey), -flap (blue), Mg (II) ion (yellow), sigma (orange), 
template strand (dark green), and non-template strand (light green) are shown. 
The negative charges (red) represent the acidic property of region 1.1 and 3-4 
linker. The positive charges (blue) represent the basic regions within the active 
channel and 2. (A) Closed complex formation. (B) Showing initial DNA melting, 
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DNA kinking, and displacement of the domain 1.1. (C) This representation 
shows downstream DNA melting, nucleotide entry (NTP), and de novo RNA 
synthesis (red). (D) Showing RNA elongation after 3-4 linker is displaced. (E) 
Showing 4 losing interaction with RNAP and the -35 element. (F) Sigma 
dissociated off RNAP. Copyright license No.: 2937560968109 (Murakami & 
Darst, 2003). 
 
 
Open complex formation 
Promoter melting commences when the RNAP holoenzyme contacts the double-
stranded DNA and unwinds the DNA from -11 to +3 without requiring any 
external energy. In T. aquaticus A, strand separation starts at -11 when W256 
interacts with A-11 of the -10 element on the non-template strand (Fig. 1.6B) and 
causes the base to flip out and sit in a hydrophobic pocket in domain 2. This 
pocket is composed of Y253, R246, F242 and F248 which all interact with A-11. 
When the DNA is absent, the side chain of R246 is unstable and moves, which 
allows A-11 to flip into the pocket. However, this side chain becomes stabilised 
by E243 and the phosphate of the T-12 when A-11 is in the pocket. A-11 is very 
highly conserved as its pocket can only accommodate an A. This is thought to 
initiate full DNA melting (Feklistov & Darst, 2011).  
 
Residues in region 2.3 contact the non-template strand of the promoter DNA. 
This is followed by the unwinding of the DNA and induces a 90° bend in the 
DNA between -10 and -9 (Fig. 1.6B) (Feklistov & Darst, 2011). In T. aquaticus 
A, T252 is the most conserved residue that interacts with the phosphate of A-9 
and plays a critical role in DNA melting. In addition, T255 interacts with the base 
of A-8. These residues cause the T-7 base to also flip out into a hydrophilic 
pocket that is composed of residues from region 1.2, 2.1 and 2.3. This 
interaction, together with the recognition of the discriminator region, might be a 
final check before DNA melting continues towards the transcription start site 
(Fig. 1.6B) (Feklistov & Darst, 2011). 
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1.1 is then displaced from the active site channel (Fig. 1.6B) and this together 
with the conserved basic residues of region 2.3 and domain 3 direct the melted 
template DNA strand through a tunnel into the active site of RNAP (Fig. 1.6C) 
(Murakami et al., 2002a). The DNA region +5 to +12 is held by the  and ’ 
subunits contributing to the stability of the complex. De novo RNA synthesis 
starts by the incorporation of the incoming nucleotides from the 5’ to 3’ direction 
at the active site of the RNAP (Fig. 1.6C). The nucleotides enter the active site 
through a secondary channel (Fig. 1.6C). A phoshodiester bond is formed 
between the incoming nucleotides, and the nascent RNA starts to elongate 
(Murakami & Darst, 2003). 
 
Abortive initiation 
Abortive initiation is the recurring synthesis of short RNAs and their release from 
the RNAP. Nascent RNA with 5-6 nt can be supported in the channel of RNAP. 
However, when the RNA elongates to 12-14 nt, the nascent RNA encounters the 
3-4 linker in the RNA exit channel and competes with the linker for binding 
(Fig. 1.6C). This leads to an arrest in initiation and destabilises the RNA 
transcript causing the formation of abortive transcripts (Murakami et al., 2002a, 
Kulbachinskiy & Mustaev, 2006). 
 
The mechanism of abortive initiation is thought to occur by “scrunching”, 
whereby single-stranded DNA downstream from the transcription start site is 
pulled into the RNAP 1 bp per phosphodiester bond (Kapanidis et al., 2006). 
The single-stranded DNA is accommodated within the RNAP. When the nascent 
RNA is aborted and released, RNAP pushes out the accumulated DNA restoring 
its initial position ready for another round of transcription initiation (Kapanidis et 
al., 2006).  
 
Promoter escape and clearance 
After numerous rounds of abortive initiation, the 3-4 linker is eventually 
displaced by the ~12 nt long nascent RNA (Fig. 1.6D), which will destabilise the 
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interaction between domain 4 and the -flap (Section 1.2.2.2- 4) (Kulbachinskiy 
& Mustaev, 2006). The first step of sigma dissociation from RNAP involves the 
4 domain losing interaction with RNAP, and consequently the -35 element (Fig. 
1.6E) (Yang & Lewis, 2010). The complex can now enter the elongation phase 
where the rest of the sigma factor is subsequently dissociated from the RNAP 
(Fig. 1.6F). This is the classical model of promoter escape and clearance 
(Murakami & Darst, 2003, Yang & Lewis, 2010). 
 
There is still debate as to whether the sigma factor dissociates immediately after 
promoter escape or whether it is still attached to the RNAP and dissociates 
during elongation (Murakami & Darst, 2003). It is thought that most sigma 
factors are stochastically released from the RNAP early on in transcription 
elongation. However, there is some evidence that a small fraction of sigma 
factors are present in the elongation complex and either get displaced during 
elongation, or remain bound throughout the transcription cycle (Yang & Lewis, 
2010).  
 
1.2.4.2 Elongation 
Transcription elongation occurs directly after RNAP escapes the promoter 
region of the DNA. The nascent RNA is ~12 nt long and starts elongating by 
forming phoshodiester bonds with the incoming nucleotides. To ensure efficient 
transcription elongation, proteins bind to RNAP to control the rate of 
transcription, avoid premature termination, and act in response to intrinsic pause 
signals. These regulatory proteins are known as elongation factors (Belogurov et 
al., 2009).  
 
NusA is an essential elongation factor, which plays a role in anti-termination, 
stalling of RNAP at RNA hairpin regions, termination, and in E. coli, it negatively 
regulates the activity of toxic foreign genes (Davies et al., 2005, Yang et al., 
2009). NusA has an N-terminal domain that interacts with RNAP at the -flap tip 
and a C-terminal domain that is thought to non-specifically bind to RNAP to 
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stabilise the complex. The CTD of NusA is thought to interact with the transcript 
and can therefore exert control over pausing and transcription termination (Yang 
et al., 2009).  
 
NusG and RfaH are elongation factors that increase the rate of transcript 
elongation. NusG is essential and binds to RNAP using its N-terminal domain to 
optimise transcription of most genes in E. coli. RfaH, which is evolutionarily 
related to NusG, is a non-essential elongation factor that binds to specific 
operons containing the ops element and induces the expression of foreign 
genes. The ops element recruits RfaH by displacing the CTD and allowing the 
buried region between NTD and CTD to be exposed so as to interact with 
RNAP. Another major difference between these two proteins is that NusG acts 
by possibly binding to Rho and thus, is involved in Rho-dependent termination, 
whereas RfaH does not act through Rho (Belogurov et al., 2009).  
 
Other elongation factors that maintain the processivity of transcription elongation 
are GreA and GreB. These proteins bind at the tip of the secondary channel of 
RNAP, where the nucleotides enter into the active site channel, using their CTD. 
The N-terminal coiled-coil domain extends into the RNAP active centre where it 
triggers the nucleolytic activity of the RNAP, cleaving a back-tracked RNA 
molecule. Transcription can then resume when the new 3’ end is located at the 
active site, thereby avoiding transcription arrest (Davies et al., 2005). Gre 
proteins are also involved in promoter escape and the restraint of promoter-
proximal pausing (Stepanova et al., 2007, Kusuya et al., 2011). 
 
1.2.4.3 Termination 
Transcription termination can be classified as intrinsic termination or factor-
dependent termination. For intrinsic termination, elongation proceeds until a 
terminator sequence in the nascent RNA, is reached. These sequences are 
generally a short GC-rich hairpin structure followed by a rich sequence of 
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thymine repeats. On encountering these sequences, RNAP dissociates leading 
to termination (Kingsford et al., 2007).  
 
Termination can also be Rho-dependent requiring Rho protein. Rho is an ATP-
dependent helicase or translocase that exists as a homo-hexamer and is found 
in many bacterial species. It facilitates termination by binding to newly 
synthesised RNA at the rut (Rho utilization) site, translocating along the chain 
and when it reaches the transcription elongation complex causes dissociation 
(Canals & Coll, 2009, Kalyani et al., 2011). 
 
1.2.5 Factors that affect RNAP activity 
RNAP is regulated by many effectors that interact directly or indirectly with it, to 
either inhibit or stimulate its activity. As the synthesis of proteins, rRNAs and 
ribosomal proteins utilises energy, these biosynthetic processes are strongly 
regulated to ensure they are carried out only when conditions are suitable 
(Lemke et al., 2011). Hence, under stress conditions, or at a different growth 
phase, factors will affect the activity of RNAP at different promoters to ensure 
expression of appropriate genes, whilst hindering transcription of others. 
 
1.2.5.1 Guanosine 5’-diphosphate 3’-diphosphate (ppGpp) 
ppGpp is an alarmone molecule that controls RNA synthesis in the cell. It is 
produced by RelA and SpoT, with RelA being the major ppGpp synthetase. 
During amino acid starvation, the ratio of uncharged to charged tRNA increases 
and this switches on ppGpp synthesis. SpoT has both ppGpp synthetase and 
hydrolase activities. The activity of SpoT is stimulated by carbon, phosphate, 
iron, and fatty acid starvation and thus, ppGpp responds to nutrient richness. 
During amino acid starvation, the stringent response causes the build up of 
ppGpp in the cell, which will lead to an abrupt shutdown of rRNA synthesis and 
growth arrest (Jin et al., 2011a, Lemke et al., 2011).  
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At rrn promoters, ppGpp seems to have a key role in decreasing the half-life of 
open complexes and shifting the equilibrium towards the closed complex (Jin et 
al., 2011a). ppGpp also regulates the expression of amino acid biosynthesis and 
uptake genes, whereas it down-regulates rRNA genes (Cavanagh et al., 2010). 
In addition, ppGpp is thought to play a role in transcription elongation by 
stimulating RNAP pausing on rrn operons and other non-rrn promoters 
containing high G/C “discriminator” sequences (Haugen et al., 2008, Jin et al., 
2011a).  
 
Gourse and coworkers discovered that ppGpp works co-operatively with DksA to 
control rRNA synthesis (Section 1.2.6.1) (Lemke et al., 2011). ppGpp is, 
however, the main effector in the control of rRNA synthesis. Apart from its direct 
effect on promoters, ppGpp can also act indirectly during the stringent response 
by redistributing RNAP to non-rrn promoters. The number of RNAP in the cell is 
limited for the activation of transcription from all promoters. In rich media, RNAP 
is recruited to rRNA promoters and catalyses rRNA synthesis; therefore, RNAP 
is limited for transcription of non-rrn genes. However, during the stringent 
response rRNA synthesis is shut down, releasing RNAP, which becomes 
available to transcribe non-rrn genes (Jin et al., 2011a).  
 
ppGpp was shown to target RNAP and bind at the substrate entry channel 
adjacent to the active centre of the T. thermophilus RNAP (Artsimovitch et al., 
2004). However, this interaction was shown to be incorrect and the exact 
position of interaction is still under investigation (Vrentas et al., 2008). Therefore, 
further work in identifying the binding sites of ppGpp to RNAP will provide an 
insight as to the mechanism of action of ppGpp in transcription regulation during 
the stringent response. 
  
1.2.5.2 6S RNA 
6S RNA is a small untranslated RNA that controls transcription during early and 
late stationary phase in E. coli (Cavanagh et al., 2008). It is a double stranded 
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RNA that has a large bulge in the centre, resembling the DNA in the open 
complex conformation and as a result, it can be used as a template for RNAP 
(Wassarman & Saecker, 2006). The 6S RNA level builds up during late 
stationary phase and interacts with RNAP-70 holoenzyme at the active site 
channel (Wassarman & Storz, 2000, Wassarman & Saecker, 2006).  
 
Through late stationary phase, the 6S RNA binds to most of the 70-RNAP and 
inhibits RNAP-70-dependent transcription (Trotochaud & Wassarman, 2004). 
This RNAP-70/6S RNA complex sequesters 70 and decreases 70-dependent 
transcription, possibly allowing other alternative sigma factors to bind to RNAP 
and exert their effect. However, when nutrients are encountered, 6S RNA serves 
as a template and the increase in NTP will direct transcription from the bound 6S 
RNA and lead to the release of 70, which can bind to RNAP and direct70-
dependent transcription (Wassarman & Saecker, 2006). This is the direct effect 
of 6S RNA. 
 
The main contact point of 6S RNA with RNAP-70 complex is with the 70 region 
4.2 (Klocko & Wassarman, 2009). Therefore, 6S RNA competes with promoter 
DNA for binding to region 4.2 of 70. The sensitivity of promoters to 6S RNA 
relies on the strength of the -35 element and the presence of the “extended -10 
element” (Cavanagh et al., 2008). A weak -35 element together with the 
presence of an “extended -10 element” increases the inhibition effect of 6S RNA 
towards the RNAP-70-dependent transcription (Cavanagh et al., 2008). 
 
The 6S RNA also has an indirect effect on transcription regulation. During early 
stationary phase 6S RNA enhances the transcription of relA, which will increase 
the level of ppGpp and thus, the expression of amino acid biosynthesis genes 
and the shutdown of rRNA genes. Nonetheless, ppGpp is not involved in 6S 
RNA regulation of transcription during late stationary phase (Cavanagh et al., 
2010).  
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1.2.6 RNAP binding proteins 
Apart from sigma factors that interact with RNAP and aid the initiation of 
transcription, other proteins have been discovered that affect the different stages 
of the transcription cycle. As mentioned in Section 1.2.4.2, NusA and NusG 
proteins interact with RNAP and aid transcription elongation. Additionally, the 
Gre factors, GreA and GreB, are other elongation factors that directly interact 
with RNAP and aid in the processivity of transcription (Section 1.2.4.2). Another 
protein in E. coli RapA, which is an ATPase, binds to core RNAP and promotes 
its recycling and this leads to transcription activation (Jin et al., 2011b). An 
example of a phage-encoded inhibitor of RNAP is T4 AsiA. AsiA has been 
shown to interact with E. coli RNAP holoenzyme at the -flap and 70 region 4.2 
thereby inhibiting transcription initation (Yuan et al., 2009). Other examples of 
RNAP binding proteins, DksA and CarD, are discussed below (Section 1.2.6.1 
and 1.2.6.2).  
 
Some antibiotics have also been isolated that interact with RNAP and inhibit its 
function. A key example is Rif that interacts with RNAP and inhibits transcription 
initiation (Section 1.1.2.3). Other examples of antibiotics that interact with RNAP 
are: Myxopyronin, which prevents RNAP from interacting with the promoter DNA 
(Mukhopadhyay et al., 2008), Microcin J25 that prevents NTP uptake as it binds 
to the secondary channel of RNAP (Mukhopadhyay et al., 2004) and 
Streptolydigin, which binds to the bridge helix of RNAP and affect RNAP 
function (Tuske et al., 2005).   
 
1.2.6.1 DksA 
In E. coli, DksA is a transcription factor that binds to RNAP. It belongs to a set of 
regulators that interact at the secondary channel of RNAP. It is mainly helical 
and is composed of two domains; a coiled-coil domain that extends into the 
secondary channel close to the active site where it can exert its regulation, and 
a globular domain that lies outside the channel (Perederina et al., 2004, Furman 
et al., 2011). DksA contains a Zn finger motif with the Zn (II) ion being chelated 
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by two cysteines in the globular domain and two cysteines in the coiled-coil 
domain. This Zn is essential for the functional role of DksA (Paul et al., 2004, 
Blaby-Haas et al., 2011). It is a stable protein with a half-life of 44 min 
(Chandrangsu et al., 2011).  
 
DksA co-operates with ppGpp and the initiating nucleotide (iNTP) to regulate 
gene expression during stress and nutrient starvation (Lee et al., 2012). It is 
autoregulated and its level is kept relatively constant throughout growth via a 
negative feedback loop. Hence, when the level of DksA rises slightly, ppGpp 
and DksA inhibit transcription at the dksA promoter (Chandrangsu et al., 2011).  
 
One of the roles of DksA is to inhibit open complex formation by binding to 
closed complexes at rrn promoters and thus, decreasing rRNA synthesis 
(Rutherford et al., 2009). It was shown that one of the two conserved aspartate 
residues located near the tip of the coiled-coil domain, D74, is involved in 
exerting the role of DksA on transcription initiation (Lee et al., 2012). As DksA 
works with ppGpp, it can either repress transcription initiation from rrn 
promoters, or activate amino acid biosynthesis, or possibly exert no effect on 
some promoters (Paul et al., 2005). ppGpp, together with DksA, have also been 
shown to reduce the stability of promoter-RNAP complexes. This seems to be 
dependent on the promoter sequence (Haugen et al., 2006, Chandrangsu et al., 
2011).  
 
Another role of DksA, that is independent of ppGpp, is its role in DNA 
replication. DNA replication is halted when the replication fork collapses due to 
encountering a paused elongation RNAP complex. Thus, during nutrient stress, 
many stalled elongation RNAP complexes are formed. DksA has been shown to 
be important in ensuring efficient DNA replication by either preventing RNAP 
pausing or destabilising the elongation RNAP complex off the DNA to allow 
elongation of the replication fork (Tehranchi et al., 2010). The exact molecular 
mechanism is still unknown. 
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1.2.6.2 CarD 
Mycobacteria lack DksA, however, they undergo the stringent response using 
ppGpp. It was then discovered that CarD, a novel RNAP binding protein, 
regulates transcription from rRNA promoters (Stallings et al., 2009). Unlike 
DksA, CarD is essential to maintain the viability of Mycobacteria including M. 
tuberculosis and M. smegmatis. It has important implications in the DNA 
damage response and regulating the stringent response (Stallings et al., 2009).  
 
CarD is composed of two regions: the N-terminal motif, which is similar to the 
RNAP interacting domain (RID) of transcription repair coupling factor (TRCF), 
binds to the N-terminus of the -subunit of RNAP and the C-terminal region, 
which consists of a conserved leucine zipper motif and so far has an unidentified 
role (Stallings & Glickman, 2011). Nonetheless, it has been shown that CarD C-
terminal region is vital for the survival of mycobacteria (Stallings & Glickman, 
2011).  
 
CarD is required to repress rRNA synthesis from the one or two rRNA promoters 
found in mycobacteria, and also inhibit the formation of ribosomal proteins 
(Stallings & Glickman, 2011). As CarD and DksA bind at different regions of 
RNAP, their mechanism of action is different. CarD was shown to be essential 
for the pathogenesis and persistence of M. tuberculosis. Therefore, a possible 
anti-tuberculosis drug that aims to bind to CarD and disrupt its interaction with 
RNAP may be an approach for the treatment of tuberculosis (Stallings et al., 
2009). The exact mechanism of action of CarD has not yet been determined. 
 
1.2.7 Anti-sigma factors 
Transcriptional regulation is further controlled by proteins that bind to sigma 
factors and alter their effect. Proteins that bind to sigma factors can have a 
negative or a positive effect on transcription. Proteins that exert a negative effect 
are known as anti-sigma factors (Campbell et al., 2008). An example of an ECF 
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anti-sigmafactor that specifically interacts with sigma is FlgM which targets 28 
in Salmonella typhimurium.  
 
28 is activated during flagellar assembly and activates late gene expression e.g. 
flagellin and motility genes (Hughes et al., 1993). FlgM appears to sense the 
integrity of the flagellar assembly and if the flagellum is well assembled, FlgM is 
exported out of the cell by the flagellar-specific export apparatus, whereas, if 
there is a defect in the flagellar assembly, FlgM interacts with 28 and inactivates 
it, serving as an anti-sigma factor (Hughes et al., 1993). FlgM-28 complex has a 
stoichiometry of 1:1 and FlgM makes multiple contacts with region 2.1, 3.1 and 4 
(Chadsey & Hughes, 2001). FlgM was shown to interact with free 28 and 
prevent the formation of the holoenzyme (RNAP-28) (Ohnishi et al., 1992). It 
was also shown to increase the rate of dissociation of RNAP-28 leading to 
holoenzyme destabilisation (Chadsey et al., 1998). Other examples of anti- 
factors, Rsd, RsrA and Gin, are explained in detail below (Section 1.2.7.1-
1.2.7.3).  
 
1.2.7.1 Rsd 
Rsd is an anti-sigma factor of the E. coli principal sigma factor 70 and is 
produced when the cells enter stationary phase (Jishage & Ishihama, 1998). 
Rsd was shown to interact with region 4 of 70 (Fig. 1.7) (Patikoglou et al., 2007) 
and region 2 (Yuan et al., 2008) inhibiting 70-dependent transcription. The 
exact mechanism of action of Rsd is yet to be defined. Rsd is thought to interact 
with 70 forming Rsd-70 complex preventing 70 association with core RNAP 
(Jishage & Ishihama, 1999). It also appears to inhibit transcription from 
promoters with/without an “extended -10 element” and causes the dissociation 
of 70 from RNAP holoenzyme (Ilag et al., 2004, Yuan et al., 2008, Campbell et 
al., 2008). It was also shown to be involved in sigma competition favouring 70 
switching to S (Jishage & Ishihama, 1999, Hofmann et al., 2011), i.e during 
stationary phase Rsd sequesters 70 allowing S to bind to core RNAP. Rsd has 
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also been shown to stimulate the expression of some S-dependent genes 
(Mitchell et al., 2007, Hofmann et al., 2011). 
 
 
Figure 1.7: Structure of 70 region 4 in complex with anti- factor, Rsd. 
The green light ribbon represents Rsd and the thick yellow and orange ribbons 
represent the 70(4). Copyright license No.: 2942540160750 (Campbell et al., 
2008).  
 
1.2.7.2 RsrA 
RsrA, Regulator of SigR, is an anti-ECF σ factor that binds to R and inhibits R-
dependent transcription in S. coelicolor. During oxidative stress, the cytoplasmic 
thiol-disulphide balance becomes more oxidising and this leads to the activation 
of σR and increased expression of sigR. σR binds to RNAP and stimulates the 
transcription of the thioredoxin (trxBA) operon (Paget et al., 1998, Paget et al., 
2001a). Thioredoxin reduces the disulphide bonds in oxidised proteins, thereby 
restoring normal thiol levels, which ultimately switches off expression of the 
trxBA operon as well as sigR itself. 
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RsrA was the first reported member of a large family of anti-sigma factors, all of 
which are likely to require bound Zn for structure and function - the ZAS (Zn 
binding anti-sigma factor) family (Paget et al., 2001a). Whereas many members 
of the ZAS family are large proteins, often with transmembrane domains, RsrA is 
only 105 amino acids and has a Mw of 11,680. Unlike RsrA, most anti-ECF  
factors are usually membrane-bound (Staroń et al., 2009). RsrA is encoded by 
the rsrA gene, which is located directly downstream from sigR (Kang et al., 
1999). 
 
The Zn (II) ion is co-ordinated by three cysteine residues, from the overall seven 
cysteines present in RsrA, together with a histidine residue. The three 
conserved residues from the ZAS-specific sequence motif (H37xxxC41xxC44) 
together with C11 co-ordinate the Zn (II) ion (Li et al., 2003, Zdanowski et al., 
2006). RsrA forms up to three intra-molecular disulphide bonds when it is 
oxidised in vitro and this causes a conformational change in its structure and 
release of the Zn (II) ion. However, it is likely that a single disulphide bond 
between C11 and C44 is initially formed and that this represents the key redox 
switch (Li et al., 2003, Zdanowski et al., 2006). 
 
During oxidative stress in vivo, RsrA oxidation allows σR to dissociate and bind 
to RNAP allowing it to activate transcription of σR-dependent genes (over 50 
genes), many of which are involved in thiol-disulphide metabolism and the HspR 
heat-shock regulon, Clp and Lon ATP-dependent AAA(+) proteases (Kallifidas 
et al., 2010). One of the target genes encodes thioredoxin, from the txrBA 
operon, that reduces the oxidised RsrA. RsrA in its reduced state can now bind 
σR inhibiting σR-dependent transcription. This homeostatic system thereby 
restores the normal balance of reduced thiols in the cytoplasm (Paget et al., 
2001a).  
 
RsrA was shown to interact mainly with region 2.1-2.4 of R in a 1:1 
stoichiometry. The mechanism of inhibition of R activity by RsrA is by blocking 
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R from associating with core RNAP as it binds to region 2.1 and 2.2, which 
make major interactions with core RNAP and also prevents DNA melting and the 
-10 element recognition as it binds to region 2.3 and 2.4 (Li et al., 2002). 
 
1.2.7.3 Gin 
In Bacillus subtilis, sporulation is regulated by four sigma factors (F, G, E and 
K) that stimulate specific sets of genes at precise times throughout 
morphological differentiation (Hilbert & Piggot, 2004). During sporulation, the 
axial filament is formed leading to asymmetric division, whereby the cell division 
apparatus is relocalised to the polar site and consequently, the formation of the 
sporulation division septum. DNA is transferred from the mother cell to the 
forespore, followed by complete engulfment of the forespore, the deposition of 
cortex and protective layer of proteins around the forespore known as the coat. 
The forespore then matures followed by mother cell lysis releasing the forespore 
into the environment (Hilbert & Piggot, 2004). 
 
After the asymmetric septum is formed, F is activated in the forespore and this 
eventually leads to E activation in the mother cell. G and K are later 
expressed by F and E, respectively. F controls the initial development of the 
forespore whilst G regulates genes involved in sporulation, germination, and in 
protecting the spore from DNA damage (Hilbert & Piggot, 2004, Serrano et al., 
2011). 
 
There are three regulators of G; LonA protease, anti-sigma factor SpoIIAB, 
which controls both G and F activity, and Gin. Gin, also called CsfB, a product 
of the csfB gene, has been identified as the main anti-sigma factor for G. It 
specifically binds to G and is present early in the forespore compartment. G 
expression is stimulated in the forespore towards the end of engulfment and it is 
thought that Gin inhibits its activity until after the complete forespore engulfment 
when G becomes active (Serrano et al., 2011).  
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Gin is a small protein and, together with its orthologues, has 44 to 74 amino 
acids. It contains six conserved residues; four cysteines (C11, C14, C30, C33), 
a glycine (G21) and a tyrosine (Y47) (Rhayat et al., 2009). Gin is thought to exist 
as a dimer and to co-ordinate a Zn (II) ion. C11 and C14 on one polypeptide 
chain are thought to co-ordinate Zn with C30 and C33 on another polypeptide 
chain (Rhayat et al., 2009).  
 
Mutation of five conserved residues of Gin: C11, C14, C30, C33 and Y47 
restored G activity. However, C14, C33 and Y47 mutants cannot interact with 
G showing that these residues are important for Ginteraction. A mutation in 
region 2.2 of G substituting asparagine 45 to glutamic acid (N45E) inhibited 
binding of Gin to G and therefore, increased the activity of G. It was also 
observed that substitution of this single amino acid in F, E39 to N, allowed the 
binding of Gin to F. Hence, Gin loses its specificity by replacement of this single 
amino acid (Serrano et al., 2011). 
 
1.2.8 Proteins that bind to anti-sigma factors 
Anti-sigma factors are regulated by proteins that bind to them and either inhibit 
their activity (known as anti-anti-sigma factors) or collaborate with the anti-sigma 
factors (known as co-anti-sigma factors). Another way in which anti-sigma 
factors are regulated is through proteolysis (Campbell et al., 2008).  
 
RsfA is an anti-sigma factor that interacts with F in S. coelicolor. As mentioned 
earlier, F is a Group III sigma factor that is involved in later stages of 
sporulation. It has been shown that there are two anti-anti-sigma factors, 
SCO0781 and SCO0869, which interact with RsfA (Kim et al., 2008). SCO0869 
has a serine residue in its HATPase_c domain, which is phosphorylated by RsfA 
whilst SCO0781 lacks the serine residue. The exact mechanism of action is still 
under investigation (Kim et al., 2008). 
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RseB is a co-anti-sigma factor of E in E. coli. E is involved in the cell-envelope 
response and is held inactive by RseA, the anti-sigma factor. RseB is a 
homodimer that is embedded in the periplasm and it secures the interaction of 
E/RseA complex. It also inhibits RseA degration by DegS and RseP (Wollmann 
& Zeth, 2007). Misfolded outer membrane proteins in the periplasm are thought 
to cause the release of RseB interaction with RseA and lead to RseA cleavage 
and hence E is released (Campbell et al., 2008, Kulp & Kuehn, 2011). The 
precise mechanism by which E is released and the role RseB plays is still to be 
determined (Campbell et al., 2008).  
 
Figure 1.8: Structure of E/RseA complex. 
E region 2 (green), E linker (orange), E region 4 (yellow), regions that interact 
with RNAP (grey) are shown. RseB homodimer (blue) is found in the periplasm 
and binds to two separate RseA (red) to form a heterotetramer, 2RseB:2RseA. 
Only the cytoplasmic domain of RseA is shown. Copyright license No.: 
2942540160750 (Campbell et al., 2008).  
 
 
1.2.9 Positive regulators of sigma factors 
Most proteins that bind sigma factors have been shown to be negative 
regulators of transcription - anti-sigma factors. However, one protein, Crl, has 
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been shown to bind to sigma and positively regulate its activity (Section 1.2.9.1). 
The main subject of this project, RbpA, has also been shown to bind to the 
principal sigma factor and activate transcription of its genes in S. coelicolor (P. 
Doughty and M. Paget, personal communication; Section 1.2.9.2).  
 
1.2.9.1 Crl 
Crl is a small global regulatory protein found in E. coli and Salmonella that has 
been shown to bind to the stationary phase sigma factor, s, with a stoichiometry 
of 1:1. s is encoded by rpoS and its transcription increases during exponential 
growth under particular stress conditions: low temperature, pH and high 
osmolarity (England et al., 2008). s associates with core RNAP and activates 
the transcription of over 300 genes some of which are responsible for the 
regulation of stationary phase-specific genes and stress response factors, 
formation of biofilm and stimulating the virulence of S. enterica serovar 
Typhimurium (Bang et al., 2005, Weber et al., 2005, Monteil et al., 2010b). In E. 
coli, s has the lowest affinity for core RNAP in vitro and has to compete with the 
six other sigma factors. This association is facilitated by Crl, which directly binds 
to s and not to DNA (England et al., 2008).  
 
Crl appears to play a major role in sigma competition by increasing the affinity of 
s for core RNAP seven-fold, leading to the formation of the holoenzyme, RNAP-
s (Gaal et al., 2006, Typas et al., 2007, England et al., 2008). Crl was also 
shown to stimulate to a lesser extent RNAP-70 transcription (Gaal et al., 2006). 
In addition, it was shown to affect the rate of open complex formation, which 
leads to activation of s-dependent genes ( Monteil et al., 2010a, Monteil et al., 
2010b). Monteil et al., determined, using a bacterial adenylate cyclase two-
hybrid system that the Crl binds to domain 2 of s. They also showed that four 
conserved residues of Crl, Y22, F53, W56 and W82, are important for 
maintaining the activity of Crl (Monteil et al., 2010b). 
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S. Typhi Ty19 contains a naturally occurring mutant allele of rpoS, that encodes 
the sTy19 protein that is present in low amounts and has a very weak affinity for 
core RNAP compared to wild-type s. Monteil, V et al., also showed that Crl 
increases the activity of thissTy19 to wild-type levels. The mutation in rpoSTy19 is 
the substitution of glycine 282 to valine (G282V) and this is found in region 4 of 
sTy19. Therefore, it was suggested that the interaction of Crl with region 2 of 
sTy19 would lead to a conformational change causing
s
Ty19 to bind to core 
RNAP forming the holenzyme, RNAP-sTy19 , and activating 
s-dependent genes 
(Monteil et al., 2010b).  
 
1.2.9.2 RbpA 
RbpA is a newly discovered RNAP-binding protein that was identified when it co-
eluted with RNAP during gel filtration (Paget et al., 2001b). Interest in rbpA was 
increased when it was discovered that σR induces its expression in response to 
oxidative stress, suggesting that it might be involved in the oxidative stress 
response (Section 1.2.7.2) (Paget et al., 2001b). Further studies, however, 
suggested that RbpA plays a more general role in transcription.  
 
rbpA mutants displayed a slow-growth phenotype, with a two-fold longer 
doubling time, although they appeared to be unaffected in morphological 
differentiation (Newell et al., 2006). These mutants also showed more sensitivity 
to rifampicin, an antibiotic that inhibits transcription initiation by binding to a 
pocket in the β subunit of RNAP located deep within the DNA/RNA channel. 
Furthermore, mutants produced in excess, the blue pigmented antibiotic 
actinorhodin (Newell et al., 2006). RbpA was also shown to be a metalloprotein, 
co-ordinating a Zn (II) ion (P. Doughty, and M. Paget, personal communication). 
 
Unpublished in vitro studies suggest that RbpA is a positive effector of 
transcription and stimulates σHrdB-dependent transcription from rRNA promoters 
and all σHrdB-dependent promoters tested so far. Thus, it appears to be a 
general regulator of σHrdB-dependent transcription (P. Doughty and M. Paget, 
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unpublished observation). The slow growth rate of rbpA mutants might therefore 
be due to the reduced rate of rRNA synthesis (Newell et al., 2006). RbpA 
appears to be involved in stimulating transcription initiation as it activates single-
round transcription assays (P. Doughty, and M. Paget, personal 
communication). Preliminary work using potassium permanganate (KMnO4) 
assays have shown that RbpA stimulates promoter melting, suggesting a 
possible role of RbpA in open complex formation assays (P. Doughty, and M. 
Paget, personal communication).  Although RbpA was found to co-elute with S. 
coelicolor RNAP, more recently it has been found that RbpA also interacts 
directly with σHrdB to form a complex independent of RNAP core assays (P. 
Doughty, and M. Paget, personal communication) (Section 4.1.1).  
 
1.3 Project aims 
This project focuses on understanding the structural and functional role of RbpA, 
a RNAP binding protein that is present only in the Actinobacteria including the 
pathogenic bacterium M. tuberculosis. As mentioned in Section 1.2.9.2, RbpA 
was shown to be essential for the normal growth of S. coelicolor (Newell et al., 
2006). It appeared to stimulate promoter melting (P. Doughty and M. Paget, 
personal communication) suggesting a possible role of RbpA in open complex 
formation or an earlier role in transcription initiation. RbpA was also suggested 
to bind to HrdB, the principal sigma factor of S. coelicolor, and activate HrdB-
dependent prmoters (P. Doughty and M. Paget, personal communication). The 
aims of this thesis are outlined below: 
 
1) To investigate the biological function of RbpA through the analysis of an 
∆rbpA strain. 
2) To determine whether RbpA is involved in holoenzyme formation. 
3) To test whether RbpA binds specifically to HrdB or with a variety of sigma 
factors from groups II, III and IV.  
4) To identify the region of HrdB to which RbpA binds and vice versa. 
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5) To identify key residues that might be involved in the functional role of 
RbpA. 
6) To obtain the structure of RbpA and its M. tuberculosis orthologue, 
Rv2050. 
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2- Materials and Methods 
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2.1 Chemicals and reagents 
 Acrylamide solutions (Severn Biotech Ltd) 
 Agarose powder (Melford Laboratory) 
 Ammonium persulphate (Sigma) 
 Ampicillin (Melford) 
 Antifoam (Sigma) 
 Apramycin (Duchefa Biochemie) 
 Bicinchoninic acid (BCA) Solution (Sigma)  
 Bradford Reagent (Sigma) 
 Bromophenol blue (Amersham Biosciences) 
 Casamino acids (Difco) 
 Chloramphenicol (Melford) 
 Chloroform (Fisher) 
 Deoxyribonucleotide phosphates- dNTPs (New England Biolabs) 
 Dimethylsulphoxide (DMSO) (BDH) 
 Dithiothreitol (DTT) (Melford) 
 Isopropyl-β-D-thiogalactopyranoside (IPTG) (Melford) 
 Kanamycin (Melford) 
 Malt extract (Oxoid) 
 Nalidixic acid (Duchefa Biochemie) 
 N, N-dimethyl-formamide (Fisher) 
 Nutrient agar (Difco) 
 N-Tris(hydroxymethyl)methyl-2-aminoethane sulfonic acid (TES) (Fisher) 
 Phenol (Fisher Scientific) 
 Phenylmethylsulfonyl Fluoride (PMSF) (Sigma) 
 Radiochemicals: [32P] UTP 10 ci/l, specific activity 800 G/mmol, 0.625 
M 
 Sigmacote® (Sigma) 
 Sodium dodecyl sulphate (SDS) (Fisher) 
 Spectinomycin (Duchefa Biochemie) 
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 Ultra Pure Sequagel® Urea Gel™ Complete (national diagnostics) 
 Ultra Pure Sequagel® Urea Gel™-6 (national diagnostics) 
 Tetramethyl-ethylenediamine (TEMED) (Fisher) 
 N-Tris(hydroxymethyl)methyl-2-aminoethanesulfonic acid (TES) (Fisher 
Scientific) 
 Trichloroacetic acid (TCA) (Sigma) 
 2-Amino-2-hydroxymethyl-propane-1,3-diol (Tris) (Fisher Scientific) 
 Tryptone (Difco) 
 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside (X-gal) (Melford 
Laboratories Ltd) 
 Yeast extract (Oxoid) 
 
2.1.1 Enzymes  
 
2.1.1.1 Polymerases 
 Accuzyme (Bioline) 
 Kod™ (Merck Bioscience) 
 Phusion™ (New England Biolabs) 
 Taq DNA polymerase (New England Biolabs) 
 
2.1.1.2 DNA modifying enzymes 
 Shrimp alkaline phosphatase (Promega) 
 T4 DNA Ligase (New England Biolabs) 
 
2.1.1.3 DNA/RNA restriction enzymes 
 Restriction endonucleases (New England Biolabs) 
 RQ RNAse-fee DNAse (Promega) 
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2.1.2 Plasmids and expression vectors 
Plasmids and expression vectors used in this project are shown in Table 1. 
 
Table 1: List of plasmids and expression vectors used in this project. 
Plasmids Description Reference 
pBlueScript II SK (+) E. coli cloning vector, ori f1, 
bla, AmpR, ori Co1E1, lacZ 
(blue/white selection) 
Stratagene (Alting-Mees & 
Short, 1989) 
pBlueScript II SK (+)::rbpA pBlueScript II SK (+) 
including rbpA gene cloned 
at EcoRI site in the multiple 
cloning site (MCS) 
(P. Doughty and M. Paget, 
unpublished) 
pBlueScript II SK 
(+)::hrdB(1.1-2), hrdB(2), 
hrdB(3-4), hrdB(2-4), hrdB(4) 
pBlueScript II SK (+) 
including hrdB regions: 
domains 1.1-2, domain 2, 
domain 3-4, domain 2-4 and 
domain 4  
(P. Doughty and M. Paget, 
unpublished) 
pET15b E. coli expression vector, N-
terminal His-tag® sequence, 
AmpR 
(Novagen limited) 
pET20b E. coli expression vector, C-
terminal His-tag® sequence, 
AmpR 
(Novagen limited) 
pMT3000 E. coli cloning vector, 
pIJ2925 with modified MCS, 
bla, AmpR, lacZ (blue/white 
selection) 
(Paget et al., 1994) 
pMT3000::rbpA pMT3000 including rbpA 
gene with its promoter 
region (735bp) flanked by 
EcoRI & KpnI 
(Newell., 2006) 
pIJ6902 PtipA, attPøC31, aac(3)IV 
(apramycin-resistance 
gene), tsr (thiostrepton-
resistance gene), oriT 
(derived from RK2 for 
Streptomyces) 
(Huang et al., 2005) 
pSETΩ Shuttle plasmid, 
bifunctional: replicates in E. 
coli and integrates in S. 
coelicolor, derived from 
pSET152; aac(3)IV -, aadA+, 
(O'Connor et al., 2002) 
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attPøC31, oriTRK2, 
 
pUT18 
Derived from pUC19, AmpR, 
T18 fragment (225-399 aa) 
of CyaA under control of a 
lac promoter, MCS inserted 
at the 5’ end of  T18 
(Karimova et al., 1998) 
pKT25 Derived from pSU40, KanR, 
T25 fragment (1-224 aa) of 
CyaA, under control of a lac 
promoter, MCS inserted at 
the 3' end of T25  
(Karimova et al., 1998) 
 
2.1.3 S. coelicolor and E. coli strains 
 
2.1.3.1 E.coli  
JM109 and DH5 strains were used for routine laboratory cloning and are 
suitable for blue/white screening (Table 2). BL21 (λDE3) (pLysS) strain was 
used for protein over-expression experiments (Table 2). ET12567 containing 
pUZ8002 (ETZ) is a non-methylating E. coli strain (Table 2). It has three 
mutations on three DNA methyl transferase genes (dam-, dcm-, hsdM-) hence, 
defective in methylation (MacNeil et al., 1992). ETZ produces unmethylated 
plasmid or cosmid DNA therefore, efficient in conjugation (Paget et al., 1999). 
BTH101 is an E. coli reporter strain that is deficient in adenylate cyclase (cya) 
(Table 2). It was used for the bacterial adenylate cyclase two-hybrid system 
(BACTH) to detect protein-protein interactions (Karimova et al., 1998). 
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Table 2: A list of E. coli strains used in this study 
E. coli Strain Description Reference 
JM109 F’, traD36, proA+B+, laclq, 
∆(lacZ)M15/ ∆(lac-proAB), 
glnV44 e14-, gyrA96, recA1, 
relA1, endA1, thi, hsdR17 
(Yanisch-Perron et al., 
1985) 
DH5TM 
 
F-, ø80dlacZ∆M15, endA1, 
recA1, hsdR17 (rk
-,mk
+), 
supE44, thi-1, gyrA96, 
relA1, ∆(lacZYA-argF)U169, 
- 
Invitrogen Limited 
BL21 (DE3/pLysS) F
-, ompT, hsdSB (rB
- mB
-), 
dcm, gal, (DE3) has 
chromosomal copy of T7 
RNAP gene under control of 
lacUV5, pLysS is a plasmid 
which carries gene encoding 
T7 lysozyme, Cm
r 
(Studier & Moffatt, 1986) 
 
ET12567/pUZ8002 dam-13::Tn9, dcm-6, hsdM, 
Cmr, pUZ is a derivative of 
RK2 with a mutation in the 
oriT (aph) 
(MacNeil et al., 1992, 
Paget et al., 1999) 
BTH101  F-, cya-99, araD139, galE15, 
galK16, rpsL1 (Str r), hsdR2, 
mcrA1, mcrB1 
(Karimova et al., 1998) 
 
2.1.3.2 S. coelicolor  
A list of the S. coelicolor A3 (2) strains used is shown in Table 3. M145 is 
plasmid free and is a prototrophic derivative of the wild-type strain A3 (2). J1981 
was created from M145 and used as wild-type models through this study. 
 
Table 3: List of S. coelicolor strains used in this study 
S. coelicolor strains Description Reference 
M145 SCP1- SCP2- (Hopwood et al., 1985) 
J1981 M145 ∆rpoC::rpoCHIS (Babcock et al., 1997) 
S129 J1981 (ΔrbpA::aac(3)IV) (Newell et al., 2006) 
J1915 M145 ∆glkA SCP1- SCP2- (Kelemen et al., 1995) 
S101 J1915 (∆rbpA::aac(3)IV) (Newell., 2006) 
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2.1.4 Growth media and selection 
 
2.1.4.1 E.coli growth media  
Lennox broth (LB) 
This is a liquid media used for general growth of E. coli strains. Per litre: 10 g 
Difco Bacto-tryptone, 5 g Difco yeast extract, 5 g NaCl and 1 g glucose. 50 ml 
aliquots in universal bottles were sterilised by autoclaving. LB media was 
prepared with no glucose for BACTH assays. 
 
Lennox agar (LA) 
This was prepared as LB, but with the addition of 1.5 g of agar per 100 ml in 250 
ml Erlenmeyer flasks. The flask was stoppered with foam bung, covered with foil 
and autoclaved.  
 
2xYT 
A rich liquid medium used in the conjugation procedure and heat shocking of 
Streptomyces spores. Per litre: 16 g Difco Bacto-tryptone, 10 g Difco Yeast 
Extract, and 5 g NaCl. 10 ml aliquots in universal bottles were sterilised by 
autoclaving. 
 
5x M63 minimal media 
This liquid media was used for growth of BTH101 cells for BACTH assays. Per 
litre: 10 g (NH4)2SO4, 68 g KH2PO4, 2.5 mg FeSO4 .6H2O, and 5 mg Vitamin B1. 
The pH was adjusted to 7.0 with KOH and then sterilised by autoclaving.   
 
Optimized high-cell density IPTG-induction minimal media  
This liquid media was used to label proteins with 13C and 15N for Nuclear 
Magnetic Resonance (NMR) Spectroscopy. 50 mM Na2HPO4.7H2O, 25 mM 
KH2PO4 pH 8-8.2, 10 mM NaCl, 5 mM MgSO4, 0.2 mM CaCl2, 0.25 x BME 
vitamins (Sigma), 0.25 x Trace Metals, 0.1% 15NH4Cl and 1% 
13C-Glucose. 
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1000 x Trace metal solution:  1 ml 0.1 M FeCl3 in 0.12 M HCl to 1 ml Trace 
metal mixture (50 mM FeCl3, 20 mM CaCl2, 10 mM MnCl2, 10 mM ZnS04, and 2 
mM of each CoCl2, CuCl2, NiCl2, Na2MoO4, Na2SeO3, and H3BO3 in 60 mM 
HCl). Stock solutions were made and all were autoclaved separately and kept at 
RT (Sivashanmugam et al., 2009). 
 
2.1.4.2 S. coelicolor growth media  
NMMP 
NMMP is a liquid medium used for the dispersed growth of S. coelicolor to 
stationary phase. Per litre: 2 g (NH4)2SO4, 5 g Difco Casamino acids, 0.6 g 
MgSO4.7H2O, 50 g PEG 6000 and 1 ml NMMP Minor Elements. NMMP Minor 
Elements were made up: 1 g/L ZnSO4.7H2O, 1 g/L FeSO4.7H2O, 1 g/L 
MnCl2.4H2O, and 1 g/L anhydrous CaCl2 and kept at 4°C. 80 ml of NMMP media 
was aliquoted out into 100 ml bottles and autoclaved.  
 
Prior to use, 15 ml 0.1 M NaH2PO4/K2HPO4, pH 6.8 and 2.5 ml 20% (w/v) 
glucose was added to 80 ml NMMP media. 0.1 M NaH2PO4/K2HPO4 buffer was 
prepared by mixing 0.1 M NaH2PO4 with 0.1 M K2HPO4 and pH adjusted to 6.8. 
 
Mannitol soya flour medium (MS) 
This is a solid media used for general growth of Streptomyces and production of 
spores. Per litre: 20 g mannitol and 20 g soya flour. 100 ml MS was aliquoted 
into 250 ml Erlenmeyer flasks containing 1.5 g agar. These flasks were 
stoppered with foam bung, covered with foil and autoclaved. When it was ready 
to use, it was heated for 2-3 min to melt the agar. 
 
2 x Pre-germination medium (2 x PG) 
This is a liquid medium used for germination of Streptomyces spores before 
inoculation for growth. Per 100 ml: 1 g Difco yeast extract and 1 g Difco 
Casamino acids. 1 ml aliquots were made in 2 ml universal bottles and 
autoclaved.  
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Yeast extract-malt extract medium (YEME) 
This is a rich liquid medium used to grow S. coelicolor and obtain the growth 
curves of the different strains. Only 10% (w/v) sucrose was added for these 
experiments. Per litre: 3 g Difco yeast extract, 5 g Difco Bacto-peptone, 3 g 
Oxoid malt extract, 10 g glucose and 100 g sucrose. 200 ml aliquots were 
measured into 250 ml bottles and autoclaved. Prior to use: 0.4 ml 2.5 M 
MgCl2.6H2O and 2 ml of 1% (v/v) Antifoam was added. 
 
2.1.4.3 Antibiotics and additives 
A plasmid with a known antibiotic resistance is selected for by addition of the 
appropriate level of antibiotics. Blue/White Screening is achieved by the addition 
of X-gal which gets broken down to a blue dye. Below is a table of the different 
antibiotics and additives used in this study. 
 
Table 4: A list of antibiotics and additives added to growth media for 
selection. 
Name Stock 
concentration 
Stock made 
up in 
Concentration 
used in liquid 
media 
Concentration 
used in solid 
media 
Ampicillin 
 
100 mg/ml 60% ethanol 100 g/ml 100 g/ml 
Apramycin 50 mg/ml dH2O (Filter-
sterilised) 
20-50 g/ml 20 g/ml 
Choramphenicol 
 
34 mg/ml 100% ethanol 34 g/ml 25 g/ml 
IPTG 1 M dH2O (Filter-
sterilised) 
1 mM 0.5 mM 
Kanamycin 50 mg/ml dH2O (Filter-
sterilized) 
50 g/ml 25 g/ml 
Nalidixic Acid 
 
25 mg/ml 0.15 M NaOH 25 g/ml 25 g/ml 
Spectinomycin 50 mg/ml dH2O (Filter-
sterilised) 
50 g/ml 100 g/ml 
Thiostrepton 
 
50 mg/ml Dimethyl-
sulphoxide 
N/A 10-15 g/ml 
X-gal 40 mg/ml N, N-dimethyl-
formamide 
N/A 40 g/ml 
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2.1.4.4 Growth and storage of E. coli and S. coelicolor strains 
E. coli strains were grown at 37°C on solid or in liquid media. Colonies formed 
on solid media were kept for 1 week at 4°C before being discarded. For long-
term storage, overnight LB cultures were mixed with an equal volume of 40% 
(v/v) glycerol then stored at -80°C.  
 
Streptomyces coelicolor was grown at 30°C on solid or in liquid media. To 
prepare spores for long-term storage, confluent lawns were incubated for 4-5 
days to allow sporulation, collected and suspended in 20% (v/v) glycerol 
(Section 2.2.5.2). Spores were stored at -20°C. Prior to growth in liquid media, 
spores were pre-germinated (Section 2.2.5.3). S. coelicolor was cultured in 60ml 
broth in 250 ml Erlenmeyer flasks. The flasks contained stainless steel springs 
(1.3 cm diameter coil, 19 sw gauge, marine grade) around the base of the flasks 
to improve aeration and prevent the formation of compact mycelial sediments. 
 
2.1.5 Primers 
 
2.1.5.1 Bacterial two-hybrid  
Primers designed for the bacterial two-hybrid system and used in this project are 
shown in Table 5. 
 
Table 5: List of primers designed for bacterial two-hybrid system analysis.  
Name  Primer sequence (5’ to 3’) Chapter 
used in: 
T18_rbpA F- 
R- 
GGGGATCCGATGAGTGAGCGAGCTCTTCG  
GGGGAATTCCCCGCACTCTTGCGGCTGTC  
4.1.1 
T18_rbpA∆H1-
AMP 
F- 
R- 
GGGAATTCCCCAGCCGCCAGC 
CTCAGGGCCGTCGCCGTCAAC 
5.1.1 
T18_rbpA∆AMP F- 
R- 
GGGAATTCCCCAGCCGCCAGC 
GGTGCGTCGCTCCATCAGCATGTC 
5.1.1 
T18_rbpA∆ F- 
R- 
GGGGATCCGGAGAAGAAGGCCAAGCCCG 
GGGGAATTCCCCGCACTCTTGCGGCTGTC 
5.1.1 
T18_Rv2050 F- 
R- 
GGGGATCCGATGGCTGATCGTGTCCTGAG  
GGGAATTCCCGCCGCGCCGACGTGACCGAATG  
4.3.1 
T25_hrdB(2-4) F- GGTCTAGAGACCGCCGACCCGGTCAAGGAC  4.1.1 
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R- GGGGAATTCCTAGTCGAGGTAGTCGCGCAG  
T25_sigAMt F- 
R- 
GGTCTAGAGGTGGCAGCGACCAAAGCAAG  
GGGGAATTCTCAGTCCAGGTAGTCGCG CAG 
4.3.1 
T25_sigBMt   F- 
R- 
CCTCTAGAGGCCGATGCACCCACAAGGGCCA 
CCGAATTCCTGGCTCAGGATGTCCAGCT 
4.3.1 
T25_hrdB(1.1-
2) 
F- 
R- 
GGTCTAGAGGTGTCGGCCAGCACATCCCGTAC  
GGGGAATTCCTAGCGCGCCTGGTCGGCCATCGC  
4.2.1 
T25_hrdB(2) F- 
R- 
GGTCTAGAGACCGCCGACCCGGTCAAGGAC  
GGGGAATTCCTAGCGCGCCTGGTCGGCCATCGC  
4.2.1 
T25_hrdB(3-4) F- 
R- 
GGTCTAGAGAGCTTCACACTGCTGCAGGAGC  
GGGGAATTCCTAGTCGAGGTAGTCGCGCAG  
4.2.1 
T25-hrdB(4) F- 
R- 
GGTCTAGAGAGCTTCACACTGCTGCAGGAGC  
GGGGAATTCCTAGTCGAGGTAGTCGCGCAG 
4.2.1 
T25_sigA(2) F- 
R- 
GGTCTAGAGTCCGCCGACTCGGTTCGCGCC  
GGGGAATTCTCAGCGGGCCTGGTCGGCCATGGCGC  
4.3.2.1 
T25_hrdA(2-4) F- 
R- 
GGTCTAGAGTCCTCCGACCTGTTCCGGCAG 
GGGGAATTCTCAGTCCAGGTAGCCCCTCAG 
4.1.2 
T25_hrdC(2-4) F- 
R- 
GGTCTAGAGGAACCCGACCTGCTCGGC 
GGGGAATTCTCAGCTCGCCCAGTCCAGC 
4.1.2 
T25_hrdD(2-4) F- 
R- 
GGTCTAGAGGACCGCGATCTGGTCGGCATG 
GGGGAATTCTCAGGCCGCCGCCTCGAAGC 
4.1.2 
T25_sigBSc F- 
R- 
GGTCTAGAGATGACGACGACGACCGCGCGAGCCAC 
GGGGAATTCTCAGGTGGTGCTGAGCATGCCTTCC 
4.1.3 
T25_sigR F- 
R- 
GGTCTAGAGGTGGGTCCGGTCACTGGGAC 
GGGGAATTCTCATGACCCCGAGCCTTTCG 
4.1.3 
T25_sigE F- 
R- 
GGTCTAGAGATGGGCGAGGTGCTCGAGTTCG 
GGGGAATTCTCAGGCCGCGCAACGCTCC 
4.1.3 
T25_whiG F- 
R- 
GGTCTAGAGATGCCCCAGCACACCTCCG 
GGGGAATTCTCAGCGGCCGAAACCCGCAAG 
4.1.3 
pUT18  CAAGTCGATGCGTTCGCGATC 5.3 
The bold letters represent the restriction enzyme sites introduced. F- and R- represent 
forward and reverse primers, respectively. 
 
  
75 
 
2.1.5.2 Site-directed mutagenesis  
Primers designed and used in this project for RbpA site-directed mutagenesis 
are shown in Table 6. 
 
Table 6: List of primers designed for rbpA site-directed mutagenesis.  
Name  Primer sequence (5’ to 3’) Chapter 
used in: 
rbpA_NdeI F- 
R- 
ATGAGTGAGCGAGCTCTTCG 
ATGTCGTGCCTCCCGGGCTTG  
5.2.1 
rbpAR80A F- 
R- 
GCCACGCACTGGGACATGCTG 
CGCGGGCTTGGCCTTCTTCTCC 
5.2.2 
rbpAT81A F-
R- 
GCCCACTGGGACATGCTGATGG 
ACGCGCGGGCTTGGCCTTCTTCTCC 
5.2.2 
rbpAH82A F- 
R- 
GCCTGGGACATGCTGATGGAGCG 
CGTACGCGCGGGCTTGGCCTTC 
5.2.2 
rbpAW83A F- 
R- 
GCCGACATGCTGATGGAGCGACG 
GTGCGTACGCGCGGCTTGGCC 
5.2.2 
rbpAD84A F- 
R- 
GCCATGCTGATGGAGCGACGC 
CCAGTGCGTACGCGCGGGGCTTG 
5.2.2 
rbpAM85A F- 
R- 
GCCCTGATGGAGCGACGCACC 
GTCCCAGTGCGTACGCGCGGGCTTG 
5.2.2 
rbpAL86A F- 
R- 
GCCATGGAGCGACGCACCCGCGAG 
CATGTCCCAGTGCGTACGCGCGG 
5.2.2 
rbpAM87A F- 
R- 
GCCGAGCGACGCACCCGCGAGG 
CAGCATGTCCCAGTGCGTACG 
5.2.2 
rbpAE88A F- 
R- 
GCCCGACGCACCCGCGAGGAAC  
CATCAGCATGTCCCAGTGCGTA  
5.2.3 
rbpAE94A F- 
R- 
GCCCTCGAAGAGGTCCTCGAGG 
CTCGCGGGTGCGTCGCTCCATC 
5.2.4 
rbpAE97A F- 
R- 
GCCGTCCTCGAGGAGCGGCTGG 
TTCGAGTTCCTCGCGGGTGCGT  
5.2.4 
rbpAE101A F- 
R- 
GCCCGGCTGGCCGTTCTGCGCT 
CTCGAGGACCTCTTCGAGTTCC 
5.2.4 
rbpA3EA F- 
R- 
GCCGTCCTCGAGGCCCGGCTGGCCGTTCTGCGCT 
TTCGAGGGCCTCGCGGGTGCGTCGCTCC  
5.2.4 
rbpAR89A F- 
R- 
GCCCGCACCCGCGAGGAACTCG 
CTCCATCAGCATGTCCCAGTGC  
5.2.3 
rbpAR90A F- 
R- 
GCCACCCGCGAGGAACTCGAAG  
TCGCTCCATCAGCATGTCCCAG  
5.2.3 
rbpA2RA F- 
R- 
GCCACCCGCGAGGAACTCGAAG  
GGCCTCCATCAGCATGTCCCAG  
5.2.3 
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rbpAR102A F- 
R- 
GCCCTGGCCGTTCTGCGCTCCG 
CTCCTCGAGGACCTCTTCGAG 
5.2.4 
rbpAR107A F- 
R- 
GCCTCCGGCGCGATGAACATCG 
CAGAACGGCCAGCCGCTCCTCGAG 
5.2.4 
NdeI site (CATATG) was introduced into rbpA by using rbpA_NdeI primer which 
introduced CAT upstream of ATG using the reverse primer. The bold letters represent 
the alanine mutations introduced. F- and R- represent forward and reverse primers, 
respectively. 
 
 
2.1.5.3 Protein expression 
 Primers used in this project for protein expression are shown in Table 7. 
 
Table 7: List of primers designed for protein over-expression.  
Name  Primer sequence (5’ to 3’) Chapter 
used in: 
Rv2050 F- 
R- 
 GGCATATGGCTGATCGTGTCCTGAGG 
CCGGATCCCGGGTCAGCCGCGCCGACGTG 
4.3.1 
sigA(2) F- 
R- 
GGCATATGTCCGCCGACTCGGTTCGCGCC 
CCGGATCCCCATCAGCGGGCCTGGTCGGCCATGGC  
4.3.2.1 
Bold letters represent restriction sites introduced at the N-terminal and C-terminal of the 
genes. F- and R- represent forward and reverse primers, respectively. 
 
 
2.1.5.4 In vitro transcription  
Primers used in this project to obtain templates used for in vitro transcription 
assays are shown in Table 8.  
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Table 8: Primers used to amplify genes used as a template for in vitro 
transcription assays. 
Name  Primer sequence (5’ to 3’) Chapters 
used in: 
sco4652 F- 
R- 
GGGAATTCGCGCCCGGCCCGCTCCGGTCGCCG 
GGAAGCTTGTCCTCTTTCGAACACACGGCAACG 
5.6 
sco0527 F- 
R- 
GGGAATTCGTCGGCAACAAGGTTCCCGCTCAC 
GGAAGCTTCCCGCACTCCTGGGCGGGCGGTCT 
5.6 
rpoB F- 
R- 
GGGAATTCCAACGAGGAGCGAACACGGTCCCCGA 
GGAAGCTTGTAGACCCCTGGTGACGGGCAGGG 
5.6 
M13/pUC  
(-47)  
F- 
 
CGCCAGGGTTTTCCCAGTCACGAC (Chapter 5) 
M13/pUC  
(-48) 
R- AGCGGATAACAATTTCACACAGGA (Chapter 5) 
F- and R- represent forward and reverse primers, respectively. 
 
2.1.6 Solutions/buffers 
 
2.1.6.1 DNA manipulation 
Buffers for basic cloning 
 TE buffer: 1 mM EDTA, 10 mM Tris-HCl pH 8.0, autoclaved. 
 6 x DNA loading dye: 25 mg Bromophenol blue and 30% (v/v) glycerol in 10 
ml and filter-sterilised.  
 10 x TBE buffer: 107.8 g Tris base, ~ 55 g boric acid pH 8.3 and 7.44 g 
EDTA in 1 L. 
 Gel Red Stain: 1 x TBE and 10 l GelRedTM (Cambridge Bioscience). Stored 
in the dark.  
 
Buffers for preparation of competent cells 
 Tfb1 buffer: 100 mM RbCl2, 50 mM MnCl2.4H2O, 30 mM potassium acetate, 
10 mM CaCl2.2H2O, 15% (v/v) glycerol. Filter-sterilised, stored at 4ºC and 
protected from light. 
 Tfb2 buffer: 10 mM MOPS, 10 mM RbCl2, 10 mM CaCl2.2H2O, 15% (v/v) 
glycerol. Filter-sterilised, stored at 4ºC and protected from light. 
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Plasmid purification by alkaline lysis buffers 
 Solution I: 50 mM Tris-HCl, pH 8; 10 mM EDTA. Stored at RT. 
 Solution II: 200 mM NaOH; 1% (v/v) SDS, prior to use add 500 l SDS 
per 10 ml.  
 Solution III: 3 M potassium acetate, pH 5.5. Stored at 4ºC. 
 Phenol/Chloroform: 20 ml phenol added to 20 ml of chloroform and stored 
at 4ºC away from light. 
 
2.1.6.2 Protein purification  
Ni-column affinity purification buffers for soluble proteins 
 Charge buffer: 50 mM NiCl2.6H2O. 
 Binding buffer: 5 mM imidazole, 0.5 M NaCl, 20 mM Tris-HCl pH 7.9. 
 Wash buffer: 60 mM imidazole, 0.5 M NaCl, 20 mM Tris-HCl pH 7.9. 
 Elution buffer: 1 M imidazole, 0.5 M NaCl, 20 mM Tris pH-HCl 7.9. 
 Strip buffer: 100 mM EDTA, 0.5 M NaCl, 20 mM Tris-NaOH pH 7.9. 
All were made with dH2O, filter-sterilised and stored at RT. 
 
Ni-column affinity purification buffers for insoluble proteins 
 Binding buffer: 5 mM imidazole, 0.5 M NaCl, 20 mM Tris-HCl pH 7.9, 6 M 
urea. 
 Wash buffer: 60 mM imidazole, 0.5 M NaCl, 20 mM Tris-HCl pH 7.9, 6 M 
urea. 
 Elution buffer: 1 M imidazole, 0.5 M NaCl, 20 mM Tris-HCl pH 7.9, 6 M urea. 
 Urea Renaturation buffer: 50 mM Tris-NaOH pH 7.9, 1 mM EDTA, 1 mM 
DTT, 20% (v/v) glycerol, 0.05% (v/v) Triton X-100, 0.5 M proline and urea 
ranging from 4 M to 0 M.  
All were made up with dH2O, filter-sterilised and stored at RT. 
 
Anion-exchange purification buffers 
 Binding buffer: 50 mM Tris-HCl pH 7.9, 50 mM NaCl, 5% (v/v) glycerol and 5 
mM β-mercaptoethanol. 
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 Anion-exchange Elution buffer: 50 mM Tris-HCl pH 7.9, 1 M NaCl, 5% (v/v) 
glycerol and 5 mM β-mercaptoethanol. 
They were made up with dH2O, filter-sterilised and stored at RT. 
 
Gel filtration and NMR buffer 
 Gel filtration buffer: 20 to 50 mM Tris-HCl pH 7.9, 50 to 200 mM NaCl, 5% 
(v/v) glycerol and 5 mM β-mercaptoethanol and filter-sterilised. 
 NMR buffer: 25 mM phosphate buffer pH 6.8, 50 mM NaCl and 1 mM DTT. 
 
Other protein purification buffers 
 Coomassie Brilliant Blue stain solution: 0.25% (w/v) Coomassie Brilliant 
BlueTM R-250 (Sigma), 50% (v/v) methanol, 10% (v/v) glacial acetic acid. 
 Destainer solution: 20% (v/v) methanol, 10% (v/v) glacial acetic acid. 
 2 x Protein loading dye with DTT: 250 mM Tris-NaOH pH 6.8, 2% (v/v) SDS, 
10% (v/v) glycerol, 0.01% (w/v) Bromophenol Blue and 20 mM DTT. 
 Phenylmethylsulfonyl fluoride (PMSF): 10 mg/ml in isopropanol and stored at 
-20°C. 
 10 x SDS polyacrylamide gel running buffer: 100 ml 10% (v/v) SDS, 30.9 g 
Tris-HCl, pH 8.3, 144.1 g glycine in 1 L. 
 10 x Thrombin cleavage buffer: 500 mM Tris-HCl pH 8.0, 1.5 M NaCl and 25 
mM CaCl2. 
 
2.1.6.3 Western blotting  
 Transfer buffer: 14.4 g glycine, 3 g Tris-HCl, 200 ml methanol, 2 ml 10% (v/v) 
SDS and 800 ml dH2O. 
 10 x TBS-Tween buffer: 12 g Tris-HCl, pH 7.6, 40 g NaCl and 5 ml Tween 
20™ in 500 ml. 
 Blocking solution: 5% (w/v) skimmed milk in 1 x TBS-Tween, made fresh 
before use. 
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2.1.6.4 In vitro transcription assays  
 10 x transcription buffer: 0.4 M Tris-HCl pH 7.9, 0.1 M MgCl2 and autoclaved. 
Prior to use add: 50 mM -Mercaptoethanol and 0.1 mg/ml BSA (Hsu, 2009). 
 Formamide loading buffer: 80% (w/v) deionized formamide, 1 x TBE buffer, 
10 mM EDTA, 0.08% (w/v) xylene cyanol, 0.08% (w/v) Amaranth. The 
deionized formamide was divided into 0.8 ml aliquots and stored at -20ºC.  
 RNAP dilution buffer: 10 mM Tris-HCl, pH 8.0, 10 mM KCl, 5% (v/v) glycerol, 
0.4 mg/ml BSA, 0.1% Triton X-100 and 10 mM -mercaptoethanol (added 
prior to use). 
 10 x NTP mix: 100 M ATP, 100 M GTP, 100 M CTP, 10 M of UTP and 
50 M UTP in 15 l. 
 
2.1.6.5 β-galactosidase assay 
 PM2 medium: 70 mM Na2HPO4.12H2O, 30 mM NaH2PO4, 1 mM Mg2SO4, 
0.2 mM MnSO4, pH 7.0, autoclaved and 100 mM β-mercaptoethanol (added 
prior to use) 
 1 M Na2CO3: autoclaved. 
 O-nitrophenol-β-galactosidase (ONPG): 4 mg/ml in PM2 medium without β-
mercaptoethanol. Stored at -20°C (equilibrated to 30°C prior to use). 
 
2.1.6.6 Others 
 TES buffer: 0.05 M TES, pH 8.0 and autoclaved 
 Kirby mix (Kieser et al., 2000): 1% (w/v) sodium-triisopropylnapthalene 
sulphonate, 6% (w/v) sodium 4-amino salycilate, 6% (v/v) phenol made up in 
50 mM Tris-HCl pH 8.3.   
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2.2 DNA manipulation and cloning 
 
2.2.1 DNA manipulation 
 
2.2.1.1 General Polymerase chain reaction (PCR) 
Basic PCR reactions were set up in 0.2 ml PCR tubes as follows: 
 20-50 pmol/µl forward and reverse primers,  
 200 M dNTPs,  
 1 x reaction buffer,  
 2 ng/l plasmid DNA or 25 ng/l chromosomal DNA, 
 Presence of either 5% (w/v) glycerol, 5% (v/v) DMSO or 5x Hi-Specificity 
Additive (Bioline) and made up to 50 l with autoclaved dH2O 
 
The tubes were placed in the thermal cycler at 97°C for 5 min, held at 80°C and 
then DNA polymerase was added. The PCR cycle: 
 Melting at 96°C for 1 min 
 Annealing at 55-65°C for 45 s  
 Extension at 72°C for 0.5-1 min per 1 kb 
 Final Extension at 72°C for 5 min  
 Held at 4°C 
 
The PCR cycle was altered by increasing or decreasing the annealing 
temperature depending on the GC content of the primers. High GC content 
requires an increase in annealing temperature and vice versa.  
 
2.2.1.2 Inverse PCR 
Primers were phosphorylated by combining 200 pmol oligonucleotides, 1 x T4 
DNA kinase buffer, 2 mM ATP and 0.005 units T4 DNA kinase. The reaction 
was left at 37°C for 30 min and then heated at 90°C for 2 min to inactivate the 
enzyme. The primers were used to set up a PCR reaction as stated in Section 
2.2.1.1, using Accuzyme (Bioline) as the thermostable DNA polymerase. 
x 28-30 
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For large products (>3kb), the following PCR cycle was used: 
 Melting at 96°C for 1 min 
 Annealing at 55-65°C for 45 s  
 Extension at 72°C for 2.5 min per 1 kb 
  Melting at 96°C for 1 min 
 Annealing at 55-65°C for 45 s 
 Extension at 72°C for 3.5 min per 1 kb  
 Final Extension at 72°C for 15 min  
 Held at 4°C 
The PCR products were then separated on a 0.8 to 1% of agarose gel and the 
gene of interest was purified using QIAquick™ PCR Purification Kit (Qiagen) as 
per manufacturer’s protocol.  
 
2.2.1.3 Restriction digestion 
DNA digestion was performed by adding ~1 g DNA, 1 x restriction buffer and 
~10 units of each enzyme. Digestion mixture was left at 37°C water bath for 2-3 
h.  
 
2.2.1.4 DNA gel purification 
The gel extraction and purification was performed using QIAquick™ or 
MinElute™ Gel Extraction Kit for larger and smaller fragments, respectively, 
according to manufacturer’s instruction (Qiagen).  
 
2.2.1.5 Dephosphorylation of DNA 
Digested vectors were inhibited from self-ligation by dephosphorylation. 0.5 units 
shrimp alkaline phosphatase (SAP) was added to the digested vector and the 
reaction mixture left at 37°C water bath for 0.5-1 h. The enzyme was inactivated 
by heating at 65°C for 20 min.  
 
 
 
x 10 
x 10 
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2.2.1.6 DNA ligation 
Ligations were prepared in a final volume of 15 l using an insert DNA to vector 
DNA ratio of 4:1 together with 1 x T4 DNA ligase buffer, 0.2 units of T4 DNA 
Ligase (New England Biolabs), and incubated at 4°C overnight.  
 
2.2.2 E. coli DNA transformation 
 
2.2.2.1 Heat shock 
Preparation by CaCl2 method 
An overnight culture was used to inoculate 50 ml LB (1:100) and grown to an 
OD600 of 0.4-0.5. The cells were harvested by centrifugation at 2,000 x g for 10 
min and the pellet re-suspended in 20 ml ice-cold 0.1 M MgCl2 10% glycerol. 
The cell suspension was centrifuged at 2,000 x g for 10 min and the pellet re-
suspended in 10 ml ice-cold 0.1 M CaCl2 10% glycerol. The solution was 
incubated on ice for 30 min before being centrifuged for a further 10 min at 
2,000 x g. The cell pellet was re-suspended in the residual volume, 
approximately 3 ml, and 150 l aliquots were frozen in dry ice and stored at -
80°C. 
 
Preparation by RbCl2 method 
2 x 50 ml of selective LB were inoculated with 500 ml of overnight culture and 
grown to an OD600 of 0.5. The cells were then chilled on ice for 15 min. They 
were harvested by centrifugation at 2,000 x g for 5 min and the pellet re-
suspended in 6 ml Tfb1 buffer (Section 2.1.6.1). The 2 x 50 ml cell cultures were 
combined and chilled on ice for 15 min. The 12 ml cells were then centrifuged at 
2,000 x g for 5 min. The pellet was re-suspended in 2 ml TfbII buffer (Section 
2.1.6.1) and kept on ice. The cells were aliquoted into 100 l fractions and 
frozen on dry ice ethanol bath. They were stored at -80ºC. 
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Transformation procedure 
The ligation mixture or plasmid of interest was added to competent cells, placed 
in a 42°C water bath for 60 s and immediately after, 900 l of LB was added. 
The cells were recovered at 37°C at 250 rpm for 0.5-1 h. They were then plated 
on LA plates containing appropriate selection. The plates were left at 37°C 
overnight. The next day the colonies were selected and checked for 
recombinants or colonies grown for protein over-expression. 
 
2.2.2.2 Electroporation 
Preparation of electro-competent cells 
50 ml of selective LB were inoculated with 500 l of overnight culture and grown 
to an OD600 of 0.4. The cells were harvested by centrifugation at 2,000 x g for 10 
min and the pellet re-suspended with 50 ml of 10% chilled glycerol. This was 
centrifuged again at 2,000 x g for 10 min and pellet re-suspended with 25ml of 
10% chilled glycerol. This was centrifuged again as above, and re-suspended 
with 10 ml of 10% chilled glycerol. Centrifugation was again performed as 
above, pellet was re-suspended in the residual volume, ~1.5 ml. 50 l aliquots 
were frozen on dry ice and stored at -80°C.  
 
Electroporation procedure 
Electroporation was done in an Eppendorf Electroporator 2510 system, with a 
voltage of 2,500 V, 400 Ω and 330 F. To 50 l of competent cells 
approximately 2 ng of the plasmids were added and were immediately 
transferred to an ice-cold electroporation cuvette, immediately shocked, and 900 
µl of LB was added. This was left for 1 h at 37°C at 250 rpm for the cells to 
recover. These cells were plated on LA plates with appropriate selection and left 
to grow overnight at 30°C.  
 
 
 
 
85 
 
2.2.3 DNA extraction and purification 
 
2.2.3.1 Small scale Wizard® Miniprep plasmid purification 
The plasmid purification was performed as per the Promega kit and following the 
manufacturer’s instructions for “Wizard® Plus SV Minipreps DNA purification 
systems”. The plasmid was eluted in a total volume of 100 l using TE buffer.  
 
2.2.3.2 Small scale plasmid purification by alkaline lysis 
3 ml of overnight inoculants were harvested by centrifugation at 16,100 x g. The 
cell pellet was resuspended into 200 l Solution I (Section 2.1.6.1). 400 l 
Solution II (Section 2.1.6.1) was added, mixed by inverting, followed by 300 l 
Solution III (Section 2.1.6.1). 1 l 10 mg/ml RNAse was added, incubated at RT 
for 10 min and centrifuged at 16,100 x g for 5 min. The supernatant was 
extracted, added to 150 l phenol/chloroform, vortex mixed for 2 min and 
centrifuged again as above. The upper phase was transferred to 600 l 
isopropanol, chilled on ice for 10 min and centrifuged as above. The pellet was 
washed with 200 l 70% ethanol, centrifuged again at 16,100 x g for 1 min and 
all the supernatant was removed. The pellet was resuspended in 30 l TE 
buffer.  
 
2.2.3.3 Large scale Midiprep plasmid purification (Qiagen) 
For large scale purifications, 50 ml of culture was extracted by the Qiagen 
Plasmid Midi kit and the protocol followed as per manufacturer’s instructions. 
The pellet was finally resuspended in 100 l of TE buffer and stored at -20ºC.  
 
2.2.4 RNA extraction and purification 
 
2.2.4.1 Small scale RNA miniprep 
30 ml of S. coelicolor culture was centrifuged at 2,000 x g for 1 min. The pellet 
was resuspended in 1 ml Kirby mix solution (Section 2.1.6.6) and sonicated 
twice for 3 s. 700 l phenol /chloroform was added, vortex mixed for 2 min and 
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centrifuged at 16,100 x g for 5 min at 4°C. The upper phase was extracted with 
700 l phenol/chloroform and method repeated (see above). The upper phase 
was then added to 90 l sodium acetate, 900 l isopropanol, mixed by inverting 
and stored at -20°C for 1 h. The suspension was then centrifuged at 16,100 x g 
for 10 min at 4°C, pellet washed with 180 l 70% ethanol, and then resuspended 
in 200 l 1 x DNAse buffer. It was placed on ice for 5 min, 0.5 l DNAse was 
added and incubated at 37°C for 1 h. 200 l phenol/chloroform was added, 
vortex mixed for 2 min, centrifuged at 16,100 x g for 5 min at 4°C. The upper 
phase was again extracted, 40 l sodium acetate and 400 l isopropanol were 
added and stored at -20°C for 1 h. This was finally centrifuged at 16,100 rpm for 
10 min at 4°C and pellet washed with 100 l 70% ethanol. The pellet was 
resuspended in 100 l RNAse-free water. The RNA was cleaned by using the 
RNeasy mini Kit (Qiagen) and the manufacturer’s instructions were followed. 
 
2.2.5 Microbiological methods 
 
2.2.5.1 Conjugation of DNA from E. coli to S. coelicolor 
Transformed ETZ cells were used to inoculate LB containing 25 g/l 
Chloramphenicol and Kanamycin and appropriate selection for the incoming 
plasmid. This was grown overnight at 37°C with vigorous shaking. The overnight 
culture was diluted 1:100 in fresh LB with antibiotic selection and grown at 37°C 
to an OD600 of 0.4-0.6. The cells were washed twice with an equal volume of 
chilled LB and resuspended in 0.1 volume of LB. 108 Streptomyces spores were 
added to 500 l of 2xYT (Section 2.1.4.2) and heat shocked at 50°C for 10 min. 
500 l of E. coli cells together with 500 l of heat-shocked spores were mixed 
together and briefly centrifuged. Most of the supernatant was removed and the 
pellet was resuspended in residual volume. These were plated on MS agar 
plates with 10 mM MgCl2 and incubated at 30°C for 16-20 h. Overlay was 
performed by adding 1 ml of sterile dH2O containing 0.5 mg of nalidixic acid with 
the appropriate plasmid antibiotic selection. The plates were incubated for 
another 4-5 days at 30°C.  
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2.2.5.2 Harvesting S. coelicolor spores 
A single colony of S. coelicolor was chosen and streaked into a spore plate. The 
spore plate was incubated at 30°C for 5-7 days allowing the mycelium to 
sporulate forming a uniform grey surface. 10 ml sterile dH2O was added then 
spores were scrapped off using a loop. The spore content was poured into a 15 
ml centrifuge tube and vortex mixed for 2 min. The mixture was filtered from the 
agar suspension by adding it to an autoclaved syringe stuffed with cotton wool 
and collecting the filtered suspension. This was centrifuged at 890 x g for 5 min. 
The spore pellet was resuspended in 1 ml 20% glycerol and stored at -20°C. 
 
2.2.5.3 Determining the growth curve of S. coelicolor in liquid media 
Spores were added to 1 ml TES buffer (Section 2.1.6.6) to give a starting OD450 
of 0.05-0.06 in 50-60 ml liquid media. The spores were centrifuged briefly and 
spore pellet resuspended in 1 ml TES buffer. They were heat shocked at 50ºC 
for 10 min, added to 1 ml 2 x PG media (Section 2.1.4.2) and 2 l 5 M CaCl2. 
This was transferred into 20 ml glass universal with springs and incubated at 
37ºC with vigorous shaking for 3-5 h to pre-germinate. The cell broth was then 
transferred into 2 ml Eppendorf tube, centrifuged briefly, the pellet resuspended 
in 1 ml S. coelicolor liquid media broth YEME (Section 2.1.4.2) and left to grow 
at 30ºC with shaking at 200 rpm. When the cultures reach early exponential 
phase, 0.25-1 ml of samples were taken at 2 h interval and absorbance at OD450 
was measured.  
 
 
2.3 Protein expression and purification 
 
2.3.1 Protein expression 
 
2.3.1.1 Unlabelled proteins 
BL21 (pLysS) transformants were inoculated in LB with 100 g/l Ampicillin and 
34 g/l Chloramphenicol and left overnight at 37°C with vigorous shaking. 
Using the overnight inoculants, 20-500 ml culture was grown in the presence of 
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Ampicillin and Chloramphenicol at 37ºC with vigorous shaking to an OD600 of 
0.4-0.7. The cultures were cold-shocked on ice for 15 min and protein 
expression induced with 1 mM IPTG for 3 h at 30-37°C with vigorous shaking. 
The cells were then harvested and the cell pellet stored at -80°C until required 
for protein purification.  
 
2.3.1.2 13C 15N labelling of protein  
BL21 (pLysS) transformants were grown in LB in the presence of 100 g/l 
Ampicillin and 34 g/l Chloramphenicol to an OD600 of 3-5. The cells were 
centrifuged at 1500 x g for 5 min and the cell pellet resuspended in equal 
volume of optimized high-cell density IPTG-induction minimal media (Section 
2.1.4.1). The culture was grown in minimal media for 1.5-2 h at 37°C with 
vigorous shaking, induced with 1 mM IPTG at 30°C for 3 h. The culture was 
harvested and the cell pellet stored at -80°C until required for protein purification 
(Studier, 2005, Sivashanmugam et al., 2009) 
 
2.3.2 Protein purification 
 
2.3.2.1 Preparing cell lysate 
The cell pellet was resuspended in Binding buffer (composition dependent on 
the purification method - Section 2.1.6.2), 25 g/l PMSF and 1 protease 
inhibitor cocktail tablet (Complete mini EDTA-free, Roche) were added. The cell 
suspension was sonicated 6 times for 10 s with 50 s intervals. The cell 
suspension was centrifuged at 20,000 x g for 10 min at 4°C. If the protein was 
soluble, the cleared cell lysate (supernatant) was loaded on the column for 
purification. If the protein was however insoluble, the whole cell lysate pellet was 
resuspended in urea binding buffer, sonicated twice for 5 s with 50 s intervals 
and centrifuged at 20,000 x g for 10 min at 4°C. The cleared cell lysate was then 
loaded on the column for insoluble protein purification in the presence of urea 
(Dombroski, 1996). 
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2.3.2.2 Ni-NTA sepharose hand-made column  
Iminodiacetic acid (IDA) Sepharose fast-flow resin was added into a syringe 
barrel (sealed using glass wool) to give a column volume (CV) of 1-4 ml. The 
buffers were pumped into the column using a peristaltic pump. The resins were 
washed with 3 CV of dH2O followed by 5 CV of Charge buffer (Section 2.1.6.2) 
and 3 CV of dH2O. The column was equilibrated with 5 CV of Binding buffer 
(Section 2.1.6.2) prior to the addition of the cleared cell lysate. The column was 
then washed with 10 CV of Binding buffer, 5 CV of Wash buffer and 1-2 CV of 
Elution buffer (Section 2.1.6.2). Samples collected from the flow-through and 
elution were analysed by SDS polyacrylamide gel (Section 2.3.6). The column 
was stored by washing with 6 CV of Strip buffer (Section 2.1.6.2) followed by 3 
CV of dH2O before being stored with 20% ethanol.  
 
2.3.2.3 Ni-NTA spin column 
Ni-NTA spin column (Qiagen) was used for fast and small scale His-tag protein 
purification. Refer to the Manufacturer’s Ni-NTA Spin handbook for a detailed 
protocol on Protein Purification under Native Conditions. The Lysis buffer, Wash 
buffer and Elution buffers were all made up as per manufacturer’s instruction.   
 
2.3.2.4 Dynabeads® His-tag isolation and pull-down  
Dynabeads® (Invitrogen) contain immobilised cobalt ions which allows His-
tagged proteins to bind to them with a high affinity. 2 x Binding/Wash buffer and 
His Elution buffer were made as per manufacturer’s instructions (Invitrogen). 
The manufacturer’s His-tag protein purification protocol was followed with few 
alterations. The two proteins of interest were mixed on ice, then added to 20 l 
of magnetic dynabeads and left to incubate for 30 min at RT with vigorous 
shaking. This was then placed on a magnet, washed 4 times with 1 x 
Binding/Wash buffer, incubated for 15 min with 100 l His Elution buffer with 
vigorous shaking prior to eluate collection. 
 
 
90 
 
2.3.2.5 Anion-exchange chromatography 
HiTrap Q SepharoseTM Fast Flow (QFF) column 
The QFF column (GE Healthcare) has a CV of 1 ml, a flow rate of 1 ml/min, a 
maximum pressure of 0.3 MPa and the purification was done on an AKTA prime 
(Amersham Biotech). The pumps were first washed with dH2O and then the 
column was connected and 5 CV dH2O was passed through. The pumps and 
column were then rinsed with 5 CV Anion-exchange binding buffer (Section 
2.1.6.2) and the protein was injected into the column. A gradient of 0-100% of 
Elution buffer (Section 2.1.6.2), was passed through the column and the protein 
was eluted and collected in 1 ml fractions in the fraction collector. A curve of UV 
absorption against fractions collected was obtained that gave peaks at 280 nm 
where the protein eluted. From this curve, fractions were chosen and analysed 
on SDS polyacrylamide gel. The column was stored by pumping 5 CV dH2O 
through the column and then 20% ethanol as a storage buffer. 
 
Mono Q 5/50 GL column 
Mono QTM 5/50 GL column (GE Healthcare) has a CV of 1 ml, a flow rate of 0.5-
3 ml/min, a maximum pressure of 4.2 MPa and the purification was performed 
on the AKTA purifier Box-900 (Amersham pharmacia) using UNICORN 
Software. The protocol is as explained for the QFF (see above). However, the 
gradient used ranged from 30-100%. Using the UV absorption against fractions 
collected curve, fractions were chosen and analysed on SDS polyacrylamide 
gel. The column was stored as above.  
 
2.3.2.6 Gel filtration chromatography 
The column used for the gel filtration was the HiLoadTM 16/60 SuperdexTM 200 
prep grade (GE Healthcare). It has a CV of 124 ml, a flow rate of 0.3-1.6 ml/min, 
a pressure limit of 0.5 MPa and the purification was performed on the AKTA 
purifier Box-900 (Amersham pharmacia) using the UNICORN software. The 
pumps and column were washed with 1 CV dH2O followed by 1 CV of the gel 
filtration buffer (Section 2.1.6.2). The protein was subsequently injected into the 
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column and 1 ml fractions were collected in the fraction collector. A curve was 
generated of the UV absorption against the fractions collected, which was used 
to select fractions to analyse on SDS polyacrylamide gel. The column was 
stored by pumping 1 CV dH2O and then 20% ethanol, which serves as the 
storage buffer. 
 
2.3.3 Protein buffer exchange  
To exchange protein buffer, it was placed in a dialysis tubing cellulose 
membrane, (MWCO 12,000 Daltons, Sigma), which was sealed on both ends 
and placed in 0.5-1 L of dialysis buffer (composition varied – Refer to results) 
and stirred overnight at 4°C.  
 
2.3.4 Concentrating protein 
VIVASPIN-6 membrane 5,000 MWCO PES (Sartorius stedim biotech) and 
VIVASPIN-500 membrane 3,000 MWCO PES (Sartorius stedim biotech) were 
used to concentrate protein samples. The manufacturer’s instructions were 
followed. Prior to use, dH2O was added to the column and centrifuged at 2,000 x 
g, for 5 min at 10°C. The protein sample was then added and centrifuged at 
10,000 x g at 4°C until the required concentration or volume was achieved. 
 
2.3.5 Determining the protein concentration 
Protein concentrations were determined using two alternative procedures: 
 
2.3.5.1 Bradford assay 
The Bradford assay is based on the absorbance shift of the Brilliant Blue G dye 
in the Bradford Reagent (Sigma) from 465 to 595 nm when the protein binds. To 
quantify the protein concentration, a standard curve was prepared using known 
concentrations of Bovine Serum Albumin (BSA). 0-5 l of 1 mg/ml BSA was 
added to 500 l dH2O, 500 l Bradford Reagent and absorbance at 595 nm 
were measured. To measure the concentration of unknown protein, X l of 
protein was added to 500 l dH2O and 500 l Bradford reagent and absorbance 
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measured. The standard curve was plotted and the equation obtained was used 
to calculate the protein concentration. 
 
2.3.5.2 Bicinchoninic acid assay (BCA) 
The BCA assay is based on the reduction of Cu2+ to Cu1+ by the protein, which 
forms a complex with BCA reagent (Sigma) and the absorbance measured at 
562 nm. The procedure is followed as per manufacturer’s recommendation. The 
protein determinant reagent was prepared by adding 1 ml of 4% (w/v) 
CuSO4.5H2O solution to 49 ml of the BCA solution. A standard curve was first 
generated adding known concentrations of BSA, samples vortex mixed, 
incubated at 37ºC for 30 min and then the absorbance measured at 562 nm. To 
determine the unknown protein concentration, 0.01-0.1 ml of the protein sample 
was added to 2 ml of the protein determination reagent and the same procedure 
was repeated. Using the absorbance reading, the concentration was determined 
by extrapolation from the standard curve. 
 
2.3.6 Protein sample analysis by SDS polyacrylamide gel 
 
2.3.6.1 NuPAGE® 4-12% Bis-Tris gels 
Precast NuPAGE® 4-12% Bis-Tris gels (Invitrogen) were used for analysis of 
protein samples. The protein samples were prepared to load on the gel as per 
manufacturer’s instruction. SeeBlue®Plus2 Pre-stained standard marker 
(Invitrogen) was also loaded on the gel. The gels were run on Hoefer SE260, a 
mini-vertical gel electrophoresis unit (Amersham Biosciences) at 120 V for 1 h 
20 min. The running buffer used was NuPAGE® MES SDS Running Buffer 
(Invitrogen).  
 
2.3.6.2 SDS polyacrylamide gel preparation 
SDS polyacrylamide gel were prepared with a 15% resolving gel and a 5% 
stacking gel. The gel plates were washed with detergent, wiped with 70% 
ethanol and the plates assembled using a Hoefer Mighty Small dual gel caster 
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(Hoefer miniSE 260 unit– Amersham Biosciences) as per manufacturer’s 
recommendation. The resolving and stacking gels were made as follows: 
 
15% resolving gel: 5 ml 30% (v/v) acrylamide/bis-acrylamide mix solution 
(Severn Biotech), 2.5 ml 1.5 M Tris pH 8.8, 0.1 ml 10% (v/v) SDS, 50 l 10% 
(w/v) Ammonium Persulphate (APS), 20 l TEMED and 2.33 ml dH2O.  
 
5% stacking gel: 0.75 ml 30% (v/v) acrylamide/bis-acrylamide mix solution 
(Severn Biotech), 1.25 ml 0.5 M Tris pH 6.8, 50 l 10% (v/v) SDS, 50 l 10% 
APS, 8 l TEMED and 2.89 ml dH2O. 
 
The resolving gel was first poured into the gel cassette to cover ¾ of the gel 
plates and 70% ethanol was added. After 15 min, the resolving gel had 
polymerized, the ethanol was poured out and the gel was rinsed with dH2O. The 
stacking gel was added and immediately the comb was inserted carefully 
ensuring no air bubble was introduced. This was left to stand for about 30 min. 
The protein samples were then prepared to load on the gel by adding 2 x protein 
loading dye with DTT (Section 2.1.6.2). The samples were heat denatured at 
100°C for 5 min and ran on the SDS polyacrylamide gel on Hoefer SE260, a 
mini-vertical gel electrophoresis unit (Amersham Biosciences) at 200 V for 70 
min using 1x SDS running buffer (Section 2.1.6.2). The protein bands were 
visualized by staining with Coomassie Brilliant Blue (Section 2.1.6.2) and the 
background removed by the destainer solution (Section 2.1.6.2). 
 
2.3.7 Hanging drop vapour diffusion 
The “hanging drop vapour diffusion” method was used to check for appropriate 
buffer conditions for the formation of crystals. 1 ml of different buffers was added 
into each well of a 24-well plate. To the coverslip, 1 l of the buffer and 1 l of 
the protein sample were mixed in a single drop and sealed with grease on the 
wells. These plates were left at 4°C for 2-5 days. 
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2.3.8 Protein preparation for ICP-MS 
A quick buffer exchange into Charge buffer (Section 2.1.6.2) was performed on 
0.5 mg purified protein. This was then dried at 105°C for 2-4 h and allowed to 
cool. 70% metal analysis grade nitric acid was added to digest the protein for 10 
min at 105°C and metal analysis grade H2O was added to a volume of 3 ml. This 
was sent for inductively coupled plasma mass spectrometry (ICP-MS) together 
with a control to serve as background (University of Sussex). 
 
 
2.4 Western blotting 
 
2.4.1 Preparing samples 
At specific stages of growth, S. coelicolor samples were collected to test for the 
level of protein expression. 200-500 l samples were taken at specific time 
points, centrifuged at 16,100 x g, for 10 sec at 4°C, 240 l ice-cold 0.9% (w/v) 
NaCl was added followed by 60 l of 50% (v/v) TCA and left on ice for 15 min. 
This was then centrifuged at 16,100 x g for 1 min at 4°C, pellet resuspended in 
100 l of 1 x loading buffer with reducing agent (Invitrogen), boiled at 100ºC for 
5 min and centrifuged at 16,100 rpm for 8 min at 4ºC. The supernatant was then 
loaded on 4-12% Bis-Tris polyacrylamide gel for electrophoresis followed by 
western blotting. 
 
2.4.2 Determining protein concentration  
The samples were centrifuged and TCA-precipitated as in Section 2.4.1. 
However, the pellets were resuspended in 0.1 ml of 5% (v/v) SDS/0.1 M Tris. 
The samples were vortex mixed, boiled at 100ºC for 5 min and added to 2 ml 
BCA reagent for protein concentration quantification (Section 2.3.5.2). 
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2.4.3 Immunoblotting protocol 
After electrophoresis, the Protran® nitrocellulose membrane (0.2m- Whatman) 
was cut at the desired size and soaked together with the sponge pads and 
chromatography paper sheets (3mm- Whatman) in chilled Transfer buffer 
(Section 2.1.6.3). The cassette was placed with the dark side down and the 
order was: sponge pad - filter paper - gel - membrane - filter paper - sponge 
pad. The cassette was closed and placed in the transfer tank together with 
Transfer buffer and transferred at 100 V, 4ºC, for 1-1.5 h depending on the size 
of the protein of interest. 
 
2.4.4 Washes and antibodies 
After the proteins were transferred onto the nitrocellulose membrane, it was 
rinsed in Transfer buffer and incubated in blocking solution (Section 2.1.6.3) at 
RT for 1-2 h with continuous agitation. The membrane was then washed 3 times 
for 10 min with 1 x TBS-Tween (Section 2.1.6.3) and incubated overnight at 4ºC 
with gentle rocking in the appropriate dilution of primary antibody, which was 
diluted in freshly made blocking solution. The membrane was again washed 3 
times with 1 x TBS-Tween for 10 min and then incubated with gentle rocking at 
4ºC for 1 h in an appropriate dilution of secondary antibody HRP conjugate, 
which was made in fresh blocking solution. The membrane was again washed 3 
times for 10 min and then subjected to ECL detection.  
 
2.4.5 ECL detection and developing 
The Amersham™ ECL™ Prime Western Blotting Detection Reagent (GE 
Healthcare) was used as per manufacturer’s instructions. 500 l Solution I and 
500 l Solution II (GE Healthcare) were mixed together, added to the membrane 
and left to stand for 1 min. The membrane was then removed with forceps and 
gently touched on the filter paper to remove any excess solution. The soaked 
membrane was then wrapped in Saran™ wrap and then exposed in the DNr 
Bio-Imaging Systems F-chemiBls 3.2 M machine using the Gel capture software 
for 20-120 s depending on the intensity of the protein bands.  
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2.5 In vitro transcription assays 
 
2.5.1 Preparing the gel 
The plates and comb were washed with detergent and wiped with 100% ethanol. 
To the top plate, 100 l Sigmacote® (Sigma) was added and wiped over the face 
of the plate to ensure that the gel sticks to the bottom plate. This was again 
wiped with 100% ethanol. The gel was assembled onto the AE-6141 
MiniQuencer (31 x 18 x 32 cm) (Atto corporation- Japan). 10 ml Urea Ultra Pure 
Sequagel® Urea Gel™ Complete (national diagnostics) was added to 20 ml Ultra 
Pure Sequagel® Urea Gel™-6 (national diagnostics) together with 200 l 10% 
APS. This was quickly poured into the assembled plates, comb inserted and the 
cassette lied down to set for 2 h. The gel was then pre-run on AE-6141E 
MiniQuencer (Atto) at 600 V, 50 W for 30 min at 55ºC. The samples were then 
loaded on gel and ran at 600 V, 50 W for 1 h at 55ºC.  
 
2.5.2 In vitro transcription assays 
1 l 5-25 M RbpA was first added to 1 l 2.5 M HrdB, incubated on ice for 15 
min, followed by addition of 1 l 500 nM RNAP and again incubated on ice for 
15 min.1 l 50 nM template was then added and left on ice for 15 min. 2 l 10 x 
transcription buffer/2 M KCl (Section 2.1.6.4) was added and RNAse-free H2O 
used to make up the reaction mixture to 10 l. The reaction was started by 
adding 1 l radioactive NTP mix and placing the reaction at 30ºC for 15 min. The 
reaction was stopped by adding 10 l Formamide loading buffer (Section 
2.1.6.4), heated at 80ºC for 5 min, loaded on the gel and ran at 600 V, 50 W for 
1 h at 55ºC. The gel was then transferred to a piece of Whatmann 3 MM paper 
and dried at 65°C for 1 h using a gel vacuum drier. The dried gel was then 
exposed to a phosphoimaging plate (Amersham Biochemia) at RT for 16-48 h. 
The bands were visualized using the typhoon scanner.  
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2.6 β-galactosidase assay 
In vivo protein-protein interactions were detected using Bacterial adenylate 
cyclase two-hybrid system (BACTH). The amplified genes were cloned into 
pBlueScript II SK (+) (Table 1) and then subcloned into either pUT18 or pKT25 
vector (Table 1). The recombinant pUT18 and pKT25 vectors were transformed 
into BTH101 (Table 2) competent cells by heat shock. The BTH101 cells used 
for the assay were grown in 5 ml LB (without glucose) in the presence of 50 
g/l Kanamycin, 100 g/l ampicillin and 0.5 mM IPTG at 30°C overnight with 
vigorous shaking. These were diluted 1:5 with M63 minimal medium (Section 
2.1.4.1) and the OD600 was recorded. The cells were permeabilized with 30 l 
chloroform, 30 l 0.1% (v/v) SDS, vortex mixed for 10 s and lightly plunged with 
cotton wool. These were vigorously agitated at 37°C for 30-40 min to allow 
evaporation of chloroform.  
 
For the enzymatic reaction, 0.1-0.2 ml of permeabilised cells was added to PM2 
medium (Section 2.1.6.5) to a volume of 1 ml. These tubes were placed in a 
28°C water bath for 5 min. A control tube containing 1 ml PM2 assay buffer was 
also prepared to serve as the blank. The enzymatic reaction was started by 
adding 250 l pre-equilibrated 4 mg/ml ONPG and the time added was noted. 
When a sufficient yellow colour was observed, 500 l 1 M Na2CO3 was added to 
stop the reaction and the time was also noted to calculate the reaction time of 
the enzyme. The OD420 was recorded and the enzymatic reaction was done in 
triplicate to ensure accuracy.  
 
The calculation was done based on the formula: 
 
Activity units/ml =                           1000 x absorbance at 420nm 
                    Reaction time (min) x volume of culture (ml) x absorbance at 600nm 
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3.0 Overview 
RbpA is a newly discovered RNAP binding protein and thus, there is little 
information available in the literature regarding its structure and function. 
Therefore, the first section of this chapter presents a bioinformatics study on 
RbpA, particularly its conservation among the Actinobacteria, some structural 
predictions and also the presence of its paralogue, RbpB, in some 
Actinobacteria. The second section presents some experimental attempts to 
determine the biological role of RbpA, in particular, transcriptome analysis and 
the role of RbpA in determining RNAP composition.  
 
3.1 Bioinformatic analysis of RbpA 
The recent increase in the number of available bacterial genomes allows an 
assessment of the distribution of RbpA homologues in bacteria as well as useful 
insights into the conservation of certain amino acid residues. In S. coelicolor, 
RbpA was shown to have a paralogue, RbpB. The distribution of this protein was 
also assessed. 
 
3.1.1 RbpA in the Actinobacteria 
RbpA (SCO1421) is encoded by rbpA, a monocistronic gene that was shown to 
be partially controlled by R (Paget et al., 2001b). The rbpA gene is 375 bp long, 
and encodes a protein of 124 amino acids with a molecular weight of 
approximately 14 kDa. To identify the level of conservation and distribution of 
RbpA, BLASTP and TBLASTN searches using the Integrated Microbial Genome 
(IMG) database were performed with the amino acid sequence of RbpA. RbpA 
homologues were present in 255 genomes, all belonging to the Actinobacteria 
including the following genera: Streptomyces, Frankia, Mycobacteria, 
Bifidobacterium, and Corynebacterium (Table A1- Appendices). No RbpA-
related protein was identified outside of the Actinobacteria.  
 
There are three distinct classes of RbpA homologues. Two are closely related 
differing by the presence or absence of putative Zn ligands, for example Zn-
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binding RbpA in S. coelicolor, and the putative Zn-free Rv2050 in M. 
tuberculosis (Section 6.3). The third class is distinct from RbpA and is 
represented by the paralogue, RbpB in S. coelicolor (Section 3.1.2). A multiple 
sequence alignment was generated for 22 RbpA homologues, selected from a 
wide range of Actinobacteria in order to reveal highly conserved amino acid 
residues (Fig. 3.1). The multiple sequence alignment showed that the RbpA 
homologues share a high level of similarity (Fig. 3.1).  
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RbpA_Sc     1 -MSERALRGTRLVV-TSYETDRGIDLAPRQAVEYACEKGHRFEMPFSVEAEI--PPEWEC 
RbpA_Sa     1 -MSERALRGTRLVV-TSYETDRGIDLAPRQAVEYACEKGHRFEMPFSVEAEI--PPEWEC 
RbpA_Sp     1 -MSERALRGTRLVV-TSYETDRGIDLAPRQAVEYACQNGHRFEMPFSVEAEI--PPEWEC 
RbpA_Ca     1 -MSERALRGTRLGA-TSYESDAGIDFAPRQDIEYVCPNEHRFVMPFSVEADV--PSTWEC 
RbpA_Tc     1 -MAERALRGTRLGA-TSYENDRNTDLAPRKTVDYTCPKGHRFTVTLAAEAEV--PMTWEC 
RbpA_Sr     1 -MGERALRGTRLGA-TSYENDRNTDLAPRQEVSYTCPKGHRFDVPLAAEAEI--PATWEC 
RbpA_Fs     1 -MGERILRGSRLGA-VSYETDRSTELAPRQSASYDCPNGHQFTMPFAAEAEV--PSVWEC 
RbpA_Se     1 -MADRVLRGSRLGA-VSYETDRNHDLAPRRTVRYACTKDHEFEVPFSDDAEI--PPTWEC 
RbpA_Am     1 -MADRVLRGSRLGA-VSYETDRNHDLAPRRSVRYACPKDHDFEVPFSDDAEI--PHTWEC 
RbpA_Sare   1 -MGERMLRGSRLGA-VSYESDRNTELAPRQTREYLCAKGHQFEVPFAVDAEV--PTTWEC 
RbpA_Maur   1 -MGERMLRGSRLGA-VSYESDRNTELAPRQTREYLCAKGHQFEVPFAVDAEV--PTTWEC 
RbpA_Ns     1 -MAERTLRGARLGG-QSFEDERGIEFAARQQVGYRCPQGHEFEITMSVEADV--PAVWEC 
RbpA_Kf     1 -MSNRVLRGSGLGG-VSFEDDRGVEFAPRQMISYDCPRGHVVEVTMAHDAEV--PAVWEC 
RbpA_Kr     1 -MSERNLRGSRLGA-ASLESESGVEPAERQMVTYNCPEGHTVVVPMSLEADV--PPLWEC 
RbpA_Bd     1 -MAERSLRGMSIGA-KSLESDDNVDFAARNDIAYVCPKGHRTILPFAEGAEV--PDEWEC 
RbpA_Bl     1 -MAERSLRGMSIGA-KSLESDDNVDFAARNDVAYVCPKGHRTILPFAEGAEI--PDEWEC 
RbpA_Ah     1 -MVERSLRGMKIGA-NSLESDIGVALVERHDEDYVCERSHKFTITFAQDADV—-PATWEC 
RbpA_Cd     1 -MADRVLRGSRMGA-VSYETDRDHDLAPRQMVCYKTETGEIFDVPFAHDAEI--PSEWLC 
RbpA_Cg     1 -MADRVLRGSRMGA-VSYETDRDHDLAPRQLVKYKTADGEIYEVPFADDAEI--PEEWMC 
RbpA_Ma     1 -MADRVLRGSRLGA-VSYETDRNHDLAPRQIARYRTENGEEFEVPFADDAEI--PGTWLC 
RbpA_Mt     1 –MADRVLRGSRLGA-VSYETDRNHDLAPRQIARYRTDNGEEFEVPFADDAEI--PGTWLC 
RbpB_Sc     1 MASGNAIRGSRVGAGPMGEAERG-ESAPRLRISFWCSNGHETQPSFASDAQV--PETWDC 
 
 
 
 
 
RbpA_Sc    57 KVCGAQALLVD--GDGPEEKKAKPARTHWDMLMERRTREELEEVLEERLAVLRSGAMN-- 
RbpA_Sa    57 KVCGAQALLVD--GDGPEEKKAKPARTHWDMLMERRTREELEEVLEERLAVLRSGAMN-- 
RbpA_Sp    57 KACGAQALLVD--GDGPEEKKGKPARTHWDMLMERRTREELEEVLAERLAVLRSGAMN-- 
RbpA_Ca    57 KVCGATALLVD--GAPPEEKAGKPARTHWDMLLERRTMADLEEVLAERLAVLRDGGISRS 
RbpA_Tc    57 RNCGTTALRVN--GEAPQPKPTKAPRTHWDMLMERRTIEDLEEVLAERLAILR--AQRK- 
RbpA_Sr    57 RMCGATAIRVD--GELPEAKKAKPPRTHWDMLLERRTIEDLEEVLNERLAILR--AQRR- 
RbpA_Fs    57 RVCGGASVIVD--GERPEPKKAKPPRTHWDMLMERRTTDDLEEVLAERLAVLRGAGTDR- 
RbpA_Se    57 RLHGTESKIVD--GSEPEQKKAKPPRTHWDMLLERRSIPELEELLNERLEMLRGRRSHSA 
RbpA_Am    57 RLHGQESKIID--GNEPEAKKVKPPRTHWDMLLERRSIPELEELLDERLEELKGRRTRTA 
RbpA_Sare  57 KFDGSVARLVD--GNEPEQKKAKPPRTHWDMLLERRSIAELEDILAERLKEVRTRRGRA- 
RbpA_Maur  57 KFDGSVARLVD--GTEPEQKKAKPPRTHWDMLLERRSIAELEDILAERLQEVRTRRGRA- 
RbpA_Ns    57 PRCGAEALSVS--GIQPEAKAEKPARTHWDMLLERRSEKELEDILKERLQLLRDGEIGPA 
RbpA_Kf    57 PHCGSEAARST--GEKPEPKQEKPARTHWDMLRERRSISELEELLAERVQLLRNGEIGPA 
RbpA_Kr    57 -RCGAEALRAD--TDAPERKAGKPARTHWDMLLERRTIAELEVLLDERLELLRSREL--- 
RbpA_Bd    57 R-CGAVAHREGDEDRQADE-ISKPTRTHWDMLLERRSEDELKTLLEKRLQMHRDGWFPDY 
RbpA_Bl    57 R-CGSVAHREGDADREGDE-IAKPTRTHWDMLLERRSEEELATLLEKRLQMHRDGWIPDY 
RbpA_Ah    57 K-CGSEAKLVGNHGEDGDEKALKPARTHWDMLLERRSEEELQILLDERLELLRTGRLYAR 
RbpA_Cd    57 K-NGQLGILME--GEGVEAKPVKPARTHWDMLRERRSLEELDVLLEERIEMLRKRRRNAA 
RbpA_Cg    57 K-NGKLGILME--GEGVESKPVKPPRTHWDMLRERRSIEELDVLLEERIEALRKRRRNAA 
RbpA_Ma    57 R-NGMEGTLIE--GDLPEPKKVKPPRTHWDMLLERRSIEELEELLKERLEIIKSRRRG-- 
RbpA_Mt    44 R-NGMEGTLIE--GDLPEPKKVKPPRTHWDMLLERRSIEELEELLKERLELIRSRRRG-- 
RbpB_Sc    58 PRCGFPAGQDRDNPPDPPR--TEPYKTHLAYVRERRSDADGEAILAEALAKLR-----GE 
 
  
RbpA1 
RbpA2 
RbpB 
RbpA1 
RbpA2 
RbpB 
Helix 1 Helix 2 
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RbpA_Sc    112 IAVHPRDSR-------KSA------------------------------------ 
RbpA_Sa    112 IAVHPRDSR-------KSA------------------------------------ 
RbpA_Sp    112 IAVHPRDSR-------KSA------------------------------------ 
RbpA_Ca    114 DVVRPAPARTMAGRAKKSAAAAKASSVKAPAAPAGKPKTTAARSGARKAAAHSSD 
RbpA_Tc    111 ----------------KSA------------------------------------ 
RbpA_Sr    111 ----------------KSA------------------------------------ 
RbpA_Fs    113 ----------------RSA------------------------------------ 
RbpA_Se    114 ------------------------------------------------------- 
RbpA_Am    114 ------------------------------------------------------- 
RbpA_Sare  113 ------------------------------------------------------- 
RbpA_Maur  113 ------------------------------------------------------- 
RbpA_Ns    114 HLHRANQKK-----RKATA------------------------------------ 
RbpA_Kf    114 HLHRARNTS-----GKRTA------------------------------------ 
RbpA_Kr    110 --------------IKRSA------------------------------------ 
RbpA_Bd    114 E------------------------------------------------------ 
RbpA_Bl    114 E------------------------------------------------------ 
RbpA_Ah    115 RH----------------------------------------------------- 
RbpA_Cd    113 RLLKQQQEEAAA---AQNS------------------------------------ 
RbpA_Cg    113 KLLKAQQEAEEA---EKAAEEV--------------------------------- 
RbpA_Ma    111 ------------------------------------------------------- 
RbpA_Mt     98 ------------------------------------------------------- 
RbpB_Sc    110 -I----------------------------------------------------- 
 
Figure 3.1: Multiple sequence alignment of 22 homologues of RbpA in the 
Actinobacteria phylum.  
The Clustal W2 multiple sequence alignment tool and the BOXSHADE 3.21 
server were used. Amino acid residues shown in white font with black highlight 
showed identical residues whilst the amino acid residues in white font with grey 
highlight showed similar residues. The homology was tested to the 0.8 fraction 
that must agree for shading. The black vertical arrows show the conserved 
residues that co-ordinate Zn. The PSIPRED server was used to predict the 
secondary structure of RbpA in S. coelicolor with the horizontal green arrows 
representing the -strands, the purple cylinder: Helix 1 and the blue cylinder: 
Helix 2. On the side of the alignment, RbpA1: Zn-containing, RbpA2: Non-Zn 
containing, RbpB: paralogue of RbpA. RbpA_Sc: Streptomyces coelicolor A3(2), 
RbpA_Sa: Streptomyces avermitilis MA-4680, RbpA_Sp: Streptomyces 
pristinaespiralis ATCC 25486, RbpA_Ca: Catenulispora acidiphila DSM 44928, 
RbpA_Tc:Thermomonospora curvata DSM 43183, RbpA_Sr: Streptosporangium 
roseum DSM 43021, RbpA_Fs: Francci3_2270 Frankia sp. CcI3, RbpA_Se: 
Saccharopolyspora erythraea NRRL 2338, RbpA_Am: Actinosynnema mirum 
DSM 43827, RbpA_Sare: Salinispora arenicola CNS-205, RbpA_Maur: 
Micromonospora aurantiaca ATCC 27029, RbpA_Ns: Nocardioides sp. JS614, 
RbpA_Kf: Kribbella flavida DSM 17836, RbpA_Kr: Kineococcus radiotolerans 
RbpA1 
RbpA2 
RbpB 
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SRS30216, RbpA_Bd: Bifidobacterium dentium Bd1, RbpA_Bl: Bifidobacterium 
longum subsp. longum JDM301, RbpA_Ah: Arcanobacterium haemolyticum 
DSM 20595, RbpA_Cd: Corynebacterium diphtheriae NCTC 13129, RbpA_Cg: 
Corynebacterium glutamicum ATCC 13032, RbpA_Ma: Mycobacterium avium 
subsp. paratuberculosis K-10, RbpA_Mt: Mycobacterium tuberculosis H37Ra, 
RbpB_Sc: Streptomyces coelicolor A3 (2). 
 
 
3.1.2 The RbpA paralogue, RbpB 
There is a paralogue of RbpA in S. coelicolor, known as RbpB (Fig. 3.1) (Paget 
et al., 2001b). To determine whether RbpB is as widely conserved in the 
Actinobacteria as RbpA, BLASTP and TBLASTN searches were performed 
using the IMG database. This revealed 63 orthologues of RbpB (Table A1- 
Appendices). RbpB was shown to be 100% conserved amongst the 
Streptomyces genus and the Frankia genus. Other examples of organisms that 
have RbpB include Micromonospora sp., Nocardioides sp., Propionibacterium 
acnes, Thermobifido fusca (Fig. 3.2). In contrast, the Mycobacterium genus 
completely lacked RbpB. The putative Zn ligands, three cysteines and one 
histidine, are well conserved in RbpB homologues suggesting that RbpB might 
be a Zn metalloprotein.  
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RbpB_Sa     1 MASG-NAIRGSRVGAGPMGEAERG-ESAPRLRISFWCSNGHETQPSFASDAQV--PDTWD 
RbpB_Sc     1 MASG-NAIRGSRVGAGPMGEAERG-ESAPRLRISFWCSNGHETQPSFASDAQV--PETWD 
RbpB_Pa     1 MSGG-SAIRGSRVGAGPMGEAERG-EAAPREYVSYFCANHHVIRPAFAAEAEI--PDTWE 
RbpB_Tf     1 MGSG-SAIRGSRVGAGPMGEAERG-EAAPRIRVAFYCANKHQVVPSFAHDAQI--PDEWD 
RbpB_Fa     1 MAGG-NAIRGSRVGAGPMGEAERG-ETAPRQRISFWCANAHETRPSFAADAAI--PDTWD 
RbpB_Ns     1 MAGGGNAIRGSRVGAGPMGEAERG-EAAPRQAVTYFCAHEHRSVVTFSVEAQV--PDSWD 
RbpB_Se     1 M-TGGNAIRGTRVGAGPMGESERG-ESAPRKRVDYWCANGHHTRPSFALDADV--PEQWD 
RbpB_Kr     1 MAGG-NAIRGSRVGAGPMGEAERG-DTAPRIRISYWCANGHETKPSFAEESGVEPPETWD 
RbpB_Ami    1 MAGG-NAIRGTRVGAGPMGESERG-ESAPRRRVSYWCANAHESRPSFAVEADV--PEMWD 
RbpB_Sv     1 MVGG-NAIRGTRIGAGPSNETERG-EAAPRRRVSYWCANGHESRPSFAMDAET--PEQWD 
RbpB_Ks     1 MVTGGQAIRGTRVGSGPMGEMERG-EDAPGTDVTFHCSKGHTTTVRFSAETDAELPEQWD 
RbpB_Nm     1 MAAG-NPIRGSRVGAGRMGESDRG-ESAPRQRFEFYCANGHATALAFAMDAEI--PDLWD 
RbpB_Sal    1 MASG-NAIRGSRVGAGPMGEAERG-ESAPRLRLSFWCANGHETQPSFASDAQV--PDTWD 
RbpB_Svi    1 MASG-NAIRGSRVGAGPMGEAERG-ESAPRLRISFWCSNGHETQPSFASDAQV--PETWD 
RbpB_Am     1 MAAG--AIRGSRIGSGPMGEAERG-EAAPRQRVVYFCIHDHETVLNFSVEAEV--PETWD 
RbpB_Tc     1 MASG-NAIRGSRVGAGPMGEAERG-EAAPRVWVSYYCANRHETRPSFATDVAI--PETWD 
RbpB_Kf     1 MAGGGGAIRGSRVGAGPMGEAERG-ESAPRQRIVFFCANGHETATVFAVEAAI--PEAWD 
RbpB_Go     1 MSGG-NAIRGTRVGAGPMGEAERG-ETAPRRRVPFWCAQGHETQVSFASDAEV--PELWD 
RbpB_Pac    1 MSGG-SAIRGSRVGAGPMGEAERG-EAAPREYVSYFCANHHVIRPAFAAEAEI--PDTWE 
RbpB_Fdg    1 MAGG-NAIRGSRVGAGPMGEAERG-ETAPRQRISFWCANNHETRPSFAADATI--PETWD 
RbpB_Ma     1 MPSN-NVIRGTRIGSAPERFDQRV-EPAPRRPVVYWCRHGHRVEFLIAAEAET--PAAWE 
RbpA_Sc     1 MSER--ALRGTRLVVTS-YETDRGIDLAPRQAVEYACEKGHRFEMPFSVEAEI--PPEWE 
 
 
 
 
 
RbpB_Sa    56 CPRCGFPAGQDQDNPPDPPRTEPYKTHLAYVRERRSDADGEAILAEALAKLRGEI----- 
RbpB_Sc    56 CPRCGFPAGQDRDNPPDPPRTEPYKTHLAYVRERRSDADGEAILAEALAKLRGEI----- 
RbpB_Pa    56 CPRCGLPANRDQANPPAPPKIVPYKTHLAYVKERRSEAEAAAILAEALENLRQRRRDGEV 
RbpB_Tf    56 CPRCGFPAGKDPENPPAPPKTEPYKTHLAYVKERRSEADGEAILQEAIAKLRAERAAMSS 
RbpB_Fa    40 CPSCGFPAGRDRDNTPAPPRTEPYKTHLAYVRERRNEKDGEAILAEALAKLRGAP----- 
RbpB_Ns    57 CPKCGLPASLDSENPPPAPKIEPYKTHLAYVKERRSDQEAADILDEALQLLRSRRKSGDI 
RbpB_Se    40 CPRCGLPAGQDEQNPPEARRNEPYKSHLAYVKERRSDSDGMAILEEALSKLKERKGR--- 
RbpB_Kr    58 CPRCGFPAGTDRANPPAPPKNEPYKTHLAYVKERRSDADGEAILNEALDSLRARGLIR-- 
RbpB_Ami   40 CPRCGLPAGRDEQAPPAPPRNEPYKTHLAYVKERRSDADGEAILEEALTKLRRQREEEG- 
RbpB_Sv    56 CPRCGLPAGRDRENPPAAPRTEPYKSHLAYVKERRSDADGEAILAEALERLRRRREGAEG 
RbpB_Ks    59 CIRCGLPAGTDPANPPDPPSITPYKTHLAYVQERRDDAAGAALLDEALGKLREQRGTA-- 
RbpB_Nm    56 CPRCGSPAGRDRAAPPPATKVEPYKSHLAYVKERRSDEDGEALLAEALARIEDKRTPRS- 
RbpB_Sal   56 CPRCGFPAGQDRDDPPAPPRTEPYKTHLAYVRERRSDADGEAILAEALAKLRGEI----- 
RbpB_Svi   56 CPRCGFPAGQDRDNPPDPPRTEPYKTHLAYVRERRSDADGEAILAEALAKLRGEI----- 
RbpB_Am    55 CPRCGMPASPDSDNRPTAPKTEPYKTHLAYVKERRSDDEAQQILAEAIDLLRSRRKSGEV 
RbpB_Tc    56 CPRCGFPAGKDPDNPPAPPKTEPYKTHLAYVKERRSDADGQAILEEALAKLRERRAAVKA 
RbpB_Kf    57 CPRCGLPTSTDVNNPPPPPKIEPYKTHLAYVKERRSEQEAAQILEEALERLRARRAGGEI 
RbpB_Go    56 CPRCGLPAGQDQAAPPPAPRTEPYKTHLAYVRERRSDADGDALLEEALAKLRARRGA--- 
RbpB_Pac   56 CPRCGLPANRDQANPPAPPKIVPYKTHLAYVKERRSEAEAAAILAEALENLRQRRRDGEV 
RbpB_Fdg   40 CPNCGFPAGRDRDNAPAPPKTEPYKTHLAYVRERRNEKDGEAILAEALAKLRGTA----- 
RbpB_Ma    56 CPRCGEPAGPDPGDPPGRQRAEPYKTHLAYVQERRTPEEGEALLAEALDALRRRRGRA-- 
RbpA_Sc    55 CKVCGAQALLVDGDGPEEKKAKPARTHWDMLMERRTREELEEVLEERLAVLRSGAMNIAV 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Helix 1 Helix 2 
-strands 
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RbpB_Sa   111 --------- 
RbpB_Sc   111 --------- 
RbpB_Pa   116 IY-------  
RbpB_Tf   116 ALKSFTD--  
RbpB_Fa   95  --------- 
RbpB_Ns   117 IF------- 
RbpB_Se   97  --------- 
RbpB_Kr   116 --------- 
RbpB_Ami  98  --------- 
RbpB_Sv   115 --------- 
RbpB_Ks   117 --------- 
RbpB_Nm   115 --------- 
RbpB_Sal  111 --------- 
RbpB_Svi  111 --------- 
RbpB_Am   115 IF-------  
RbpB_Tc   116 AMESVNNRN  
RbpB_Kf   117 LF-------  
RbpB_Go   113 --------- 
RbpB_Pac  116 IY-------  
RbpB_Fdg  95  --------- 
RbpB_Ma   114 --------- 
RbpA_Sc   115 HPRDSRKSA 
  
Figure 3.2: Multiple sequence alignment of 22 homologues of RbpB in the 
Actinobacteria phylum.  
The Clustal W2 multiple sequence alignment tool and the BOXSHADE 3.21 
server were used. Amino acid residues shown in white font with black highlight 
showed identical residues whilst the amino acid residues in white font with grey 
highlight showed similar residues. The homology was tested to the 0.7 fraction 
that must agree for shading. The black vertical arrows show the conserved 
residues that co-ordinate Zn. The PSIPRED server was used to predict the 
secondary structure of RbpB in S. coelicolor with the horizontal green arrows 
representing the -strands, purple cyclinder: Helix 1 and blue cylinder: Helix 2. 
RbpB_Sc: Streptomyces coelicolor A3 (2), RbpB_Sa: Streptomyces avermitilis, 
RbpB_Pa: Propionibacterium acnes, RbpB_Tf: Thermobifida fusca,  RbpB_Fa: 
Frankia alni ACN14a,  RbpB_Ns: Nocardioides sp. JS614,  RbpB_Se: 
Saccharopolyspora erythraea NRRL 2338, RbpB_Kr: Kineococcus radiotolerans 
SRS30216, RbpB_Ami: Actinosynnema mirum DSM 43827, RbpB_Sv: 
Saccharomonospora viridis DSM 43017, RbpB_Ks: Kytococcus sedentarius 
DSM 20547, RbpB_Nm: Nakamurella multipartita DSM 44233, RbpB_Sal: 
Streptomyces albus J1074, RbpB_Svi: Streptomyces viridochromogenes DSM 
40736, RbpB_Am: Aeromicrobium marinum DSM 15272, RbpB_Tc: 
Thermomonospora curvata DSM 43183, RbpB_Kf: Kribbella flavida DSM 17836, 
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RbpB_Go: Geodermatophilus obscurus DSM 43160, RbpB_Pac: 
Propionibacterium acnes J139, RbpB_Fdg: Frankia symbiont of Datisca 
glomerata ctg00111, RbpB_Ma: Micromonospora aurantiaca ATCC 27029, 
RbpA_Sc: Streptomyces coelicolor A3 (2). 
 
 
3.1.3 The secondary structural predictions of RbpA 
Prior to this study (see Chapter 6), a structure of a member of the RbpA family 
was not available and there seemed to be no related proteins in the protein 
structure database. Therefore, a secondary structure prediction of RbpA was 
performed using the PSIPRED protein structure prediction server (Fig. 3.1). 
RbpA was predicted to have a significant amount of random coil at the N-
terminus, suggesting that parts of the protein might be disordered. RbpA also 
appears to have four β-strands located N-terminally (Fig. 3.1) and two -helices 
located C-terminally (Fig. 3.1). The two helices are labelled Helix 1 (H1) and 
Helix 2 (H2) and seem to be connected by a short loop (Fig. 3.1). The helices 
have a high confidence level of 9 or 8.  
 
3.1.3.1 The N-terminal region  
The sequence-based structural prediction programme Phyre (Protein 
Homology/analogy Recognition Engine) was used to identify possible structural 
homologues of RbpA. RbpA appeared to be related to members of the 
rubredoxin superfamily and has a predicted rubredoxin-like fold (-fold). An 
example of a protein distantly similar in structure to RbpA is the rubredoxin 
(Protein Data Bank, d6rxna) from Desulfovibrio desulfricans strain 27774. The 
d6rxna Chain A structure has 45 amino acids and is complexed with iron. When 
the d6rxna secondary structure was compared to that of RbpA, a rubredoxin-like 
fold was predicted between amino acid residues 30-60 in RbpA. 
 
Another distantly related structure to RbpA was PDB c2v3b chain B from 
Pseudomonas aeruginosa. Its crystal structure was solved and it was shown to 
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contain two chains: chain A, which is a Rubredoxin Reductase and Chain B, 
which is Rubredoxin 2 (Hagelueken et al., 2007). Chain B has 55 residues with 
10% of it being helical and 21% occurring as -sheets. This domain has 
important functions in iron ion binding and electron carrier activity (Hagelueken 
et al., 2007). 
 
PDB d6rxna and c2v3b both bind to a metal complex (iron). This iron is co-
ordinated by four cysteine residues (Hagelueken et al., 2007). RbpA has also 
been shown to complex a metal (Zn) (P. Doughty, M. Paget, personal 
communication). Hence, it is likely that RbpA is similar to these rubredoxins 
structurally but not functionally.  
 
3.1.3.2 The C-terminal region  
The C-terminal region of RbpA was predicted to have two -helices separated 
by a short turn. H1 was composed of residues that were very highly conserved 
in most RbpA homologues (Fig. 3.1). H1 was also present in RbpB and was 
highly conserved amongst the RbpB homologues (Fig. 3.2). The ERR motif 
located just downstream of H1 was also very highly conserved amongst the 
RbpA and RbpB homologues (Fig. 3.1 & 3.2).  
 
H2 in RbpA has high conservation in leucine (L), glutamate (E) and arginine (R) 
residues. Due to the high presence of hydrophobic residues (L & V) and 
hydrophilic residues (E), the helical wheel applet was used to determine whether 
this was an amphipathic helix. From the helical wheel representation, it was 
seen that one side of H2 is mainly acidic and hydrophilic (E), whilst the other 
side is mostly non-polar and hydrophobic (L & V) (Fig. 3.3). This indicates that 
H2 is an amphipathic helix (EELEEVLEERLAVL). In RbpB, H2 is not 
amphipathic as it has high presence of hydrophobic residues (alanine- A & L) 
with very few hydrophilic residues (E & aspartate- D) (helical wheel not shown).   
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Figure 3.3: A helical wheel representation of Helix 2 showing the amino 
acid distribution in the helix.  
The line drawn in the middle separates the hydrophilic residues (Glu) from the 
hydrophobic residues (Leu & Val). The group coloring key is included at the top 
right hand side of the image. The size of the coloured circles signify the position 
of these residues within the helix, that is large to small circles represent residues 
from start to further down in the helix.  
 
 
3.2 Biological role of RbpA in S. coelicolor 
 
3.2.1 Essential for normal growth  
Much of the work in this thesis involves the use of S. coelicolor strains S129 and 
J1981 (Table 3 - Section 2.1.3.2), which have rbpA::aac(3)IV and wild-type 
(w/t) alleles, respectively, together with a His-tagged ’ subunit. The strains were 
streaked to single colonies on MS agar plates and left to grow at 30°C for 4 to 5 
days. J1981 (w/t) showed normal growth with appropriately sized colonies, 
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efficient sporulation (grey) and appropriate production of the antibiotic 
actinorhodin (Fig. 3.4A). S129 (rbpA::aac(3)IV) grew slowly producing smaller 
sized colonies, efficient sporulation (grey), and the over-production of 
actinorhodin (Fig. 3.4A). Hence, RbpA was shown to be required for the normal 
growth of S. coelicolor as already shown by Newell, K., et al 2006.  
 
Previous growth curves were performed using a supplemented minimal medium 
(Newell et al., 2006). To confirm if the growth rate phenotype was retained in a 
rich medium, S129 and J1981 were grown in YEME medium (Fig. 3.4B). The 
spores were pre-germinated for 4 h with a starting OD450 of 0.06 (Section 
2.2.5.3). These spores were then inoculated in YEME (10% (w/v) sucrose) liquid 
media and left to grow to early exponential phase before absorbance readings 
were taken at 2 h intervals until stationary phase (Fig. 3.4B).  
 
J1981 had a short lag phase, entering early exponential phase (OD450 of 0.8) in 
approximately 8 h and reached early stationary phase (OD450 of 5) around 22 h 
(Fig. 3.4B). S129, on the other hand, had a longer lag phase entering early 
exponential phase (OD450 of 0.7) in approximately 19 h and reached early 
stationary (OD450 of 4.2) in approximately 31 h. Thus, S129 had a 10 h longer 
lag phase compared to J1981.  
 
The doubling time of J1981 during exponential phase is 2 h and that of S129 
varied from 2 to 3 h. However, at particular points during exponential phase the 
doubling time of S129 was only slightly slower than that of the w/t. The doubling 
time of S129 observed in YEME is faster than that observed with NMMP by 
Newell, K., et al (2006). J1981 exhibited a classical transition phase, shifting 
from primary to secondary metabolism around 18 h. This transition occurs when 
the nutrient level is being depleted and therefore, the cells stop growing and 
start switching on secondary metabolism, e.g. production of antibiotics. This was 
then followed by the major transition state from late exponential phase to early 
stationary phase around 22 h (Fig. 3.4B). S129, also exhibited a classical 
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transition phase around 27 h, which was only seen when the dry weights of the 
cultures were taken, shown in Fig. A1 (Appendices), and entered stationary 
phase at approximately 31 h (Fig. 3.4B). 
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Figure 3.4: RbpA is essential to maintain the normal growth rate of S. 
coelicolor.  
(A) S. coelicolor J1981 (w/t) and S129 (rbpA::aac(3)IV) strains were streaked 
into single colonies on MS agar and left to grow at 30ºC for 4-5 days. (B) 
Graphical representation of the growth curve of J1981 and S129 using 
SigmaPlot. Samples were taken at early exponential phase and then at 2 h 
intervals until stationary phase and the absorbance at OD450 were measured. 
The error bars shown represent the standard deviation of triplicate samples.  
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3.2.2 Gene expression in S. coelicolor ∆rbpA strain 
S. coelicolor rbpA strains have a slower growth rate, form small colonies and 
over-produce the antibiotic actinorhodin (Fig. 3.4). S101, an ∆rbpA strain, 
together with its parental strain, J1915, were used to obtain microarray data on 
the differential expression of genes in ∆rbpA relative to its parent (Table 3- 
Section 2.1.3.2). For each strain, four independent NMMP + 0.5% glycerol 
cultures were inoculated with a starting OD450 of 0.05 and the RNA was isolated 
in early exponential phase with absorbance (OD450) readings of 0.5 to 0.6 
(Section 2.2.4). The RNA purification protocol included a final QIAGEN 
RNAeasy clean-up step to obtain highly purified RNA. The RNA was quantified 
with a Bioanalyzer Prokaryote Total RNA Nano chip (Agilent) and only RNA 
having a RNA Integrity Number of 6.5 or above was labelled. Hybridisations 
were performed and analysed by the Surrey Microarray Group (G. Bucca, E. 
Laing and C.P. Smith, University of Surrey, UK) using custom-designed 4 x 
44,000 Agilent Technology slides. In each of the four hybridisations, Cy3- or 
Cy5-labelled cDNA from S101 was mixed with Cy3- or Cy5-labelled cDNA from 
J1915 (In collaboration with M. Paget., University of Sussex).  
 
The data was filtered based on quality (as assessed by the Agilent Feature 
Extraction software), such that probes that did not have good quality data were 
filtered out. Genes were then filtered out of the data analysis if they did not have 
a value in each of the four arrays, in order to retain the dye balance in the 
experiment.  
 
Genes that were differentially expressed in ∆rbpA relative to w/t were identified  
by performing a Rank products analysis (Breitling et al., 2004) (E. Laing, 
University of Surrey). This approach looks at conservation of rank in the data set 
rather than the level. The genes with a pfp value of less than 0.15 were chosen 
as they had more than 95% probability that the difference in expression had not 
occurred by chance. A table was generated of the genes down-regulated and 
up-regulated in S101 compared to J1915 (Table A2 & A3- Appendices).  
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3.2.2.1 Down-regulated genes 
In S101 (rbpA), it was found that 59 genes were down-regulated relative to w/t. 
Of these genes, many had unknown functions and were assigned as 
hypothetical proteins (Table A2- Appendix). Some of the genes with assigned 
functions include genes involved in cold shock response, amino acid synthesis, 
amino-acylated tRNA synthesis and ribosomal protein synthesis, which are all 
involved in protein synthesis (Table 9). Although these data might indicate that 
the genes are regulated by rbpA, it is also possible that the genes are subject to 
growth rate control, since ∆rbpA mutants have a  decreased growth rate. 
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Table 9: Genes that are downregulated in S. coelicolor ∆rbpA strain, S101, 
relative to wild-type strain, J1915.  
Gene 
Name 
Inv. 
log2 Description 
   SCO0527 
 
0.47 
 
Cold shock protein: involved in cell survival at low 
temperatures 
   *SCO1578 0.44 Acetylglutamate kinase: has a role in L-arginine synthesis 
   *SCO1579 
 
0.50 
 
Bifunctional ornithine acetyltransferase/N-acetylglutamate 
synthase protein: has a role in L-arginine synthesis 
   *SCO2628 
 
0.56 
 
Amino acid permease: amino acid transmembrane 
transporter  
   SCO3731 
 
0.50 
 
Cold shock protein involved in cell survival at low 
temperatures 
   *SCO3795 
 
0.47 
 
Aspartyl-tRNA synthetase: catalyses attachment of aspartate 
to tRNA 
   *SCO3961 
 
0.42 
 
Seryl-tRNA synthetase: catalyses attachment of serine to 
tRNA 
   *SCO4078 
 
0.49 
 
Phosphoribosyl formylglycinamidine synthase I: involved In 
purine metabolism  
   *SCO4079 
 
0.62 
 
Phosphoribosylformylglycinamidine synthase subunit II: 
involved in purine metabolism  
   SCO4089 0.59 Valine dehydrogenase: involved in L-valine degradation 
   SCO4652 0.74 50S ribosomal protein L10: formation of ribosome 
   *SCO4660 0.58 30S ribosomal protein S7: formation of ribosome 
   *SCO4716 0.7 30S ribosomal protein S8: formation of ribosome 
   *SCO4717 0.76 50S ribosomal protein L6: formation of ribosome 
   *SCO4718 0.72 50S ribosomal protein L18: formation of ribosome 
   *SCO4719 0.69 30S ribosomal protein S5: formation of ribosome 
   *SCO4720 0.74 50S ribosomal protein L30: formation of ribosome 
   *SCO4721 0.73 50S ribosomal protein L15: formation of ribosome 
   
SCO5209 
 
0.49 
 
tetR-family transcriptional regulator: controls TetR, a 
repressor of antibiotic biosynthesis, efflux pumps and osmotic 
stress 
   *SCO5680 0.57 Cytidine deaminase: Pyrimidine metabolism 
   *SCO7036 
 
0.53 
 
Argininosuccinate synthase: involved in L-arginine 
biosynthesis 
   *: represent genes expressed in an operon.  
The table lists the gene names of 21 genes that had a pfp value < 0.15, therefore, there 
is >95% probability that the difference in expression has not occurred by chance.  
Gene names and functions were obtained from UnitProTKB. 
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3.2.2.2 Up-regulated genes 
It was found that approximately 200 genes were up-regulated in S101 compared 
to J1915 (Table A3– Appendices). Many of these genes have unknown 
functions and thus, were allocated as hypothetical proteins. The genes that were 
up-regulated in S101 relative to J1915 with predicted or known function included 
those involved in glycerol metabolism, Streptomyces differentiation and 
sporulation, antibiotic actinorhodin production, antibiotic RED production, gas 
vesicle synthesis and the production of stress proteins (Table 10). These results 
are consistent with the fact that ∆rbpA over-produce actinorhodin (blue) (Fig. 
3.4A) and also RED antibiotic (this was observed when grown in YEME liquid 
media).  
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Table 10: Genes that are upregulated in S. coelicolor ∆rbpA strain, S101, 
relative to wild-type strain, J1915.  
Gene 
Name 
Inv. 
log2 Description 
SCO0409 2.3 spore-associated protein precursor 
SCO0600 1.64 RNA polymerase sigma factor: sig8 
*SCO0650 1.85 gas vesicle synthesis-like protein 
*SCO1659 
 
2.11 
 
glycerol uptake facilitator protein: glycerol metabolism and 
transport 
*SCO1660 
 
1.71 
 
glycerol kinase: Key enzyme in the regulation of glycerol 
uptake and metabolism 
*SCO1661 
 
1.63 
 
glycerol-3-phosphate dehydrogenase: involved in glycerol-3-
phosphate metabolism 
SCO2113 2.24 bacterioferritin: iron storage protein 
*SCO2828 
 
1.64 
 
probable amino acid ABC transporter protein, solute-binding 
component 
SCO3034 2.53 sporulation regulatory protein: WhiB 
SCO3090 2.51 ABC transporter integral membrane protein 
*SCO3110 1.64 ABC transport system integral membrane protein 
*SCO3111 2.93 ABC transport system ATP-binding protein 
SCO3202 2.27 RNA polymerase sigma factor: HrdD 
SCO3323 
 
1.95 
 
RNA polymerase sigma protein: BldN involved in formation of 
aerial hyphae 
SCO3397 
 
1.67 
 
integral membrane lysyl-tRNA synthetase: catalyses 
attachment of lysine to tRNA 
*SCO4148 1.63 ABC transport system ATP-binding protein 
SCO4277 1.74 tellurium resistance protein: responds to bacterial stress 
*SCO4562 
 
 
1.82 
 
 
NADH-quinone oxidoreductase  subunit: transfers electrons 
from NADH to quinines in respiratory chain through FMN and 
Fe-S centers 
*SCO4585 1.77 ABC transporter ATP-binding protein 
SCO4635 1.71 50S ribosomal protein L33: formation of ribosome 
*SCO5080 2.04 hydrolase: in actinorhodin cluster 
*SCO5084 2.18 hypothetical protein: in actinorhodin cluster 
*SCO5085 4.14 actinorhodin cluster activator protein: actII-0RF4 
SCO5086 1.77 ketoacyl reductase: in actinorhodin cluster 
*SCO5088 
 
2.78 
 
actinorhodin polyketide -ketoacyl synthase  subunit: in 
actinorhodin cluster 
*SCO5091 1.85 cyclase: in actinorhodin cluster 
*SCO5130 1.92 ABC transporter integral membrane protein 
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Gene 
Name 
 
Inv. 
Log2 Description 
*SCO5877 2.11 transcriptional regulator RedD: in RED cluster 
*SCO5885 2.83 hypothetical protein: in RED cluster 
*SCO6500 1.72 
gas vesicle synthesis-like protein: might aid in spore 
buoyancy 
*SCO6501 1.76 gas vesicle synthesis protein: gas vesicle organisation 
*SCO6502 3.04 gas vesicle synthesis protein 
*SCO6815 1.76 Bi-domain ABC transporter permease protein 
*SCO6816 2.98 ABC transporter binding lipoprotein 
SCO7325 
 
1.86 
 
Stage II sporulation protein: belongs to anti-sigma factor 
antagonist 
*: represent genes expressed in an operon. 
The table lists the gene names of 35 genes that had a pfp value <0.15, therefore, there 
is > 95% probability that the difference in expression has not occurred by chance.  
Gene names and function obtained from UnitProTKB. 
 
 
3.2.3 The level of HrdB during growth of S. coelicolor  
As RbpA was shown to act by activating transcription of HrdB-dependent genes 
(P. Doughty and M. Paget, personal communication), it was decided to 
determine the level of HrdB in both J1981 (w/t) and S129 (∆rbpA::aac(3)IV) 
strains. J1981 and S129 spores were pre-germinated for 3 h and 4 h, 
respectively, and inoculated with a starting OD450 of 0.06 in YEME containing 
10% (w/v) sucrose. J1981 and S129 were incubated at 30°C with vigorous 
shaking for 8 h and 19 h, respectively, before entering exponential phase. At 
specific time points, samples were collected from each culture in duplicate, and 
one sample was used to determine the total protein concentration using BCA 
Reagent (Section 2.4.2) whilst the other subject to SDS polyacrylamide gel 
analysis (Section 2.4.1).  
 
3.2.3.1 J1981 
Duplicate samples of 200 to 500 l of J1981 were taken from early exponential 
phase to mid-stationary phase at time points of 9.5 (OD450 0.66), 11.5 (OD450 
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2.2), 13.5 (OD450 3.6), 15.5 (OD450 4.3), 17.5 (OD450 5.3), 24 (OD450 5.5), 33 
(OD450 6.6), and 37 h (OD450 5.4). The samples were prepared for western 
blotting as explained in Section 2.4.1. Samples of 8.7 g total protein were 
separated on SDS polyacrylamide gel together with 10 and 20 ng of pure HrdB.  
 
The proteins on the gel were then transferred onto nitrocellulose membrane and 
probed with the primary anti-HrdB antibody SK3523 (Section 2.4.3). The 
antibody was used at a dilution of 1:6000 and left overnight at 4°C with gentle 
rocking. Anti-Rabbit HRP (Sigma) was used as the secondary antibody and 
diluted into blocking solution to 1:1000 (Section 2.4.4). The bands were detected 
using ECL detection Kit (GE Healthcare) and membrane developed using DNr 
Bio-Imaging Systems F-chemiBlS 3.2 M machine and visualised by the Gel 
capture software (Section 2.4.5).   
 
A graph of J1981 growth curve together with the concentration of HrdB at 
specific times was plotted using SigmaPlot (Fig. 3.5C). The bands were 
quantified and normalised to the 20 ng HrdB control using ImageJ software. It 
was evident that the concentration of HrdB was high during the exponential 
phase, that is from 9.5 to 13.5 h (OD450 0.66 to 3.6), then decreased significantly 
towards the late exponential phase, 15.5 h (OD450 4.3), and remained relatively 
constant during the stationary phase, 17.5 to 37 h (OD450 5.3 to 5.4) (Fig. 3.5A & 
B). 
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Figure 3.5: The concentration of HrdB during growth of J1981. 
(A) 4-12% Bis-Tris polyacrylamide gel showing the level of HrdB of the 8 
samples collected along J1981 growth at: 9.5, 11.5, 13.5, 15.5, 17.5, 24, 33 and 
37 h. C1 (20 ng) and C2 (10 ng) are HrdB controls. The gel was separated at 
120 V for 80 min and proteins were transferred onto nitrocellulose membrane at 
100 V for 90 min. (B) Same as A to serve as duplicate. (C) A graphical 
representation of the concentration of HrdB relative to the total cell protein 
(ng/g) present at specific time points along the growth curve of J1981 plotted 
using SigmaPlot. The second set of samples from B were plotted to give a 
general representation. These were normalised to the 20 ng HrdB control (C1). 
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3.2.3.2 S129 
S129 samples of 200 to 500 l were collected in duplicate along a growth curve  
from early exponential phase to mid-stationary phase at specific time points of 
18 (OD450 0.61), 20 (OD450 1.35), 24 (OD450 2.04), 26 (OD450 2.5), 28.5 (OD450 
3.2), 32.5 (OD450 3.3), 41.5 (OD450 3.34), and 45.5 h (OD450 3.6). The samples 
were prepared for western blotting as explained in Section 2.4.1.  
 
A graph of S129 growth curve together with the concentration of HrdB at specific 
times was plotted using SigmaPlot (Fig. 3.6C). The bands were quantified and 
normalised to the 20 ng HrdB control using ImageJ software. It was apparent 
that the concentration of HrdB was low during the early exponential phase, that 
is from 18 to 20 h (OD450 0.61 to 1.35), then increased significantly towards the 
late exponential phase, 24  to 28 h (OD450 2.04 to 3.2), and finally decreased 
before remaining relatively constant during the stationary phase, 32.5 to 45.5 h 
(OD450 3.3 to 3.6) (Fig. 3.6A & B). 
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Figure 3.6: The concentration of HrdB during growth of S129.  
(A) 4-12% Bis-Tris polyacrylamide gel showing the level of HrdB during a S129 
growth curve at 18, 20, 24, 26, 28.5, 32.5, 41.5, and 45.5 h. C1 (40 ng), C2 (20 
ng), and C3 (10 ng) are HrdB controls. The gel was separated at 120 V for 80 
min and proteins were transferred onto nitrocellulose membrane at 100 V for 90 
min. (B) Same as A to serve as duplicate. (C) A graphical representation of the 
concentration of HrdB relative to the total cell protein (ng/l) present at specific 
time points along the growth curve of S129 plotted using SigmaPlot. The second 
set of samples from B were plotted to give a general representation. These were 
normalised to the 20 ng HrdB control (C2).  
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3.2.4 RbpA in holoenzyme formation 
RbpA appears to be involved in an early stage of transcription initiation (P. 
Doughty and M. Paget, personal communication), therefore it was decided to 
test the role of RbpA in recruiting HrdB to bind to the core RNAP, that is the 
formation of the holoenzyme. The effect of RbpA on holoenzyme formation was 
tested in vivo using J1981 (w/t) and S129 (∆rbpA::aac(3)IV) S. coelicolor strains. 
J1981 and S129 were pre-germinated with a starting OD450 of 0.06 for 3 to 4 h, 
respectively, and then inoculated in YEME containing 10% (w/v) sucrose. These 
were left to grow at 30ºC with vigorous shaking and samples of 2 to 8 ml were 
collected at five specific time points; early exponential, mid-exponential, late-
exponential, early stationary and mid-stationary phase. The J1981 samples 
were taken at 9.5 (OD450 0.7), 11.5 (OD450 2), 13.5 (OD450 3.6), 24 (OD450 5.5), 
and 37 h (OD450 5.4), whilst the S129 samples were taken at 18 (OD450 0.6), 24 
(OD450 2.0), 28.5 (OD450 3.2), 32.5 (OD450 3.3), and 45.5 h (OD450 3.6). The 
protein concentration was determined by collecting 200 to 500 l samples at the 
exact time points, followed by performing BCA assay (Section 2.3.5.2).  
 
The samples were immediately centrifuged at 16,100 x g for 30 s at 4ºC and the 
pellet was resuspended in 1 ml ice-cold 0.9% (w/v) NaCl and again centrifuged. 
The pellets were placed on dry ice to immediately freeze. To test whether RbpA 
affects HrdB recruitment to core RNAP, the appropriate concentration of the 
samples were passed through Ni-NTA spin column (Qiagen) and protocol 
followed as per manufacturer’s instruction (Section 2.3.2.3). J1981 and S129 
have His-tagged rpoC, therefore the ’-subunit of RNAP attaches to the Ni-NTA 
column bringing any bound HrdB with it. The flow-through was kept to ensure the 
final protein concentration loaded on the gel was equal (data not included). The 
eluate samples were normalised and separated by SDS polyacrylamide gel 
together with S. coelicolor core RNAP and HrdB as controls.  
 
The proteins were then transfered onto nitrocellulose membrane. The top part of 
the membrane was incubated with mouse monoclonal anti-RNAP  subunit 
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(Abcam Ltd.) primary antibody diluted with blocking solution to 1:5000 with 
gentle rocking overnight at 4ºC. It was then incubated with secondary anti-
Mouse HRP (Sigma) diluted to 1:10000 in blocking solution for 1 h with gentle 
rocking. The bottom half of the membrane was incubated with anti-HrdB SK3523 
diluted with blocking solution to 1:6000 overnight at 4ºC. It was then incubated 
with secondary anti-Rabbit HRP (Sigma) at 1:1000 in blocking solution for 1 h 
(Section 2.4.4). The bands on the membrane were then detected using ECL 
detection kit (GE Healthcare), developed by DNr Bio-Imaging Systems F-
chemiBlS 3.2 M machine and visualised by the Gel capture software (Section 
2.4.5). Four cultures were tested in duplicates to ensure accurate results. 
 
The level of HrdB in relation to -subunit of RNAP was not higher in J1981 
compared to S129 (Fig. 3.7A & B). M145 was used as the negative control for 
J1981 as it does not have His-tagged rpoC. Two time points were selected 9 
(OD450 0.78) and 13.8 h (OD450 3.9) and were duplicated. No RNAP -subunit or 
HrdB were detected on the membrane of M145 samples as was expected (Fig. 
3.7C), suggesting that all HrdB detected was bound to RNAP. The HrdB and 
RNAP -subunit bands were quantified using ImageJ and normalised to the 10 
ng HrdB (C2) and 10 ng RNAP (C2), respectively. The ratio of HrdB to RNAP 
was then calculated at each time point (Fig. 3.7A & B) and it was found that this 
ratio was not higher in J1981 compared to S129. Thus, RbpA appears to have 
no effect in recruiting HrdB to RNAP, that is in holoenzyme formation.   
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A 
 
B 
 
C 
 
Figure 3.7: The level of HrdB relative to RNAP in J1981 and S129.  
(A) 4-12% Bis-Tris polyacrylamide gel showing the 5 samples collected along 
J1981 and S129 growth curves. The J1981 samples were taken at 9.5, 11.5, 
13.5, 24, and 37 h whilst the S129 samples were taken at 18, 24, 28.5, 32.5, 
and 45.5 h. RNAP controls: C1 (30 ng) and C2 (10 ng) and HrdB controls: C1 
(20 ng) and C2 (10 ng). The gel was separated at 120 V for 80 min and proteins 
were transferred onto nitrocellulose membrane at 100 V for 90 min. C2 of both 
RNAP and HrdB were used for normalising RNAP and HrdB samples, 
respectively, using ImageJ. (B) Same as A to serve as duplicate. (C) M145 
served as the control of J1981 with samples taken at two time points: 9 (OD450 
0.78) and 13.8 (OD450 3.9).  
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3.3 Discussion 
 
3.3.1 Actinobacteria lacking RbpA homologues 
RbpA was shown to be present in almost all the Actinobacteria; however, it is 
absent from a few Actinobacteria (Section 3.1.1 and Table A1 - Appendices). 
These organisms were then checked whether their genome was completely 
sequenced using NCBI database. Out of the 19 strains, 18 were fully 
sequenced, examples include: Acidimicrobium ferrooxidans, Atopobium 
parvulum, Collinsella aerofaciens, Conexibacter woesei, Cryptobacterium 
curtum, Eggerthella lenta, Olsenella uli, Rubrobacter xylanophilus, Slackia 
heliotrinireducens RHS 1, and Tropheryma whipplei.  
 
Most of these organisms belong to the family of Coriobacteriacaea, and are 
found in the human oral cavity, e.g.: Atopobium parvulum (Copeland et al., 
2009), Cryptobacterium curtum (Mavrommatis et al., 2009), and Olsenella uli 
(Goker et al., 2010) or in the intestinal microflora e.g.: Eggerthella lenta 
(Saunders et al., 2009) and Slackia heliotrinireducens RHS 1 (Pukall et al., 
2009). These organisms are either pathogenic or reside within the host and 
therefore, may rely on the host for survival. The GC content of these organisms 
varied from 72.7% for Conexibacter woesei to 46.3% for Tropheryma whipplei 
suggesting that the GC content may not be a factor in the presence or absence 
of RbpA. 
 
An interesting organism, Tropheryma whipplei Twist, is an intracellular human 
pathogen that has a reduced genome of only 927,303bp and encodes 808 
predicted protein-coding genes. It lacks many of the genes involved in amino 
acid metabolism, and possibly orthologues of the thioredoxin pathway (Raoult et 
al., 2003). Thus, this organism appeared to have adapted different ways of 
surviving within the host and therefore, has lost many genes including the rbpA 
gene. It is not known why RbpA is absent from these organisms and how these 
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organisms have evolved to transcribe genes without the need for RbpA (Section 
4.3.3).  
 
3.3.2 RbpB in S. coelicolor 
S. coelicolor ∆rbpA strains have a very evident phenotypic and morphological 
defect (Fig. 3.4). However, previous work showed that S. coelicolor ∆rbpB 
strains, on the other hand, had no phenotypic effect on growth or morphological 
defect in colony size (Newell et al., 2006) suggesting that RbpB is not essential. 
Initial attempts to obtain a knock-out of both rbpA and rbpB have not yet been 
successful. This might be due to the fact that RbpB might be taking over some 
of the roles of RbpA and consequently when both are mutated then the 
bacterium cannot survive as either one of these genes is essential for survival 
(Section 4.4.3). Further work to obtain an S. coelicolor strain with both 
rbpA/rbpB knock-out is in progress (R. Lewis and M. Paget, work in progress). 
 
3.3.3 Gene expression in S. coelicolor ∆rbpA mutant 
From the microarray data, it was identified that genes involved in amino acid 
synthesis, amino-acylated tRNA synthesis, and ribosomal proteins were all 
down-regulated in S. coelicolor ∆rbpA strain relative to w/t (Table 9). Many of 
these genes were present in operons. To determine whether they may be direct 
targets of RbpA or are down-regulated due to the slow growth phenotype of S. 
coelicolor ∆rbpA strains, the genes in the different operons were all checked for 
their expression level.  
 
It was found that the ribosomal genes were present in three separate operons 
and all three operons together with the genes within the operons were all down-
regulated. Also, genes involved in amino-acyl tRNA synthesis e.g. aspartyl- and 
seryl-tRNA were present in operons and each gene in the operon was down-
regulated. Interestingly, the whole operon for arginine synthesis, consisting of 
five genes, was down-regulated significantly. In addition, genes involved in 
purine metabolism were found to occur in an operon and their expression was 
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down-regulated. Does this suggest that S. coelicolor ∆rbpA is an auxotroph that 
has lost its ability to synthesis arginine and purine which is required for growth? 
This is not thought to be the case as these mutants grow slowly even in a rich 
media such as YEME. Many of the genes down-regulated in the rbpA mutant 
are house-keeping genes and are therefore likely to be transcribed by RNAP 
containing HrdB; it follows that the promoters might additionally require RbpA for 
full activity. This may explain why ∆rbpA strains have a reduced growth 
compared to w/t. Alternatively, the observed reduction in activity might be 
caused by an indirect effect on account of their possible growth rate control.  
 
The antibiotic actinorhodin is also over-produced in S. coelicolor ∆rbpA strains 
and this was further verified by the up-regulation of genes present in the act 
cluster in ∆rbpA relative to the w/t (Table 10). One of these genes is the actII-
ORF4 and it is the main transcriptional regulator that controls production of 
actinorhodin. S129 grown in YEME liquid media produced RED antibiotic as the 
cells approached stationary phase and this observation was backed up by the 
microarray data, which showed that genes present in the red cluster were also 
up-regulated in the ∆rbpA strain relative to w/t (Table 10).  
 
3.3.4 HrdB level during growth of J1981 and S129 
The expression of the HrdB gene was previously shown to be relatively constant 
throughout growth and stationary phase in S. coelicolor (Kang et al., 1997). This 
fits in with the model that HrdB is required to express rRNA genes during 
exponential phase as well as RED and actinorhodin biosynthetic genes during 
stationary phase (Fujii et al., 1996, Kang et al., 1997). However, the level of 
RNAP-HrdB holoenzyme appeared to be abundant during exponential phase 
before dropping during stationary phase (Kang et al., 1997). This latter 
observation was also observed in Fig. 3.7 where the level of RNAP-HrdB was 
highest during exponential phase in J1981 (w/t) before decreasing during 
stationary phase (Fig. 3.7). Particularly striking however, was the changes in the 
total concentration of HrdB, which increased during growth to a maximum 
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towards the end of exponential phase before dropping again during stationary 
phase (Fig. 3.5).  Why is the level of HrdB decreased in stationary phase when 
its expression is constant throughout growth? 
 
In Bacillus subtilis, the expression of the principal sigma factor (A) is constant 
throughout growth and development but the level of RNAP-A decreases during 
stationary phase as observed in S. coelicolor (Haldenwang et al., 1981). In E. 
coli, this was also observed for 70, which is expressed at a relatively constant 
level throughout growth. During stationary phase, the level of S rises and leads 
to decrease in relative level of RNAP-70 (Jishage & Ishihama, 1995). Alternative 
sigma factors compete with 70 for core RNAP, however, the affinity of 70 for 
core RNAP is much higher than that for any of the other alternative sigma 
factors. For this reason, these alternative sigma factors might require additional 
regulators to be able to successfully compete for core RNAP.  
 
Global regulators such as ppGpp, DksA and 6S RNA might play a role in sigma 
factor competition for core RNAP. ppGpp, DksA and 6S RNA interact with 
RNAP-70 complex, decreasing 70-dependent transcription and thereby, 
allowing other alternative sigma factors to compete with70 for binding to core 
RNAP (Section 1.2.5.1, 1.2.5.2 & 1.2.6.1). Rsd, an anti-sigma factor of 70, has 
also been shown to interact with free 70, core RNAP and RNAP-70 complex 
causing the dissociation of 70 and allowing alternative sigma competition 
(Section 1.2.7.1) (Ilag et al., 2004). Crl, a stationary phase protein that interacts 
with S, has been shown to increase the affinity of S for core RNAP and 
specifically aids S to compete with 70 for the core RNAP during stationary 
phase (Typas et al., 2007). 
 
Therefore, the decrease in the level of RNAP-HrdB holoenzyme at stationary 
phase may be due to alternative sigma competition, where factors such as 
ppGpp and DksA might hinder the HrdB-dependent transcription of rRNA genes 
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causing the dissociation of HrdB to allow alternative sigma factors to interact with 
RNAP and direct secondary metabolism. Free HrdB may be unstable in the cells 
which would lead to lower levels of HrdB being detected (Fig. 3.5).  
 
Unlike J1981 (w/t), S129 (∆rbpA::aac(3)IV) had low levels of HrdB in early 
exponential phase (Fig. 3.6). However, the level of HrdB increased in mid-
exponential phase to late exponential phase before decreasing and remaining 
relatively constant throughout stationary phase as observed in J1981 (Fig. 3.5 & 
3.6). The reduced HrdB level in early exponential phase might be due to the long 
lag phase and slow start of the exponential growth owing to the absence of 
RbpA. In addition, if ∆rbpA strain grows because RbpB is produced, then the 
expression of rbpB might limit the growth of the mutant. In support, RbpB 
suppresses the ∆rbpA phenotype when overexpressed under the control of a 
strong promoter ermEp. The natural expression of rbpB has not been studied in 
detail.  
 
3.3.5 RbpA in holoenzyme formation 
RbpA and Crl are unusual positive regulators of transcription (Section 1.2.9.1 & 
1.2.9.2). Crl, as mentioned above, is a positive regulator of S that increases the 
affinity of S for core RNAP. To determine whether RbpA was also involved in 
holoenzyme formation, in vivo analysis of holoenzyme HrdB content was 
determined in S. coelicolor J1981 (w/t) and S129 (∆rbpA::aac(3)IV) strains 
(Section 3.2.4). The results (Fig. 3.7) indicate that the ratio of HrdB to RNAP (as 
judged by the concentration of ) in J1981 and S129 was comparable 
throughout growth. Hence, RbpA does not appear to be involved in holoenzyme 
formation; recruiting free HrdB and facilitating its interaction with the core RNAP. 
However, it remains possible that homeostatic mechanisms present in vivo 
mask an effect, and so this needs to be verified in vitro.  
 
 
 
130 
 
 
 
 
 
 
 
 
 
 
 
 
 
4- Mapping RbpA interactions with 
HrdB
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4.0 Overview 
This chapter focuses on investigating possible interactions between RbpA (S. 
coelicolor) or Rv2050 (M. tuberculosis) with their respective sigma factors. 
Protein-protein interactions were monitored using the Bacterial Adenylate 
Cyclase-based Two-Hybrid System (BACTH) and by in vitro pull down assays. 
Previously, it was observed that RbpA interacted with the principal sigma factor, 
HrdB (P. Doughty and M. Paget, personal communication). However, the 
specificity of RbpA for different sigma factors was unknown, so this was 
investigated by BACTH. RbpA was tested for interaction with sigma factors that 
are closely related to HrdB as well as selected Group III and Group IV sigma 
factors. Finally, as RbpA was shown to interact with HrdB, it was important to 
map the exact region on HrdB that RbpA binds to. HrdB was divided into five 
fragments based on its structural domains.  
 
4.1 BACTH analysis of sigma factors with RbpA 
BACTH exploits the principle that the Bordetella pertussis’s adenylate cyclase 
catalytic site is made up of two domains, T25 and T18. When these two domains 
are expressed as separate polypeptides, the enzyme is inactive because the 
domains have no means to associate. However, the two domains can be 
brought together when each is fused to one partner of a protein-protein 
interaction pair. This leads to the activation of adenylate cyclase, which 
increases cyclic AMP production. cAMP will interact with the catabolite activator 
protein (CAP) forming the cAMP-CAP complex. This complex is recruited to 
cAMP-CAP-dependent promoters, thereby regulating gene expression including 
the lac operon of E.coli. Activation of the lac operon will induce the expression of 
the lacZ gene leading to the production of -galactosidase, which can then be 
assayed. In order to detect protein-protein interactions on a media plate, the 
chromogenic substrate X-gal was included and it is hydrolysed to a blue dye by 
-galactosidase resulting in blue colonies. The detailed methodology for BACTH 
is described in Section 2.6.  
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4.1.1 RbpA interaction with HrdB 
HrdB is the principal sigma factor of S. coelicolor that controls housekeeping 
genes and is essential for survival of the organism (Buttner et al., 1990). RbpA 
was previously shown to activate transcription of HrdB-dependent promoters 
using in vitro transcription assays (P. Doughty and M. Paget, personal 
communication). Furthermore, RbpA was shown to bind directly to HrdB in vitro 
(P. Doughty and M. Paget, personal communication). In order to confirm these 
data and to develop a system for further characterising RbpA-sigma interactions, 
the BACTH system was applied.  
 
It was decided to fuse RbpA to the T18 domain of adenylate cyclase in pUT18, 
generating a RbpA-T18 fusion, and HrdB and other sigma factors to the T25 
domain generating for example a T25-HrdB fusion. Constructs containing the 
entire hrdB gene appeared to be toxic in E. coli, and so a fragment lacking 
region 1.1 of HrdB but containing domains 2 to 4 (HrdB(2-4)) was used, which was 
determined from the structural domain organisation shown in Fig. 4.4. 
 
The HrdB(2-4) fragment was amplified using T25_hrdB(2-4) forward and reverse 
primers (Table 5- Section 2.1.5.1), introducing XbaI and EcoRI sites, 
respectively, allowing the gene to be cloned in-frame with the T25 domain when 
cloned into pKT25. rbpA was amplified with T18_rbpA forward and reverse 
primers (Table 5- Section 2.1.5.1), introducing BamHI and EcoRI sites, 
respectively, and keeping the gene in frame with the T18 domain in pUT18. 
Since the T18 subunit is located downstream of rbpA, the stop codon of rbpA 
was removed. Following amplification, the PCR products were cloned into 
pBlueScript II SK+, sequenced, then subcloned into either pKT25 and pUT18.  
 
The recombinant plasmids pKT25-hrdB(2-4) and pUT18-rbpA were used to co-
transform BTH101 competent cells by electroporation. Controls were also 
prepared containing vector only, pKT25-hrdB(2-4) alone, or pUT18-rbpA alone. 
Transformants were selected on LA plates with additional X-gal and IPTG for an 
BTH101  
pUT18 control 
pKT25 control 
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initial assessment (Fig. 4.1A). BTH101 containing both pUT18-rbpA and pKT25-
hrdB(2-4) produced blue colonies, whereas all negative controls produced white 
colonies. To quantify and confirm these interactions β-galactosidase assays 
were performed (Section 2.6) (Fig. 4.1B). BTH101 containing both pUT18-rbpA 
and pKT25-hrdB(2-4) exhibited 20-fold higher -galactosidase activity compared 
to the controls, indicating that RbpA interacts with HrdB(2-4) in this assay (Fig. 
4.1). 
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A 
 
B 
 
Figure 4.1: BACTH assay of RbpA interaction with principal sigma factor, 
HrdB(2-4), of S. coelicolor.  
(A) Blue/White screening on LA plates left to grow at 30°C for 16-24 h. (B) β-
galactosidase assay to determine RbpA interaction with HrdB(2-4). -
galactosidase activity was measured for BTH101 containing vector only, pUT18-
rbpA only, pKT25-hrdB(2-4) only and pUT18-rbpA pKT25-hrdB(2-4). This assay 
was repeated in triplicate with error bars showing standard deviation.  
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4.1.2 RbpA interaction with Group II  
The interaction of RbpA with the principal sigma factor, HrdB, raises the question 
of whether RbpA is a sigma-specific transcription factor, thereby influencing 
certain holoenzymes, or whether it binds to all sigma factors. It was therefore, 
important to test for possible interactions between RbpA and different sigma 
factors. Initially, we tested the three sigma factors that are most similar to HrdB:  
HrdA, HrdC and HrdD. Each of these is non-essential and shows extensive 
amino acid sequence similarity between domains 2 to 4, and so the domains 2-4 
of each were tested for interaction with RbpA. 
 
The conserved domains 2-4 regions of hrdA, hrdC and hrdD were amplified and 
cloned into pKT25 as described for hrdB (see above) using forward and reverse 
primers T25_hrdA(2-4), T25_hrdC(2-4) and T25_hrdD(2-4), respectively (Table 
5- Section 2.1.5.1), introducing flanking XbaI and EcoRI sites and keeping the 
genes in frame when fused to T25. pKT25-hrdA, pKT25-hrdC and pKT25-hrdD 
were electroporated together with pUT18-rbpA into BTH101 competent cells. 
BTH101 control was also prepared containing vector only.  
 
These transformants were plated on LA plates with X-gal and IPTG for 
preliminary assessment (Fig. 4.2A). BTH101 containing pUT18-rbpA and 
pKT25-hrdA or pKT25-hrdB produced blue colonies. However, BTH101 
containing pUT18-rbpA and pKT25-hrdC or pKT25-hrdD together with negative 
controls produced white colonies. To quantify and confirm these interactions β-
galactosidase assays were performed (Section 2.6) (Fig. 4.2B). BTH101 
containing pUT18-rbpA and pKT25-hrdA or pKT25-hrdB had 12-fold and 50-fold 
increase in activity of -galactosidase, respectively, compared to the control. 
These results indicate that RbpA interacts with HrdA(2-4) and HrdB(2-4) but does 
not interact with HrdC(2-4) and HrdD(2-4) in this assay (Fig.4.2). 
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A 
 
B 
 
Figure 4.2: BACTH assay of RbpA interaction with domain 2-4 of Group I 
and II sigma factors, HrdA, HrdB, HrdC, HrdD, of S. coelicolor.  
(A) Blue/White screening on LA plates grown at 30°C for 16-24 h. (B) β-
galactosidase assay of RbpA interaction with HrdA, HrdB, HrdC and HrdD. -
galactosidase assay for BTH101 cells containing vector only, pUT18-rbpA and 
pKT25-hrdA, pKT25-hrdB, pKT25-hrdC and pKT25-hrdD were measured. These 
assays were repeated using three separate colonies in triplicate with error bars 
showing standard deviation.  
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4.1.3 RbpA interaction with Group III and IV  
In addition to the Group I (principal) and Group II (principal-related) sigma 
factors, there are two remaining Groups (Groups III and IV) that include 
alternative sigma factors. Group III includes sigma factors closely related to B 
of B. subtilis, as well as WhiG, which is phylogenetically distinct from other S. 
coelicolor sigma factors, resembling the flagella-related sigma factors such as 
FliA (Helmann, 1991). Group IV contains approximately 49 ECF sigma factors of 
S. coelicolor (Paget & Helmann, 2003). The sigma factors selected to test for 
possible interaction with RbpA were the Group III sigma factors, B and WhiG, 
and the Group IV sigma factors R and E. B controls general stress response 
and is a major regulator in oxidative and osmotic stress (Viollier et al., 2003). 
WhiG is a sporulation sigma factor that triggers the onset of sporulation in aerial 
hyphae (Tan et al., 1998). R is involved in an oxidative stress response (Paget 
et al., 1998), whilst E is essential for maintaining the integrity of the cell 
envelope (Paget et al., 1999). 
 
The four different sigma factor genes sigB, sigR, sigE and whiG were amplified 
using T25_sigBSc, T25_sigR, T25_sigE and T25_whiG forward and reverse 
primers (Table 5- Section 2.1.5.1), respectively, introducing XbaI and EcoRI 
sites and keeping the genes in frame when fused to T25. The inserts were 
cloned into pBlueScript II SK+, sequenced, then sub-cloned into pKT25. 
Recombinants pKT25-sigB, pKT25-sigR, pKT25-sigE and pKT25-whiG were 
electroporated together with pUT18-rbpA into BTH101 competent cells. Positive 
and negative control strains were also prepared (see above). These were 
streaked on LA plates with additional selection with X-gal and IPTG.  
 
BTH101 containing pUT18-rbpA and pKT25-sigB, pKT25-sigR, pKT25-sigE and 
pKT25-whiG produced white colonies as the negative control. However, the 
positive control BTH101 containing pUT18-rbpA and pKT25-hrdB produced blue 
colonies (Fig. 4.3A). To confirm this result the-galactosidase assays were 
performed (Section 2.6). From the assays, there was no observed increase in -
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galactosidase activity for BTH101 pUT18-rbpA and pKT25-sigB, pKT25-sigR, 
pKT25-sigE and pKT25-whiG (Fig. 4.3B). These assays indicate that RbpA does 
not interact with B, R, E and WhiG. 
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Figure 4.3: BACTH assay of RbpA interaction with Group III and Group IV 
sigma factors: B, R, E and WhiG, of S. coelicolor.  
(A) Blue/White screening on LA plates grown at 30°C for 16-24 h. (B) β-
galactosidase assay of RbpA interaction with B, R, E and WhiG. The activity of 
-galactosidase for BTH101 containing vector only, pUT18-rbpA and pKT25-
sigB, pKT25-sigR, pKT25-sigE, pKT25-whiG and pKT25-hrdB were measured. 
These assays were repeated using three separate colonies in triplicate with 
error bars showing standard deviation. 
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4.2 Mapping the binding site of RbpA on HrdB 
After showing that RbpA interacts with HrdB, it was important to determine the 
region to which RbpA binds. Since sigma factors are composed of functionally 
distinct domains, this might shed some light on the role that RbpA plays in 
transcription initiation. Furthermore, identifying a small region of the sigma factor 
that binds to RbpA would aid in the identification of suitable sigma fragments for 
RbpA-sigma structural studies (Chapter 6).  
 
As described in Chapter 1, HrdB is composed of four domains that are 
interconnected by flexible linkers (Young et al., 2002) (Figure 4.5). These four 
domains have conserved regions 1.1, 1.2-2.4, 3.0-3.1 and 4.1-4.2. Region 1.1 is 
actually a relatively non-conserved region that has an auto-inhibitory effect on 
binding to promoter DNA. Domain 2 contains region 2.3 and 2.4 that recognise 
and bind to the -10 element of the promoter DNA and is closely linked to region 
1.2 which interacts with the “discriminator region” and is important in open 
complex stability (Haugen et al., 2008). Domain 3 recognises the “extended -10 
element”, enhancing the stability of the open complex formation. Domain 4 
interacts with -35 element of the promoter (Murakami & Darst, 2003).  
 
The structure of A of T. aquaticus was aligned against the sequence of HrdB 
using FUGUE to identify the distinct structural domains of HrdB (Fig. 4.4). The 
HrdB fragments were designed and constructed to cover the whole region of the 
sigma factor. Vassylyev et al., aligned the structure of 70 of T. thermophilus, E. 
coli and B. subtilis together and then separated the domains based on their 
structural organisation (Vassylyev et al., 2002). Using this structural organisation 
the fragments were constructed and are shown below in Figure 4.5 and Table 
11.  
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                         10        20        30        40        50   
1ku2a                                                          
HrdB             AAAKKTTAKKEDGELLEDEATEEPKAATEEPEGTENAGFVLSDEDEDDAP 
 
                          60        70        80        90        100  
1ku2a    (93)              SDPVRGYLHEIGQVPLLTLEEEIDLARKVEEGMEAIKKLS 
HrdB             AQQVAAAGATADPVKDYLKQIGKVPLLNAEQEVELAKRIEAGLFAEDKLA 

 
 
                          110       120       130       140       150  
1ku2a   (133)    EATGLDQELIREVVRAKILGTARIGKIPGLKEKPDPKTVEEVDGKLKSLP 
HrdB             NSD-------------------------------------------KLAP 
 
 
   
                          160       170       180       190       200  
1ku2a   (183)    KELKRYLHIAREGEAARQHLIEANLRLVVSIAKKYTGRGLSFLDLIQEGN 
HrdB             KLKRELEIIAEDGRRAKNHLLEANLRLVVSLAKRYTGRGMLFLDLIQEGN 


   
                          210       220       230       240       250  
1ku2a   (233)    QGLIRAVEKFEYKRRFKFSTYATWWTRQAINRAIADQARTIRIPVHMCET 
HrdB             LGLIRAVEKFDYTKGYKFSTYATWWIRQAITRAMADQARTIRIPVHMVEV 
 
 
 
                          260       270       280       290       300  
1ku2a   (283)    INKLSRTARQLQQELGREPSYEEIAEAMGPGWDAKRVEETLKIAQEPVSL 
HrdB             INKLARVQRQMLQDLGREPTPEELAKEL--DMTPEKVIEVQKYGREPISL 
 
 
                          310       320       330       340       350  
1ku3a   (333)                                       ELEKALSKLSEREAM 
HrdB             HTPLGEDGDSEFGDLIEDSEAVVPADAVSFTLLQEQLHSVLDTLSEREAG 

 
 
                          360       370       380       390       400  
1ku3a   (383)    VLKMRKGLIDGREHTLEEVGAYFGVTRERIRQIENKALRKLKYHES 
HrdB             VVSMRFGLTDGQPKTLDEIGKVYGVTRERIRQIESKTMSKLRHPSRSQVL                                                
 
 
1ku3a                               
HrdB             RDYLD 
 
Figure 4.4: Alignment of T. aquaticus A and HrdB.  
Iku2a is the PDB entry of A domain 2-3 and Iku3a is the PDB entry of A 
domain 4. There is a region within 1.2 of A that is not conserved in HrdB and 
the flexible linker between domains 3-4. This shows the different structural 
domains of HrdB together with the amino acid compositions. 
Domain 2 
Domain 3 
Domain 4 
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Figure 4.5: Constructed structural domains of HrdB.  
The fragments were designed to cover the whole region of the wild-type HrdB 
(Refer to Table 11).  
 
Table 11: HrdB fragments for BACTH analysis and in vitro pull-down 
assays.  
HrdB Fragments Nucleotide 
length (bp) 
Amino 
Acids 
N-terminal 
sequence 
C-terminal 
sequence 
Domain 1.1 and 2 
(1.1-2) 
~1000 364 fMSASTS MADQAR 
Domain 2 (2) ~430 137 TADPVK MADQAR 
Domain 3 and 4 
(3-4) 
~512 164 TIRIPV LRDYLD 
Domain 2, 3 and 4 
(2-4) 
~900 301 TADPVK LRDYLD 
Domain 4 (4) ~250 77 SFTLLQ LRDYLD 
 
 
4.2.1 In vivo analysis 
The five constructed HrdB fragments were used to identify the region to which 
RbpA binds. pKT25-hrdB(2-4) was previously obtained for BACTH analysis. The 
remaining four fragments containing domain 1.1-2, 2, 3-4, and 4, were amplified 
using T25_hrdB(1.1-2), T25_hrdB(2), T25_hrdB(3-4) and T25_hrdB(4) forward 
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and reverse primers, respectively (Table 5- Section 2.1.5.1). The fragments 
were flanked by XbaI and EcoRI sites and the fragments were cloned into 
pKT25. The recombinant pKT25-hrdB(1.1-2), pKT25-hrdB(2), pKT25-hrdB(3-4), 
pKT25-hrdB(2-4) and pKT25-hrdB(4) were electroporated with pUT18-rbpA into 
BTH101 competent cells. Control strains containing vector only were also 
prepared. These were all plated on LA with additional selection of X-gal and 
IPTG. 
 
Initial transformation experiments indicated that BTH101 containing pUT18-rbpA 
and pKT25 derivatives carrying domains 3-4 and 4 produced white colonies. 
However, BTH101 carrying pUT18-rbpA and pKT25 derivatives carrying 
domains 1.1-2, 2 and 2-4 produced blue colonies (Fig. 4.6A). β-galactosidase 
activities confirmed these data: fragments containing domain 1.1-2, 2 and 2-4 
induced 33-, 26- and 50-fold increases in -galactosidase activity compared to 
vector only controls (Fig. 4.6B). These results show that RbpA binds to HrdB(1.1-
2), HrdB(2) and HrdB(2-4) but does not bind to HrdB(3-4) and HrdB(4).  
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A 
 
B 
 
Figure 4.6: BACTH assay of RbpA interaction with the constructed 
fragments of HrdB.  
(A) Blue/White Screening on LA plates grown at 30°C for 16-24 h. (B) β-
galactosidase assay of RbpA interaction with the constructed fragments of 
HrdB. The -galactosidase activity was measured for BTH101 vector only and 
BTH101 pUT18-rbpA and pKT25-hrdB(1.1-2), pKT25-hrdB(2), pKT25-hrdB(3-4), 
pKT25-hrdB(2-4) and pKT25-hrdB(4). Three individual colonies were tested and 
the assays were done in triplicate for each colony with error bars showing the 
standard deviation. 
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4.2.2 In vitro analysis 
Using the BACTH system, RbpA was shown to bind to HrdB(1.1-2), HrdB(2) and 
HrdB(2-4) but does not seem to interact with HrdB(3-4) and HrdB(4) (Fig. 4.6). To 
further prove this, in vitro pull-down assays were designed. In this experiment, 
the fragments would be His-tagged, bound by Ni-affinity magnetic beads, and 
tested for their ability to sequester RbpA from solution. Each fragment was 
cloned as an NdeI-BglII fragment from pBlueScript II Sk (+)::hrdB(1.1-2), hrdB(2), 
hrdB(3-4), hrdB(2-4), hrdB(4) (Table 1- Section 2.1.2) into the expression vector 
pET15b, which had been digested with NdeI and BamHI. In the resulting 
expression plasmids, the HrdB fragments would be produced with N-terminal 
His-tags. Each recombinant pET15b::hrdB fragment plasmid was used to 
transform into E. coli BL21 (pLysS) and tested for expression (Section 2.3.1.1). 
Unfortunately, HrdB(1.1-2) was insoluble and therefore, work on it was 
discontinued. The remaining four fragments were soluble and purified using Ni-
NTA spin columns (Qiagen) (Section 2.3.2.3) (Fig. 4.7, lanes 3-6).  
 
In order to produce non-tagged native RbpA, rbpA was subcloned as an NdeI-
BamHI fragment from pBlueScript::rbpA (Table 1- Section 2.1.2) into the 
expression vector pET20b. pET20b::rbpA was used to transform into BL21 
(pLysS) and RbpA was purified by Q.F.F anion-exchange chromatography, 
Mono Q anion-exchange chromatography, followed by gel filtration (Fig. 4.7, 
lane 2) (Section 2.3.2.5 & 2.3.2.6). Note that RbpA often runs on SDS 
polyacrylamide gels as two bands, which is thought to be due to partial 
degradation (see below). 
 
To perform the in vitro pull-down assays, the purified His-tagged HrdB 
fragments (containing domains 2, 3-4, 2-4 and 4) were mixed with purified 
native RbpA on ice for 15 min and then mixed with magnetic Ni-affinity 
Dynabeads (Section 2.3.2.4). As a control, RbpA alone was mixed with the 
magnetic Dynabeads. The Dynabeads were washed four times with buffer, then 
any bound protein eluted using 100 l elution buffer. As shown in Figure 4.7 
lane 7, RbpA by itself did not bind to the Ni-affinity Dynabeads. In addition, 
there was no binding when mixed with HrdB(3-4) and HrdB(4) (Fig. 4.7; lane 9 & 11 
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respectively). However, when mixed with HrdB(2) and HrdB(2-4) RbpA co-eluted 
from the beads, confirming that RbpA binds specifically to HrdB fragments 
containing conserved region 1.2-2.4 (Fig. 4.7; lane 8 & 10 respectively). As 
mentioned above, RbpA was separated by SDS polyacrylamide gel as two 
bands, which might be possibly due to degradation. Indeed, in support of this 
the lower band tended to increase in relative intensity in later steps of the 
purification. Significantly, it is worth noting that only the top band interacted with 
HrdB (Chapter 5 and 6). 
 
Figure 4.7: The interaction of RbpA with HrdB(2) and HrdB(2-4).  
The pull down-assays were assessed by separating the proteins on SDS 
polyacrylamide gel. The Marker used was SeeBlue®Plus2 (Lane 1). Lanes 2 to 
6 are showing RbpA (~14kDa), HrdB(2) (~17kDa), HrdB(3-4) (~22.5kDa), HrdB(2-4) 
(~38) andHrdB(4) (~12kDa) after purification and their respective concentrations. 
Lanes 7 to 11 are the eluates from the dynabeads column. Lane 7: RbpA only, 
Lane 8: RbpA and HrdB(2), Lane 9: RbpA and HrdB(3-4), Lane 10: RbpA and 
HrdB(2-4) and Lane 11: RbpA and HrdB(4). Proteins were separated on a 4-12% 
Bis-Tris polyacrylamide gel at 120 V for 80 min, and visualised by Coomassie 
staining. 
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4.3 Rv2050 interaction with M. tuberculosis sigma factors  
RbpA homologues are found in virtually all Actinobacteria including the major 
human pathogen, M. tuberculosis. This is of particular interest because RNAP is 
the target of the frontline tuberculosis antibiotic, rifampicin. Therefore, the next 
step was to identify whether the RbpA homologue in M. tuberculosis, Rv2050, 
behaves in a similar manner to RbpA in S. coelicolor. Recently, it was found 
that Rv2050 is an essential gene in M. tuberculosis (Forti et al., 2011) raising 
the possibility that Rv2050 might be a useful drug target. 
 
HrdB, the principal sigma factor in S. coelicolor, has two homologues in M. 
tuberculosis; the first homologue is Rv2703 (A). A is the principal sigma factor 
in M. tuberculosis and is involved in expression of house-keeping genes and 
also modulates expression of some virulence genes (Rodrigue et al., 2006). It is 
81% identical to σHrdB with 528 amino acids and a molecular mass of 57768.1 
Da. The other homologue of HrdB is Rv2710 (B) which is a Group II/principal-
like sigma factor. It controls genes involved in stress response, example heat-
shock response, and stationary phase survival, and is itself induced by stress 
(Rodrigue et al., 2006). It is 61% identical to σHrdB with 323 amino acids and a 
molecular mass of 36343.2 Da. 
 
4.3.1 A and B 
Rv2050 was amplified with T18_Rv2050 forward and reverse primers (Table 5- 
Section 2.1.5.1) introducing BamHI and EcoRI sites and keeping the gene in 
frame when fused to pUT18. sigA and sigB were amplified using T25_sigAMt 
and T25_sigBMt forward and reverse primers (Table 5- Section 2.1.5.1), 
respectively, introducing an XbaI and EcoRI site and keeping the genes in 
frame when fused to pKT25. The inserts were cloned into pBlueScript II SK+, 
sequenced and sub-cloned into pUT18 or pKT25. Recombinant pUT18_Rv2050 
together with pKT25_sigAMt or pKT25_sigBMt were electroporated into 
BTH101 competent cells. Control strains were also prepared. These were 
streaked on LA plates with additional selection with X-gal and IPTG.  
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Negative control BTH101 containing vector only and pUT18-Rv2050 only 
produced white colonies. However, BTH101 containing pUT18-Rv2050 and 
pKT25-sigAMt and pKT25-sigBMt produced blue colonies (Fig. 4.8A). To 
confirm this result, the-galactosidase assays were performed (Section 2.6). -
galactosidase activity of BTH101 pUT18-Rv2050 and pKT25-sigAMt, pKT25-
sigBMt had 18- and 24- fold higher -galactosidase activity compared to the 
negative controls, respectively (Fig. 4.8B). These results suggest that Rv2050 
interacts with A and B in M. tuberculosis. 
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A 
 
B 
 
Figure 4.8: BACTH assay of Rv2050 interaction with principal sigma 
factor, A, and principal-like sigma factor, B, of M. tuberculosis.  
(A) Blue/White Screening on LA plates grown at 30°C for 16-24 h. (B) -
galactosidase assay of Rv2050 interaction with A and B. The -galactosidase 
activity was measured for BTH101 containing vector only, pUT18-Rv2050 only, 
pUT18-Rv2050 and pKT25-sigAMt and pKT25-sigBMt. Three individual 
colonies were tested and the assays were done in triplicate for each colony with 
error bars showing the standard deviation. 
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4.3.2 Rv2050 interaction with sigma domain 2 
 
4.3.2.1 In vivo analysis 
RbpA was shown to bind to HrdB(2) (Fig. 4.6) and Rv2050 was shown to interact 
with A (Fig. 4.8). Therefore, it was decided to test if Rv2050 also interacts with 
domain 2 i.e region 1.2-2.4 of its principal sigma factor, A, and HrdB(2) using 
BACTH assay. The equivalent region of HrdB(2) was determined in A using 
Clustal W alignment tool (data not shown). sigA(2) fragment was amplified using 
T25_sigA(2) forward and reverse primers (Table 5- Section 2.1.5.1), which was 
flanked by XbaI and EcoRI sites and cloned into pKT25. Recombinant pKT25-
sigA(2) and pKT25-hrdB(2)(see above) were co-transformed together with 
pUT18-Rv2050 into competent BTH101 cells by electroporation. Positive and 
negative control strains were also prepared (see above). To quantify and 
confirm these interactions, the β-galactosidase assay was performed (Section 
2.6). The assay showed that domain 2 of A and HrdB induced 46- and 28-fold 
increase in -galactosidase activity compared to the vector only control, 
respectively. This result suggests that Rv2050 interacts with both A(2) and 
HrdB(2) (Fig. 4.9). 
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Figure 4.9: The β-galactosidase activity of the interaction of Rv2050 with 
A(2) and HrdB(2).  
The -galactosidase assay was performed on BTH101 containing vector only, 
pUT18-Rv2050 and pKT25-sigA(2), pKT25-sigA, pKT25-hrdB(2) together with the 
positive control pUT18-rbpA and pKT25-hrdB(2-4). Three individual colonies were 
tested and the assays were repeated in triplicate for each colony with error bars 
showing the standard deviation. 
 
 
4.3.2.2 In vitro analysis  
To further verify the results obtained from BACTH that Rv2050 interacts with 
HrdB(2), the in vitro pull down assay was used. HrdB(2) fragment was previously 
His-tagged and purifed (Section 4.2.2). In order to produce non His-tagged 
native Rv2050, Rv2050 was amplified using Rv2050 reverse and forward 
primers (Table 7- Section 2.1.5.3), cloned into pBlueScript II SK+ and 
subcloned as an NdeI-BamHI fragment into the expression vector pET20b. 
pET20b::Rv2050 was used to transform into BL21 (pLysS) and Rv2050 was 
purified by QFF anion-exchange chromatography, Mono Q anion-exchange 
chromatography, followed by gel filtration (Section 2.3.2.5 & 2.3.2.6) (Fig. 4.10, 
lane 3). 
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Rv2050 and His-tagged HrdB(2) were mixed together with magnetic Ni-affinity 
Dynabeads (Section 2.3.2.4). The beads were washed four times with wash 
buffer and eluted in 100 l elution buffer (see above). As shown in Fig. 4.10, 
RbpA and Rv2050 by themselves did not bind to the Ni-affinity dynabeads (Fig. 
4.10, lane 9 & 10). Also, RbpA did not bind to HrdB(4) (Fig. 4.10, lane 8). 
However, when Rv2050 and RbpA were mixed with HrdB(2) both co-eluated 
from the beads (Fig. 4.10, lane 6 & 7). These results confirm that Rv2050 binds 
to domain 2 of HrdB.  
 
Figure 4.10: The interaction of Rv2050 with HrdB(2).  
The pull down-assays were assessed by separating the proteins on SDS 
polyacrylamide gel. The Marker used was SeeBlue®Plus2 (Lane 1). Lanes 2 to 
5 are showing RbpA (~14kDa), Rv2050 (~12.5kDa), HrdB(2) (17kDa) and HrdB(4) 
(~12kDa), respectively, after purification. Lanes 6 to 10 are the eluates from the 
dynabeads column. Lane 6: RbpA and HrdB(2), Lane 7: Rv2050 and HrdB(2), 
Lane 8: RbpA and HrdB(4), Lane 9: RbpA only and Lane 10: Rv2050 only. The 
gel used was 4-12% Bis-Tris polyacrylamide gel which was run at 120 V for 80 
min. The proteins were visualised using Coomassie Blue staining. 
 
 
4.4 Discussion 
 
4.4.1 RbpA binds to HrdA and HrdB  
Using BACTH, RbpA was shown to interact with the principal sigma factor, HrdB 
and to some extent with the principal-like sigma factor, HrdA. There was no 
interaction of RbpA with the other two principal-like sigma factors, HrdC and 
HrdD. The reason for RbpA interaction with HrdA and HrdB but not with HrdC 
153 
 
and HrdD is currently unknown. However, it is worth noting that the level of 
amino acid conservation between HrdB and HrdA along conserved region 1.2 to 
2.4 is slightly higher than the equivalent region of HrdC and HrdD (Fig. 4.11). 
This suggests that key amino acids that are involved in sigma-RbpA interaction 
in HrdB are absent in HrdC and HrdD.  
 
However, the result obtained from the BACTH assay of the interaction of RbpA 
with HrdD was contradictory to previous work performed using surface plasmon 
resonance (BIAcore 2000), where HrdD was shown to bind to RbpA (P. 
Doughty, and M. Paget, personal communication). However, the HrdD-RbpA 
interaction appeared to be at least 4-fold weaker than the HrdB-RbpA 
interaction. This weaker interaction might not be detected by the BACTH 
assays. Also, another disadvantage of the BACTH system is that the proteins 
fused to the pKT25 and pUT18 vectors might not be expressed or might be 
unstable when produced, and therefore degraded. As a result, further work 
needs to be done to determine whether the proteins, HrdC and HrdD were 
indeed expressed and not degraded in vivo. To verify these interactions, in vitro 
pull-down assays can also be performed.   
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HrdA    ----SSDLFRQYLREIGRIPLLSAAEEVDLARRVEAGLFAEEKLRCSPG----LDDRLAL 53 
HrdB    ----TADPVKDYLKQIGKVPLLNAEQEVELAKRIEAGLFAEDKLANSDK----LAPKLKR 53 
HrdC    ----EPDLLGQYLTQIGATPLLTAEDEVRLATRIEAGVRAREELETADTGEPAPTPRRRR 57 
HrdD    ----DRDLVGMYLDEIARTPLLDAAKEVELSQTIEAGVFARQVLEGYEETG---ADATRE 54 
 
 
 
HrdA    DLDRLVVLGRLAKRRLIEANLRLVVSVAKRYVGRGLTMLDLVQEGNLGLIRAVEKFDYAR113 
HrdB    ELEIIAEDGRRAKNHLLEANLRLVVSLAKRYTGRGMLFLDLIQEGNLGLIRAVEKFDYTK113 
HrdC    TLEETVHDGQEAKDHMVRANLRLVVSMAKRHAHRGLPLLDVIQEGNLGLIRAVEKFDHTK117 
HrdD    ELQALIDESERAKDVFIRSNLRLVVAVARRYPRSGLPLLDLIQEGNAGLVRAVEKFDYRK114 
 
 
 
HrdA    GYKFSTYATWWIRQAMSRALADQARTIRVPVHVVELINRVVRVQRRMLQERGCEPTPQEV173 
HrdB    GYKFSTYATWWIRQAITRAMADQARTIRIPVHMVEVINKLARVQRQMLQDLGREPTPEEL173 
HrdC    GFKFSTYATWWIRQAIERGLATHARTVRLPVHVVEQLQKLAKVERKLRAGLDREPTTEEV177 
HrdD    GFKFSTYATWWIRQAITRSIADQSRTIRLPVHLVEELGRIRRVQREFNREHGREPEPAEI174 
 
 
 
HrdA    AAHLDLAPERVGEVLRLAQEPVSLHAPVGEEDDVALGDLIEDGDAASPVESAAFLLLRQH 233 
HrdB    AKELDMTPEKVIEVQKYGREPISLHTPLGEDGDSEFGDLIEDSEAVVPADAVSFTLLQEQ 233 
HrdC    AAESGIDVDKVVWLRRVGRDAVSLDTPVDETGDTVVGDLIPDTEVLRAPEVAEFQALAAE 237 
HrdD    AAELGSTPERVTDVLDWARDPVSLNMSVDDEGETQFGDLLEDTSAVSPEQSVLTLLRSEE 234 
 
 
 
HrdA    LEAVLSTLGERERKVVQLRYGLADGRPRTLEEIGRLFGVTRERIRQIESKTLSKLRDHAY 293 
HrdB    LHSVLDTLSEREAGVVSMRFGLTDGQPKTLDEIGKVYGVTRERIRQIESKTMSKLRHPSR 293 
HrdC    LREAVGTLAPRESLILSLRYGLHDGRPRTLQQVAQHVGLTRERVRQLEKESLAHLRAPEN 297 
HrdD    LDDLIGRLDPRTASIIKMRYGIDDGRERTLTEVGKEHGLTRERIRQIEKHALLELKKLAR 294 
 
 
 
HrdA    ADQLRGYLD 302 
HrdB    SQVLRDYLD 302 
HrdC    RERLLDWAS 306 
HrdD    DTGFEAAA- 302 
 
Figure 4.11: The multiple sequence alignment of domains 2-4 of HrdA, 
HrdB, HrdC and HrdD.  
The Clustal W2 multiple sequence alignment tool and the BOXSHADE 3.21 
server were used. Amino acids in white font with black highlight show identical 
residues whilst amino acids in white font with grey highlight show similar 
residues. The homology was tested to the 0.7 fraction that must agree for 
shading. The most conserved domain 2 is indicated with arrows.   
  
Domain 2 
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4.4.2 The principal sigma factor, HrdB 
RbpA has been shown to interact with HrdB and HrdA using BACTH assays 
(Fig. 4.2). However, which of these sigma factors does RbpA bind to in vivo? A 
BLAST search was done using the amino acid sequence of HrdB against the 
Actinobacteria in the Integrated Microbial Genome (IMG) database. It was 
shown that some of these organisms only contained a principal sigma factor 
and no principal-like sigma factor, e.g. Actinomyces coleocanis, Actinomyces 
oris, and Bifidobacterium bifidum. Bacteria contain at least one sigma factor that 
plays a major role in expression of housekeeping genes and is vital for the 
viability of the organism. RbpA is nevertheless, present in these organisms that 
lack principal-like sigma factors, which further suggests that HrdB is the main 
target of RbpA in vivo (Table A1- Appendices). 
 
As RbpA interacts with HrdB, it was decided to determine the level of 
conservation of HrdBin the Actinobacteria.  Alignment of HrdB homologues from 
the different genera obtained from the BLAST search above, showed that HrdB 
was well conserved amongst the Actinobacteria (Fig.A2- Appendices; Sig_Mt to 
Sig_Fa). Therefore, both RbpA and HrdB were highly conserved amongst the 
Actinobacteria, although RbpA was absent in some species (Table A1- 
Appendices). 
 
It was decided to determine whether there is any clear difference in HrdB 
sequences in organisms containing RbpA with those that do not in the 
Actinobacteria. Hence, the amino acid sequences of HrdB homologues from the 
Actinobacteria lacking RbpA, together with HrdB homologues from 
Actinobacteria containing RbpA, were aligned (Fig.A2- Appendices). From this 
multiple sequence alignment, there is no apparent difference in the level of 
amino acid conservation of HrdB in either the Actinobacteria containing RbpA 
(Fig.A2- Appendices, bottom 8 sequences) or those lacking RbpA (Fig. A2- 
Appendices, top 7 sequences). Therefore, the organisms lacking RbpA may 
have evolved a different way to overcome the need for RbpA whilst keeping the 
principal sigma factor sequences relatively similar (Section 3.3.1). As a result, it 
is unclear why RbpA is utilised in some Actinobacteria but not in others.  
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4.4.3 RbpB interaction with sigma factors 
RbpA was shown to have a paralogue, RbpB, in S. coelicolor (Section 3.1.2), 
which was shown to partially compensate for the loss of RbpA in S. coelicolor 
strains when overexpressed (K. Newell and M. Paget, personal 
communication). Therefore, it was considered that the role of RbpB might be to 
activate one or more principal-like sigma factors, or possibly other sigma factors 
in S. coelicolor ∆rbpA strains, therefore ensuring viability. However, recent 
BACTH work has shown that RbpB interacted with HrdA and HrdB but not with 
HrdC, HrdD, B, E, R and WhiG (In collaboration with R. Lewis and M. Paget, 
unpublished observations). This might explain why S. coelicolor ∆rbpA strains 
are viable; RbpB might partially take over the role of RbpA through binding to 
HrdB, leading to the activation of HrdB-dependent promoters, hence, 
maintaining the survival of the organism. In addition, since both RbpA and RbpB 
interact with HrdB, they might recognise different promoter sequences and 
possibly modulate the activity of HrdB. 
 
4.4.4 RbpA interacts at domain 2 of HrdB 
RbpA was shown to interact with all the fragments of HrdB that contained 
domain 2: 1.1-2, 2 and 2-4 (Fig. 4.6). Even though BACTH is not a quantitative 
test, the -galactosidase activity was 2-fold higher for the interaction of RbpA 
with HrdB containing domain 2-4 compared to the interaction of RbpA with HrdB 
containing domain 2. This suggests that domain 2-4 may provide a better 
binding surface for RbpA. Another possibility for the decrease in -
galactosidase activity in HrdB(2) compared to HrdB(2-4) might be due to the 
difference in the folding of the fragments and their conformation, which will 
affect RbpA binding.  
 
Sigma domain 2 is composed of sub-regions 1.2, 2.1, 2.2, 2.3 and 2.4 which are 
highly conserved in the 70 family (Murakami & Darst, 2003). Each of these 
regions play an important role in the core RNAP binding (region 1.2-2.2), 
promoter melting (region 2.3), the recognition and binding of the -10 element 
(region 2.4), which leads to open complex formation (Section 1.2.4.1). E. coli 
70(2) was shown to make multiple contacts with the core RNAP via the α-helical 
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coiled-coil β’ domain (Vassylyev et al., 2002). The RNAP β’ coiled-coil subunit 
interacts with 70 region 2.2, inducing the A-11 base in the non-template strand of 
the -10 element to flip out, followed by a 90° kink in the non-template DNA 
strand, which causes the T-7 base of the non-template strand of the -10 element 
to also flip. This leads to complete promoter melting, the -10 element sequence 
recognition, and thereby, the formation of the open complex (Young et al., 2001, 
Feklistov & Darst, 2011). 
 
As RbpA interacts with region 1.2-2.4 of HrdB, it may aid in the melting of the 
DNA, allowing region 2.4 to bind to the -10 element thus, leading to the open 
complex formation. It may also increase the stability of the open complex. A role 
in open complex formation or stability is supported by the KMnO4 assay, which 
showed that in the presence of RbpA, the level of promoter DNA melting 
increased (P. Doughty and M. Paget, personal communication). The exact role 
of RbpA in transcription initiation, however, has not yet been defined.  
 
4.4.5HrdB lacks a non-conserved region between region 1.2 to 2.1 
The ability of RbpA to interact with the T. thermophilus principal sigma factor, 
A(2), was tested using BACTH assays. Interestingly, RbpA was shown not to 
interact with A(2) (In collaboration with R. Lewis and M. Paget, unpublished 
observation). The main difference between A(2) and HrdB(2) is that HrdB(2) lacks 
a non-conserved amino acid region that is present between region 1.2 to 2.1 in 
A(2) (Fig. 4.12). This NCR between region 1.2 to 2.1 is also present in E. coli, 
Salmonella typhimurium, Pseudomonas aeruginosa and other principal sigma 
factors (Malhotra et al., 1996). However, this region is absent from the principal 
sigma factors of S. coelicolor (Fig. 4.12- dark grey highlight), B. subtilis, 
Staphylococcus aureus and other principal sigma factors (Malhotra et al., 1996). 

70 NCR was shown to have no effect on transcription in vitro (Kumar et al., 
1995) on some promoters. However, the deletion of 70 NCR was shown to be 
important for cell viability (Leibman & Hochschild, 2007). 70 NCR was shown to 
interact with ’ subunit of RNAP close to its N-terminus and this interaction was 
shown to inhibit 70-dependent pausing (Leibman & Hochschild, 2007). The 70-
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dependent pausing occurs when 70(2) interacts with ’ coiled-coil subunit of 
RNAP, recognises and binds to a -10-like element on the non-template strand 
during elongation (Ring et al., 1996). 70 NCR-’ interaction was also shown to 
assist in promoter escape in contrast to the role of 70(2)-’coiled-coil interaction, 
which appears to obstruct promoter escape (Leibman & Hochschild, 2007). 
Therefore, one can speculate that a possible function of RbpA is to bind to 
HrdB(2) and possibly ’ subunit of RNAP and thereby aid in promoter escape.  
 
SigAtt      MKKSKRKNAQAQEAQETEVLVQEEAEELPEFPEGEPDPDLEDPDLALEDDLLDLPEEGEG 60 
HrdB(2)      ------------------------------------------------------------ 
 
 
SigAtt      LDLEEEEEDLPIPKISTSDPVRQYLHEIGQVPLLTLEEEVELARKVEEGMEAIKKLSEIT 120 
HrdB(2)     ----------------TADPVKDYLKQIGKVPLLNAEQEVELAKRIEAGLFAEDKL---- 40 
                            *:***::**::**:****. *:*****:::* *: * .**     
 
SigAtt      GLDPDLIREVVRAKILGSARVRHIPGLKETLDPKTVEEIDQKLKSLPKEHKRYLHIAREG 180 
HrdB(2)     -----------------------------------------------------------G 41 
                                                                       * 
 
SigAtt      EAARQHLIEANLRLVVSIAKKYTGRGLSFLDLIQEGNQGLIRAVEKFEYKRRFKFSTYAT 240 
HrdB(2)     RRAKNHLLEANLRLVVSLAKRYTGRGMLFLDLIQEGNLGLIRAVEKFDYTKGYKFSTYAT 101 
            . *::**:*********:**:*****: ********* *********:*.: :******* 
 
SigAtt      WWIRQAINRAIADQARTIRIPVHMVETINKLSRTARQLQQELGREPTYEEIAEAMGPGWD 300 
HrdB(2)     WWIRQAITRAMADQAR-------------------------------------------- 117 
            *******.**:*****                                             
 
SigAtt      AKRVEETLKIAQEPVSLETPIGDEKDSFYGDFIPDEHLPSPVDAATQSLLSEELEKALSK 360 
HrdB(2)     ------------------------------------------------------------ 
 
 
SigAtt      LSEREAMVLKLRKGLIDGREHTLEEVGAFFGVTRERIRQIENKALRKLKYHESRTRKLRD 420 
HrdB(2)     ------------------------------------------------------------ 
 
 
SigAtt      FLD 423 
HrdB(2)     --- 
 
Figure 4.12: The pairwise sequence alignment of HrdB(2) and T. 
thermophilus principal sigma factor, A.  
The light grey shaded region indicates the start and end amino acid sequences 
of region 1.2 to 2.4. The dark grey shaded region indicates the amino acids 
absent from HrdB(2). This alignment was performed using Clustal W 2.1. The 
asterisk (*)= completely conserved residues, double dots (:)= highly conserved 
residues, and single dot (.)= slightly conserved residues.  
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4.4.6 Crl, a possible analogue of RbpA 
RbpA is the first described positive regulator of the principal sigma factor that 
interacts with region 1.2 to 2.4. Most proteins that interact with domain 2 of the 
sigma factor are the anti-sigma factors, for example ChrR binds to domain 2 
and 4 of E in Rhodobacter sphaeroides preventing E from forming stable 
complex with core RNAP (Campbell et al., 2007). Another protein that has 
recently been shown to interact with sigma and might function in an analogous 
way to RbpA is Crl (Section 1.2.9.1). Crl, in Salmonella enteric, was shown to 
bind to domain 2 of s, a stationary-phase sigma factor (Monteil et al., 2010b), 
and leads to the activation of s-dependent genes (England et al., 2008). It is 
thought that Crl might be involved in aiding holoenzyme formation (Gaal et al., 
2006), or formation of the open complex (Monteil et al., 2010b). There is some 
evidence that Crl also binds to 70 and activates 70-dependent transcription 
(Gaal et al., 2006).  
 
Crl is not present in the Actinobacteria. A BLAST search showed that there are 
143 genomes that contain Crl, all in Gammaproteobacteria that contain an rpoS 
gene (Monteil et al., 2010a). Using PSIPRED secondary structure prediction, 
Crl was shown to have an N-terminal helix, followed by four -strands and a C-
terminal amphipathic helix (Fig. 4.13). RbpA was shown in Section 3.1.1 to have 
four -strands and a C-terminal amphiphatic helix. Due to the similarity in 
structure and some conserved residues in the amphiphatic helix (H2) (Fig. A3- 
Appendix), it is possible that the interaction of these proteins with sigma region 
1.2 to 2.4 might involve some residues from the H2 (Chapter 5). Hence, Crl and 
RbpA might have analogous function.  
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Conf: 999999991178866665177423357789814565455510269997423210244440 
Pred: CCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCEEEEEEEEEECCCCCCCCCCCCCEEEEEE 
  AA: MTLPSGHPKSRLIKKFTALGPYIREGQCEDNRFFFDCLAVCVNVKPAPEKREFWGWWMEL 
              10        20        30        40        50        60 
 
 
Conf: 561580799985221278999343215962679999999999999999999851553245 
Pred: EEECCEEEEEEEEECCCCCCCCEEECCCCHHHHHHHHHHHHHHHHHHHHHHHHCCCCCCC 
  AA: EAQEKRFTYRYQFGLFDKEGNWTVVPINETEVVERLEYTLREFHEKLRDLLISMELALEP 
              70        80        90       100       110       120 
 
 
Conf: 8678768743489 
Pred: CCCCCCCCCCCCC 
  AA: SDDFNDEPVKLSA 
             130 
 
Figure 4.13: Secondary structure prediction of Crl.  
The grey shaded region show the amphiphatic helix of Crl. Using the PSIPRED 
HFORMAT (V2.6) by David Jones, Conf: confidence level, Pred: secondary 
prediction and AA: amino acids. C represents random coils, E: -strands, and 
H: helices. 
 
 
4.4.7 The importance of Rv2050 in M. tuberculosis 
Rv2050, the homologue of RbpA in M. tuberculosis, has been shown to be an 
essential gene in M. tuberculosis. Recent work involving knocking out Rv2050 
by transposon mutagenesis have shown that M. tuberculosis can no longer 
grow (Forti et al., 2011). Consistent with this, Rv2050 was shown to interact 
with it’s principal essential sigma factor, A, and its principal-like sigma factor, 
B (Fig. 4.8). A is involved in controlling housekeeping genes and also some 
virulence genes, whilst B is involved in general stress response and in the 
regulation of stationary-phase genes (Section 1.2.3.2). Rv2050 was also shown 
to interact with HrdB(2) (Fig. 4.10) and this data is consistent with earlier studies 
where Rv2050 introduced into S. coelicolor ∆rbpA strain would partially 
complement the ∆rbpA strain (Newell et al., 2006). A multiple sequence 
alignment of A, B and HrdB(2) showed a high level of amino acid conservation 
between region 1.2 to 2.4 of these sigma factors (Fig. 4.14). This explains the 
strong interaction observed for Rv2050 interaction with both sigma factors, A 
and B, in M. tuberculosis (Fig. 4.8).  
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Rv2050 was shown to have no paralogues in M. tuberculosis unlike the case in 
S. coelicolor (Table A1- Appendices). In S. coelicolor, RbpB was shown to 
interact with HrdB and HrdA, and may take over some of the roles of RbpA in a 
S. coelicolor ∆rbpA strain (Section 4.4.3). This might explain why Rv2050 is 
essential in M. tuberculosis, while RbpA is not essential in S. coelicolor.  
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SigA     1 VAATKASTATDEPVKRTATKSPAASASGAKTGAKRTAAKSASGSPPAKRATKPAARSVKP 
HrdB2    1 ------------------------------------------------------------ 
SigB     1 ------------------------------------------------------------ 
 
SigA    61 ASAPQDTTTSTIPKRKTRAAAKSAAAKAPSARGHATKPRAPKDAQHEAATDPEDALDSVE 
HrdB2    1 ------------------------------------------------------------ 
SigB     1 ------------------------MADAPTR---ATTSR--------------------- 
 
 
SigA   121 ELDAEPDLDVEPGEDLDLDAADLNLDDLEDDVAPDADDDLDSGDDEDHEDLEAEAAVAPG 
HrdB2    1 ------------------------------------------------------------ 
SigB    13 -------------VDSDLDAQSP------------------------------------- 
 
 
SigA   181 QTADDDEEIAEPTEKDKASGDFVWDEDESEALRQARKDAELTASADSVRAYLKQIGKVAL 
HrdB2    1 -------------------------------------------TADPVKDYLKQIGKVPL 
SigB    23 -------------------------------------------AADLVRVYLNGIGKTAL 
 
 
 
SigA   241 LNAEEEVELAKRIEAGLYATQLMTELSERGEKLPAAQRRDMMWICRDGDRAKNHLLEANL 
HrdB2   18 LNAEQEVELAKRIEAGLFAEDKLANS----DKLAPKLKRELEIIAEDGRRAKNHLLEANL 
SigB    40 LNAAGEVELAKRIEAGLYAEHLLETR----KRLGENRKRDLAAVVRDGEAARRHLLEANL 
 
 
SigA   301 RLVVSLAKRYTGRGMAFLDLIQEGNLGLIRAVEKFDYTKGYKFSTYATWWIRQAITRAMA 
HrdB2   74 RLVVSLAKRYTGRGMLFLDLIQEGNLGLIRAVEKFDYTKGYKFSTYATWWIRQAITRAMA 
SigB    96 RLVVSLAKRYTGRGMPLLDLIQEGNLGLIRAMEKFDYTKGFKFSTYATWWIRQAITRGMA 
 
 
SigA   361 DQARTIRIPVHMVEVINKLGRIQRELLQDLGREPTPEELAKEMDITPEKVLEIQQYAREP 
HrdB2  134 DQAR-------------------------------------------------------- 
SigB   156 DQSRTIRLPVHLVEQVNKLARIKREMHQHLGREATDEELAAESGIPIDKINDLLEHSRDP 
 
 
SigA   421 ISLDQTIGDEGDSQLGDFIEDSEAVVAVDAVSFTLLQDQLQSVLDTLSEREAGVVRLRFG 
HrdB2      ------------------------------------------------------------ 
SigB   216 VSLDMPVGSEEEAPLGDFIEDAEAMSAENAVIAELLHTDIRSVLATLDEREHQVIRLRFG 
 
 
SigA   481 LTDGQPRTLDEIGQVYGVTRERIRQIESKTMSKLRHPSRSQVLRDYLD 
HrdB2      ------------------------------------------------ 
SigB   276 LDDGQPRTLDQIGKLFGLSRERVRQIERDVMSKLRHGERADRLRSYAS 
 
Figure 4.14: The multiple sequence alignment of HrdB(2) against A and B 
of M. tuberculosis.  
The Clustal W2 multiple sequence alignment tool and the BOXSHADE 3.21 
server were used. Amino acids shown in white font with black highlight show 
identical residues whilst the amino acids in white font with grey highlight show 
similar residues. The homology was tested to the 0.7 fraction that must agree 
for shading. The most conserved domain 2 is indicated with arrows. 
 
 
 
  
Domain 2 
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5- Mutagenesis of rbpA 
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5.0 Overview 
In Chapter 4, RbpA was shown to interact with domain 2 of HrdB. This chapter 
focuses on determining the region of RbpA that interacts with HrdB using a 
combination of BACTH and site-directed mutagenesis. Constructed RbpA 
mutants were tested for interaction with HrdB in vivo using BACTH and in vitro 
pull-down assays. Finally, in vitro transcription assays were performed to test 
whether selected mutations that appeared to affect RbpA function in vivo, 
influenced transcription initiation under defined conditions.   
 
5.1 Identifying the HrdB binding region of RbpA 
RbpA was found to interact with HrdB(2) both in vivo and in vitro (Section 4.2). 
However, it was not known which region of RbpA was involved in this 
interaction. RbpA is predicted to have a -strand region, a highly conserved 
Helix 1 and an amphiphatic helix, Helix 2 (Section 3.1.1). Therefore, three 
different truncated fragments of RbpA were designed and constructed as shown 
in Fig. 5.1 and Table 12: RbpA lacking Helix 1 and Helix 2 (RbpA∆H1-∆H2); RbpA 
lacking Helix 2 (RbpA∆H2); and RbpA containing only the C-terminal region, that 
is Helix 1 and Helix 2 (RbpA∆) (Fig. 5.1 and Table 12). 
 
 
 
Figure 5.1: Truncated fragments of RbpA.  
RbpA fragments were constructed containing the -strand region only (RbpA∆H1-
∆H2), the -strand and Helix 1 (RbpA∆H2), and only Helix 1 and the Helix 2 region 
(RbpA∆). 
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Table 12: The three different fragments designed for RbpA.  
RbpA 
Fragment 
Regions of 
RbpA 
Nucleotide 
length (bp) 
Amino 
acids 
N-terminal 
sequence 
C-terminal 
sequence 
RbpA∆H1-
∆H2 
-strand 
region 
~217 72 MSERA GDGPE 
RbpA∆H2 -strand 
region and 
Helix 1 
~261 90 MSERA LMERR 
RbpA∆ Helix 1 and 
Helix 2  
~158 52 EKKAK SRKSA 
 
5.1.1 HrdB interaction with RbpA fragments  
The three truncated derivatives of RbpA, that is RbpA∆H1-∆H2, RbpA∆H2, and 
RbpA∆ were amplified using T18_rbpA∆H1-∆H2, T18_rbpA∆H2 and T18_rbpA∆ 
forward and reverse primers, respectively (Table 5- Section 2.1.5.1), and 
subcloned into pUT18 (Section 4.1.1). The recombinant plasmids pUT18-
rbpA∆H1-∆H2, pUT18-rbpA∆H2 and pUT18-rbpA∆were co-transformed together 
with pKT25-hrdB(2-4) (Section 4.1.1) into E. coli BTH101 competent cells by 
electroporation. Controls were also prepared containing vector only as a 
negative control and containing pUT18-rbpA (Section 4.1.1) and pKT25-hrdB(2-4) 
as a positive control. Transformants were selected on LA with additional 
selection of X-gal and IPTG for initial assessment (Fig. 5.2A). 
 
BTH101 containing pUT18-rbpA∆and pKT25-hrdB
(2-4) together with the positive 
control produced blue colonies, whereas BTH101 containing pKT25-hrdB(2-4) 
and pUT18-rbpA∆H1-∆H2, pUT18-rbpA∆H2 and the negative control produced white 
colonies (Fig. 5.2A). To quantify and confirm these interactions β-galactosidase 
assays were performed (Section 2.6). BTH101 containing pUT18-rbpA∆and 
pKT25-hrdB(2-4) had 38-fold increase in -galactosidase activity compared to 
vector only control (Fig. 5.2B). These results indicate that the C-terminal region 
of RbpA, including Helix 1 and Helix 2, interacts with HrdB(2-4). The assays also 
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suggest that the N-terminal region of RbpA, including the -strand region, is not 
involved in the interaction with HrdB (Fig. 5.2). 
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A 
 
B 
 
Figure 5.2: BACTH assay of HrdB interaction with truncated RbpA 
derivatives.  
(A) Blue/White screening on LA plates grown at 30°C for 16-24 h. (B) β-
galactosidase assay of HrdB interaction with the constructed fragments of 
RbpA: RbpA∆H1-∆H2, RbpA∆H2, and RbpA∆The -galactosidase activity was 
measured for BTH101 containing pKT25-hrdB and pUT18-rbpA∆H1-∆H2, pUT18-
rbpA∆H2, pUT18-rbpA∆, and pUT18-rbpAw/t together with vector only control. 
Three individual colonies were tested and the assays were done in triplicate for 
each colony with error bars showing the standard deviation.  
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5.2 Site-directed mutagenesis of C-terminal region of RbpA 
The C-terminal region of RbpA was shown to interact with HrdB, using BACTH 
assays (Section 5.1.1). In order to identify amino acids that are crucial for this 
interaction, conserved residues within the C-terminal region of RbpA were 
selected (Fig. 5.3) and substituted by alanine using site-directed mutagenesis. 
Initially, the mutants were introduced into a S. coelicolor ∆rbpA strain to test for 
complementation (Section 5.2). Subsequently, selected RbpA mutant proteins 
were checked for interaction with HrdB (Section 5.3 & 5.4) and whether they 
could stimulate transcription initiation (Section 5.6).  
MSERALRGTRLVVTSYETDRGIDLAPRQAVEYACEKGHRFEMPFSVEAEIPPEWEC
KVCGAQALLVDGDGPEEKKAKPARTHWDMLMERRTREELEEVLEERLAVLRSGAMN
IAVHPRDSRKSA
Helix 2Helix 1
-strands
 
 
 
 
5.2.1 Constructing  rbpA mutants  
In order to allow the analysis of the constructed rbpA mutants in vivo and in 
vitro, an NdeI site was engineered at the start codon of the rbpA gene in the 
native promoter-ORF context. The rbpA gene together with its promoter region 
already present in pMT3000 vector (Table 1- Section 2.1.2) was amplified 
simultaneously introducing an NdeI site, using the rbpA_NdeI forward and 
Figure 5.3: The amino acid sequence and secondary structure prediction of 
RbpA.  
The horizontal arrows represent the -strands (green arrows), Helix 1 (purple 
cylinder) and the Helix 2 (blue cylinder). Residues underlined in Helix 1, ERR 
motif and Helix 2 were selected for site-directed mutagenesis.  
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reverse primers (Table 6- Section 2.1.5.2). The amplified pMT3000::rbpA_NdeI 
was sequenced and the rbpA_NdeI fragment subcloned into pSETΩ (Table 1- 
Section 2.1.2 & Fig.A4- Appendices). Prior to the use of this construct to 
analyse rbpA mutants, it was important to check whether this engineered gene, 
rbpA_NdeI, works as the wild-type rbpA and that the NdeI site had not disrupted 
gene function.  
 
pSETΩ::rbpA_NdeI was used to transform E. coli ETZ competent cells and the 
transformants inoculated in LB containing appropriate antibiotic selection. The 
inoculants were then conjugated into S. coelicolor strains: J1981 (w/t) and S129 
(∆rbpA) (Section 2.2.5.1). Vector only control strains of J1981 and S129 were 
also generated. The ex-conjugants were left to grow at 30°C for 4-5 days and 
then streaked out into single colonies. A single colony was selected from each 
ex-conjugant and streaked into one MS plate to check for any phenotypic effect 
on S. coelicolor (Fig. 5.4). 
 
S. coelicolor J1981 (w/t), grew normally producing normal sized colonies and 
the appropriate production of the antibiotic actinorhodin (Fig. 5.4). S129, ∆rbpA 
strain, together with S129 vector only control formed small sized colonies and 
had an increase in actinorhodin production (Fig. 5.4). However, when 
pSETΩ::rbpA_NdeI was introduced into S129, normal sized colonies were 
formed and the appropriate production of actinorhodin (Fig. 5.4). Therefore, 
rbpA_NdeI complemented the ∆rbpA strain, which indicates that the newly 
engineered rbpA_NdeI is functional. 
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Figure 5.4: Complementation of S. coelicolor S129 strain by introducing 
the engineered rbpA_NdeI vector.  
S. coelicolor strains: J1981 (w/t), S129 (ΔrbpA), S129 (pSETΩ::control), and 
S129 (pSETΩ::rbpA_NdeI) were streaked into single colonies on MS agar and 
incubated at 30°C for 4-5 days.  
 
 
5.2.2 Helix 1  
Site-directed mutagenesis was performed on all eight residues present in the 
predicted Helix 1 of RbpA; R80, T81, H82, W83, D84, M85, L86, and M87 (Fig. 
5.2). These residues were selected because they are highly conserved amongst 
RbpA homologues (Fig. 3.1). The residues were mutated individually to alanine 
(A), which would remove any bulky or charged R group from these amino acids 
that may be involved in structural and/or functional interactions with other 
proteins. 
 
Using pMT3000::rbpA_NdeI, the forward and reverse primers of rbpAR80A, 
rbpAT81A, rbpAH82A, rbpAW83A, rbpAD84A, rbpAM85A, rbpAL86A, and rbpAM87A (Table 
6- Section 2.1.5.2) were used to introduce the alanine substitution by inverse 
PCR mutagenesis (Section 2.2.1.2). The pMT3000::rbpA plasmids containing 
R80A, T81A, H82A, W83A, D84A, M85A, L86A and M87A substitutions were 
sequenced and each mutant rbpA fragment was extracted with BglII and 
subcloned into pSETΩ. pSETΩ containing rbpAR80A, rbpAT81A, rbpAH82A, 
rbpAW83A, rbpAD84A, rbpAM85A, rbpAL86A, and rbpAM87A were individually 
transformed into ETZ competent cells and were then conjugated into S. 
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coelicolor J1981 (w/t) and S129 (ΔrbpA) strains (Section 2.2.5.1). Vector only 
controls were also prepared. The ex-conjugants were left to grow at 30°C for 4-
5 days, then streaked out into single colonies and spores harvested. 
 
5.2.2.1 Effect of mutations in RbpA helix 1 on the phenotype of S. coelicolor 
A single colony was selected from each mutant ex-conjugant and streaked onto 
MS agar plates to check for phenotype, morphology and antibiotic production 
(Fig. 5.5). J1981 vector only control strain produced appropriate sized colonies, 
whilst S129 vector only control strain produced small sized colonies and an 
increase in the production of actinorhodin (Fig. 5.5). S129 containing 
pSETΩ::rbpAR80A and pSETΩ::rbpAM85A allowed partial complementation as 
medium sized colonies were formed (Fig. 5.5). The remaining six rbpA mutants 
restored appropriate sized colonies and therefore, appeared to fully 
complement the ∆rbpA strains (Fig. 5.5).   
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Figure 5.5: Complementation of S. coelicolor S129 strains by introducing 
mutated residues of Helix 1 of RbpA.  
The strains were plated on MS agar with 100 g/l of spectinomycin and 
incubated at 30°C for 4-5 days. (A) Showing S129 (pSETΩ::rbpAR80A), S129 
(pSETΩ::rbpAT81A), S129 (pSETΩ::rbpAH82A), S129 (pSETΩ::rbpAW83A) together 
with S129 and J1981 vector only controls. (B) Showing S129 
(pSETΩ::rbpAD84A), S129 (pSETΩ::rbpAM85A), S129 (pSETΩ::rbpAL86A), S129 
(pSETΩ::rbpAM87A) together with S129 and J1981 vector only controls. 
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5.2.2.2 Effect of mutations in RbpA helix 1 on the growth curve of S. coelicolor  
S129 (pSETΩ::rbpA) containing R80A or M85A substitution was shown to 
partially complement the ∆rbpA phenotype (Fig. 5.5). Therefore, to confirm 
these results and determine whether the mutants affect the S. coelicolor growth, 
a growth curve was generated for S129 (pSETΩ::rbpAR80A), S129 
(pSETΩ::rbpAM85A), S129 (∆rbpA) and J1981 (w/t) strains. The spores were pre-
germinated with a starting OD450 of 0.06 for 3 h and then inoculated in YEME 
(10% (w/v) sucrose) liquid media (Section 2.2.5.3) with 50 g/l spectinomycin 
at 30ºC with vigorous shaking. At 2 h intervals, the OD450 readings were taken 
(Section 2.2.5.3).  
 
S129 containing pSETΩ::rbpAR80A had a slightly shorter lag phase than that of 
∆rbpA strain but entered stationary phase at an earlier lower OD reading (~4) 
relative to J1981 (w/t). S129 containing pSETΩ::rbpAM85A had a much shorter 
lag phase compared to S129 and grew to a similar OD reading (~5) to that of 
J1981 (~6). Therefore, M85A has a very little effect on S. coelicolor growth 
whilst R80A has a more significant effect on the growth of S. coelicolor (Fig. 
5.6).  
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Figure 5.6: A graphical representation of the growth curve of J1981 (w/t), 
S129 (∆rbpA), S129 (pSETΩ::rbpAR80A) and S129 (pSETΩ::rbpAM85A).  
The graph was generated using SigmaPlot. Absorbance reading at OD450 was 
recorded at 2 h intervals for each of the S. coelicolor strains.  
 
 
5.2.3 The ERR motif 
The ERR motif lies between the two helices of RbpA: Helix 1 and Helix 2. It is 
highly conserved amongst the RbpA and RbpB homologues (Fig. 3.1 & 3.2). 
Hence, E88, R89 and R90 were mutated individually to alanine (E88A, R89A 
and R90A), then the two arginines, R89 and R90, were mutated collectively to 
two alanines (2RA), and the mutants were tested for complementation of S. 
coelicolor S129 (rbpA).  
 
rbpAE88A, rbpAR89A, rbpAR90A and rbpA2RA forward and reverse primers (Table 6- 
Section 2.1.5.2) were used to introduce their respective mutations into 
pMT3000::rbpA_NdeI by inverse PCR (Section 2.2.1.2). The vectors were 
sequenced and the respective BglII fragments were subcloned into pSETΩ (see 
above). pSETΩ::rbpA containing E88A, R89A, R90A, and 2RA substitutions 
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were conjugated into S. coelicolor J1981 (w/t) and S129 (∆rbpA) as described 
(Section 5.2.2).  
 
5.2.3.1 Effect of mutations in RbpA ERR motif on the phenotype of S. coelicolor  
The expression of RbpAE88A or RbpAR90A in S129 complemented the ∆rbpA 
phenotype, producing appropriate sized colonies (Fig. 5.7). However, 
expression of RbpAR89A in S129 only partially complemented the deletion strain 
(Fig. 5.7). Interestingly, the rbpA2RA allele, with both arginine residues mutated, 
did not complement S129, such that the strain formed small sized colonies and 
over-produced actinorhodin (Fig. 5.7).  
 
 
 
Figure 5.7: Complementation of S. coelicolor S129 strains by introducing 
mutated residues of the ERR motif of RbpA.  
The spores of S129 (pSETΩ::rbpAE88A), S129 (pSETΩ::rbpAR89A), S129 
(pSETΩ::rbpAR90A), and S129 (pSETΩ::rbpA2RA), together with S129 and J1981 
vector only control were plated on MS agar with 100 g/l spectinomycin and 
incubated at 30°C for 4-5 days.  
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5.2.3.2 Effect of mutations in RbpA ERR motif on the growth curve of S. 
coelicolor  
A growth curve was generated for S129 (pSETΩ::rbpAR89A), S129 
(pSETΩ::rbpAR90A), S129 (∆rbpA) and J1981 (w/t) vector only control strains as 
explained in Section 5.2.2.2.  
 
S129 (pSETΩ::rbpAR89A) had a relatively shorter lag phase compared to S129 
and entered stationary phase at a similar OD450 to that of J1981 (w/t) (Fig. 5.8). 
S129 (pSETΩ::rbpAR90A), on the other hand, had a very short lag phase (~8 h) 
and grew almost comparable to that of J1981 entering stationary phase at 
approximately the same OD450 of J1981 (Fig. 5.8). The results appear to be 
consistent with the phenotypic results obtained in Fig. 5.7, suggesting that 
individual alanine substitutions of R89 or R90 can be “rescued” by the other 
arginine. However, when both are mutated, the RbpA mutant loses its 
functionality (Section 5.3.2). 
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Figure 5.8: A graphical representation of the growth curve of J1981 (w/t), 
S129 (∆rbpA), S129 (pSETΩ::rbpAR89A) and S129 (pSETΩ::rbpAR90A).  
The graph was generated using SigmaPlot. Absorbance at OD450 was recorded 
at 2 h intervals for each S. coelicolor strain.  
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5.2.4 Helix 2 
Helix 2 of RbpA is amphipathic and is defined by the presence of acidic, 
hydrophilic residues (E) on one side and non-polar, hydrophobic residues (L & 
V) on the other (Section 3.1.3.2). Three glutamates were selected, and mutated 
to alanine individually (E94A, E97A and E101A) and collectively (3EA). In 
addition, two conserved arginines were individually substituted to alanine 
(R102A and R107A).   
 
The respective mutations were introduced into pMT3000::rbpA_NdeI by inverse 
PCR, fragments extracted and subcloned into pSETΩ. pSETΩ::rbpA containing 
E94A, E97A, E101A, 3EA, R102A, and R107A substitutions were conjugated 
into S. coelicolor J1981 (w/t) and S129 (∆rbpA) as described (Section 5.2.2). 
 
5.2.4.1 Effect of mutations in RbpA helix 2 on the phenotype of S. coelicolor  
Expression of RbpAE94A, RbpAE97A, RbpAE101A, RbpA3EA, RbpAR102A or 
RbpAR107A in S129 complemented the ∆rbpA phenotype, producing appropriate 
sized colonies (Fig. 5.9).  
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Figure 5.9: Complementation of S. coelicolor S129 strains by introducing 
mutated residues of Helix 2 of RbpA.  
The spores were plated on MS agar containing 50 g/l spectinomycin and 
incubated at 30°C for 4-5 days. (A) Showing S129 (pSETΩ::rbpAE94A), S129 
(pSETΩ::rbpAE97A), S129 (pSETΩ::rbpAE101A), and S129 (pSETΩ::rbpA3EA) 
together with S129 (∆rbpA) and J1981 (w/t) vector only controls. (B) Showing 
S129 (pSETΩ::rbpAR102A) and S129 (pSETΩ::rbpAR107A) together with S129 and 
J1981 vector only controls.  
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5.3 BACTH analysis of HrdB interaction with RbpA mutants 
Site-directed mutagenesis of RbpA has revealed that some residues in RbpA 
affect the phenotype, growth and antibiotic production of S. coelicolor. However, 
how these mutated residues affect the function of RbpA is not clear. Do these 
mutants still interact with the principal sigma factor, HrdB? If yes, does that 
mean that they sequester HrdB and prevent it from binding to RNAP and thus 
hinder transcription? Therefore, the first step was to test whether these RbpA 
mutant proteins generated interact with HrdB using BACTH assays. 
 
5.3.1 Helix 1 
All eight Helix 1 RbpA mutants were tested for interaction with the principal 
sigma factor, HrdB. The engineered pMT3000::rbpA containing R80A, T81A, 
H82A, W83A, D84A, M85A, L86A and M87A substitutions were used to extract 
the mutant fragments as a SacI-XhoI fragment and then individually subcloned 
into pUT18-rbpA (Section 4.1.1), which was also digested with SacI and XhoI. 
The recombinant pUT18-rbpA containing R80A, T81A, H82A, W83A, D84A, 
M85A, L86A and M87A substitutions were sequenced and individually co-
transformed with pKT25-hrdB(2-4) into BTH101 competent cells by 
electroporation. BTH101 vector only controls were also prepared. To determine 
and quantify any interactions, the β-galactosidase assays were performed 
(Section 2.6).  
 
BTH101 containing pKT25-hrdB(2-4) and pUT18-rbpA, pUT18-rbpAR80A, pUT18-
rbpAT81A, pUT18-rbpAH82A, pUT18-rbpAW83A, pUT18-rbpAD84A, pUT18-rbpAM85A, 
pUT18-rbpAL86A, and pUT18-rbpAM87A had 27- to 56- fold increase in -
galactosidase activity compared to the vector only control (Fig. 5.10). These 
assays indicated that RbpAR80A, RbpAT81A, RbpAH82A, RbpAW83A, RbpAD84A, 
RbpAM85A, RbpAL86A and RbpAM87A proteins interact with 
HrdB.  
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Figure 5.10: BACTH assay of the interaction of HrdB with the mutated 
residues in Helix 1 of RbpA.  
(A) Showing the interaction of RbpAw/t, RbpAR80A, RbpAT81A, RbpAH82A and 
RbpAW83A with 
HrdB. (B) Showing the interaction of RbpAw/t, RbpAD84A, 
RbpAM85A, RbpAL86A, and RbpAM87A with 
HrdB. These assays were repeated 
using three separate colonies in triplicate with error bars showing standard 
deviation.  
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5.3.2 The ERR motif 
The two arginines, R89 and R90, in the ERR motif appeared to have a 
significant effect on the phenotype and growth of S. coelicolor (Fig. 5.2.3). 
BACTH assays were used to determine interactions of RbpAE88A, RbpAR89A, 
RbpAR90A and RbpA2RA proteins with 
HrdB in vivo.  
 
A SacI-XhoI fragment of rbpAE88A, rbpAR89A, rbpAR90A and rbpA2RA were 
extracted from pMT3000::rbpA containing the respective mutations, individually 
subcloned into pUT18-rbpA and recombinants were co-transformed separately 
into BTH101 competent cells together with pKT25-hrdB(2-4) as explained in 
5.3.1. The β-galactosidase assays were performed to test whether the RbpA 
mutant proteins bind to HrdB (Section 2.6).  
 
BTH101 containing pKT25-hrdB(2-4) and pUT18-rbpA, pUT18-rbpAE88A, pUT18-
rbpAR89A, and pUT18-rbpAR90A had 57-, 98-, 16-, and 26-fold higher -
galactosidase activity compared to the vector only control, respectively. 
However, BTH101 containing pUT18-rbpA2RA and pKT25-hrdB
(2-4) had no 
significant difference in -galactosidase activity compared to the vector only 
control. These assays show that RbpAE88A, RbpAR90A and to some extent 
RbpAR89A proteins interact with 
HrdB, whilst the 2RA substitution abolished 
RbpA-HrdB interaction (Fig. 5.11). 
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Figure 5.11: BACTH assay of the interaction of HrdB with the mutated 
residues of the ERR motif of RbpA.  
The -galactosidase assays were performed on BTH101 containing pKT25-
hrdB(2-4) and pUT18-rbpAw/t, pUT18-rbpAE88A, pUT18-rbpAR89A, pUT18-rbpAR90A, 
pUT18-rbpA2RA and vector only control. These assays were repeated for three 
separate colonies each in triplicate with error bars showing the standard 
deviation.  
 
 
5.3.3 Helix 2 
The residues mutated in Helix 2 did not show any relevant phenotypic effect in 
S. coelicolor (Fig. 5.9). Nonetheless, the interaction of these mutated RbpA 
residues with the principal sigma factor, HrdB, was tested using BACTH. 
RbpAE101A, RbpA3EA, RbpAR102A and RbpAR107A were amplified using T18_rbpA 
forward and reverse primers (Table 5- Section 2.1.5.1) with pMT3000::rbpA 
containing E101A, 3EA, R102A and R107A mutation, respectively. A SacI-XhoI 
fragment of RbpAE94A and RbpAE97A were extracted from pMT3000::rbpAE94A 
and pMT3000::rbpAE97A, respectively. All six fragments were then subcloned 
into pUT18-rbpA and the recombinants were co-transformed individually into 
BTH101 competent cells together with pKT25-hrdB(2-4) as explained in 5.3.1. To 
determine the interaction of these mutant proteins, the -galactosidase assays 
were performed (Section 2.6).  
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The -galactosidase activity for BTH101 containing pKT25-hrdB(2-4) and pUT18-
rbpA, pUT18-rbpA containing E94A, E97A, E101A, R102, and R107A 
substitutions were around 50-fold higher compared to vector only control, whilst 
BTH101 containing pUT18-rbpA3EA and pKT25-hrdB
(2-4) was 32-fold higher than 
vector only control (Fig. 5.12). The results indicate that RbpAE94, RbpAE97A, 
RbpAE101A, RbpA3EA, RbpAR102A and RbpAR107A proteins interact with 
HrdB.  
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Figure 5.12: BACTH assay of the interaction of HrdB with mutated RbpA 
residues in Helix 2.  
(A) Showing the interaction of RbpAw/t, RbpAE94, RbpAE97A, RbpAE101A, and 
RbpA3EA proteins with 
HrdB. (B) Showing the interaction of RbpAw/t, RbpAR102A, 
and RbpAR107A proteins with 
HrdB. These assays were repeated using three 
separate colonies each in triplicate with error bars showing standard deviation.  
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5.4 HrdB interaction with selected RbpA mutants in vitro 
Some of the RbpA mutants generated appreared to have an effect on the 
phenotype of S. coelicolor strain and/or affect sigma interaction. RbpAR80A, 
RbpAM85A, RbpAR90A, and to some extent RbpAR89A proteins were shown to 
interact with HrdB using BACTH (Section 5.3.1 & 5.3.2) yet appeared to affect to 
some degree the S. coelicolor growth (Section 5.2.2 & 5.2.3). On the other 
hand, RbpA2RA protein was shown to have lost its interaction with 
HrdB (Section 
5.3.2). Thus, these RbpA mutant proteins were selected to further confirm the 
BACTH results.  
 
5.4.1 RbpAR80A and RbpAM85A  
RbpAR80A and RbpAM85A proteins were shown to interact with the principal sigma 
factor, HrdB, despite only partially complementing the ∆rbpA phenotype (Fig. 
5.10 & 5.5). To verify the results of the RbpA mutant-HrdB interactions, in vitro 
pull down assays were performed. The rbpAR80A and rbpAM85A alleles were 
subcloned into pET20b from pMT3000::rbpAR80A and pMT3000::rbpAM85A as 
NdeI-BamHI fragments in order to produce non-tagged RbpA mutant proteins. 
pET20b::rbpAR80A and pET20b::rbpAM85A were transformed separately into BL21 
(pLysS) competent cells and RbpAR80A and RbpAM85A proteins were purified by 
Q.F.F anion-exchange chromatography and Mono Q anion-exchange 
chromatography (Fig. 5.13A & B, lane 3) (Section 2.3.2.5 & 2.3.2.6). The non-
tagged native RbpA was already obtained in Section 4.2.2. 
 
The in vitro pull-down assays were performed by mixing the purified native 
RbpAR80A and RbpAM85A with purified His-tagged 
HrdB(2-4) and HrdB(2) (Fig. 
5.13A & B, lanes 4 & 5) (Section 4.2.2) and left on ice for 15 min before passing 
them through magnetic Ni-affinity Dynabeads (Section 2.3.2.4). As a negative 
control, RbpA alone was mixed with the magnetic Dynabeads (Fig. 5.13A & B, 
lane 6). Positive controls were also included by passing native RbpA together 
with His-tagged HrdB(2) and HrdB(2-4) (Fig. 5.13A & B, lane 7 & 8). The 
Dynabeads were washed four times with buffer and any bound protein eluted 
using 100 l elution buffer. 
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As shown before, RbpA by itself did not bind to the Ni-affinity Dynabeads (Fig. 
5.13A & B, lane 6). RbpAw/t, RbpAR80A and RbpAM85A each co-eluted from the 
beads together with HrdB(2) and HrdB(2-4). These results confirm that RbpAR80A 
and RbpAM85A proteins interact with
HrdB at region 1.2-2.4 (Fig. 5.13A & B, lane 
9 & 10). 
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Figure 5.13: The interaction of RbpAR80A and RbpAM85A with 
HrdB(2) and 
HrdB(2-4).  
The pull down-assays were assessed by separating the proteins on SDS 
polyacrylamide gel. The Marker used was SeeBlue®Plus2 (Lane 1). (A) Lanes 2 
to 5 show RbpAw/t (~14kDa), RbpAR80A (~14kDa), 
HrdB(2) (~17kDa), and HrdB(2-4) 
(~38kDa), respectively with their respective concentrations. Lanes 6 to 10 show 
the eluates from the dynabeads column. Lane 6: RbpAw/t only, Lane 7: RbpAw/t 
and HrdB(2), Lane 8: RbpAw/t and 
HrdB(2-4), Lane 9: RbpAR80A and 
HrdB(2) and 
Lane 10: RbpAR80A and 
HrdB(2-4). (B) Lanes 2 to 5 show RbpAw/t (~14kDa), 
RbpAM85A (~14kDa), 
HrdB(2) (~17kDa), and HrdB(2-4) (~38kDa), respectively with 
their respective concentrations. Lanes 6 to 10 show the eluates from the 
dynabeads column. Lane 6: RbpAw/t only, Lane 7: RbpAw/t and 
HrdB(2), Lane 8: 
RbpAw/t and 
HrdB(2-4), Lane 9: RbpAM85A and 
HrdB(2) and Lane 10: RbpAM85A and 
HrdB(2-4). The proteins were separated on a 4-12% Bis-Tris polyacrylamide gel 
at 120 V for 80 min, and visualised by Coomassie staining. 
 
 
188 
 
5.4.2 RbpAR89A and RbpAR90A  
Using BACTH, RbpAR90A and to some extent RbpAR89A proteins were shown to 
interact with HrdB whereas RbpA2RA protein did not interact with 
HrdB (Fig. 5.11). 
Therefore, to verify the results of RbpA mutant-HrdB interactions, in vitro pull-
down assays were performed. NdeI-BamHI fragments of rbpAR89A, rbpAR90A and 
rbpA2RA from pMT3000::rbpA containing R89A, R90A and 2RA were subcloned 
into pET20b expression vector and RbpA mutants were purified as described in 
Section 5.4.1 (Fig. 5.14, lanes 3 to 5) (Section 2.3.2.5 & 2.3.2.6).  
 
The in vitro pull-down assays were performed by separately mixing purified 
native RbpAR89A, RbpAR90A and RbpA2RA with His-tagged 
HrdB(2-4), left on ice for 
15 min and then passed through Ni-affinity beads. The beads were washed four 
times with buffer and then any bound protein was eluted with 100 l elution 
buffer (Section 2.3.2.4). Controls were also prepared as mentioned in Section 
5.4.1 (Fig. 5.14, lane 7 & 8). 
 
RbpAw/t co-eluted from the beads together with 
HrdB(2-4) (Fig. 5.14, lane 8), 
whereas, RbpAR89A, RbpAR90A and RbpA2RA were not sequestered by 
HrdB(2-4) 
(Fig. 5.14, lane 9-11). This confirms that RbpA2RA protein does not interact 
withHrdB(2-4). Nevertheless, RbpAR89A and RbpAR90A proteins may possibly 
interact with HrdB but with a lower affinity.   
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Figure 5.14: The interaction of RbpAR89A, RbpAR90A and RbpA2RA with 
HrdB(2-4).  
The pull down-assays were assessed by separating the proteins on SDS 
polyacrylamide gel. The Marker used was SeeBlue®Plus2 (Lane 1). Lanes 2 to 
6 show RbpAw/t (~14kDa), RbpAR89A (~14kDa), RbpAR90A (~14kDa), RbpA2RA 
(~14kDa), and HrdB(2-4) (~38kDa), respectively, with their respective 
concentrations. Lanes 7 to 11 show the eluates from the dynabeads column. 
Lane 7: RbpAw/t only, Lane 8: RbpAw/t and 
HrdBF4, Lane 9: RbpAR89A and 
HrdB(2-
4), Lane 10: RbpAR90A and 
HrdB(2-4), Lane 11: RbpA2RA and 
HrdB(2-4). The 
proteins were separated on 4-12% Bis-Tris polyacrylamide gel at 120 V for 80 
min and visualised by Coomassie staining. 
 
 
5.5 Testing RbpAR80A and RbpAM85A for dominant-negative effects 
As previously shown, S129 (pSETΩ::rbpAR80A) and S129 (pSETΩ::rbpAM85A) 
partially complemented the ∆rbpA phenotype (Fig. 5.5). The mutant proteins 
were, however, shown to interact with HrdB both in vivo (Section 5.3.1) and in 
vitro (Section 5.4.1). In theory, if the partially-active mutant proteins bind to HrdB 
in vivo, they might compete with wild-type RbpA and thereby prevent normal 
transcription, leading to the inhibition of growth. Therefore, these RbpA mutants 
were expressed in a wild-type background to test for this dominant-negative 
effect.  
 
NdeI-BamHI fragments of rbpAR80A and rbpAM85A obtained from 
pMT3000::rbpAR80A and pMT3000::rbpAM85A, respectively, were subcloned 
under the control of the tipA promoter in the pIJ6902 vector (Table 1- Section 
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2.1.2). Recombinant pIJ6902::rbpAR80A and pIJ6902::rbpAM85A were conjugated 
into S129 (∆rbpA), J1981 (w/t) and M145 (J1981 parental) S. coelicolor strains 
(Section 2.2.5.1). The ex-conjugants of S129, J1981 and M145 were streaked 
into single colonies and then the spores harvested (Section 2.2.5.2). The spores 
from each stock were then streaked onto MS agar plates containing 0 g/l and 
15 g/l thiostrepton and left to grow 3-5 days at 30°C (Fig. 5.15). When 
thiostrepton was added (15 g/l), the cloned rbpA mutant genes were induced 
from the tipA promoter.  
 
In the presence of thiostrepton, pIJ6902::rbpAR80A did not complement the S129 
mutant whilst pIJ6902::rbpAM85A partially complemented the ∆rbpA phenotype 
(Fig. 5.15A). When J1981 and M145 containing pIJ6902::rbpAR80A were 
streaked in the presence of thiostrepton, both grew normally as with RbpAw/t 
(Fig. 5.15B & C) showing that RbpAR80A is not a dominant mutation. However, 
J1981 and M145 containing pIJ6902::rbpAM85A produced partially reduced 
colony sizes in the presence of thiostrepton (Fig. 5.15B & C) showing that 
RbpAM85A has a dominant effect.  
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Figure 5.15: Introducing pIJ6902::rbpAw/t, pIJ6902::rbpAR80A, and 
pIJ6902::rbpAM85A into S. coelicolor S129, J1981 and M145 strains.  
The S. coelicolor spores were plated on MS agar containing 0 g/l and 15 
g/l thiostrepton and incubated at 30°C for 3-5 days. (A) Showing S129 
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(pIJ6902::control), S129 (pIJ6902::rbpAR80A), S129 (pIJ6902::rbpAM85A), S129 
(pIJ6902::rbpAw/t), and M145 and J1981 vector only controls. (B) Showing 
J1981 (pIJ6902::control), J1981 (pIJ6902::rbpAR80A), J1981 (pIJ6902::rbpAM85A), 
J1981 (pIJ6902::rbpAw/t), and M145 and S129 vector only controls. (C) Showing 
M145 (pIJ6902::control), M145 (pIJ6902::rbpAR80A), M145 (pIJ6902::rbpAM85A), 
M145 (pIJ6902::rbpAw/t), and S129 and J1981 vector only controls. 
 
 
5.6 Transcription activation by RbpAM85A and RbpA2RA proteins 
RbpAM85A protein binds to 
HrdB (Section 5.3.1 & 5.4.1) and partially restores 
growth of S. coelicolor (Section 5.2.2.1), whereas RbpA2RA protein did not 
interact with HrdB (Section 5.3.2) and did not complement the ∆rbpA strain 
(Section 5.2.3.1). Therefore, it was decided to find out whether these two 
distinct RbpA mutants had any effect on the activation of transcription from an 
RbpA-dependent promoter. In vitro transcription assays were performed using 
RbpAM85A and RbpA2RA proteins and were compared to RbpAw/t proteins, which 
served as a positive control.  
 
Three genes shown to be regulated by RbpA from the microarray data were 
selected; SCO4652, SCO0527 and rpoB (Table A2- Appendices). These were 
analysed by in vitro transcription assays to determine whether they were 
activated by RbpA (In collaboration with M. Paget, data not shown). SCO4652 
was then chosen as the desired template for further studies. The reaction 
mixture was set up containing 10 x alternative transcription buffer (Section 
2.1.6.4), 10 x NTP mix (Section 2.1.6.4), 50 nM SCO4652 template, 500 nM S. 
coelicolor core RNAP (a gift from P. Doughty), 2.5 M HrdB (a gift from P. 
Doughty), 5 and 25 M RbpA. The protocol was followed as detailed in Section 
2.5.2.  
 
Transcription was not stimulated in the presence of core RNAP only (Fig. 5.16, 
lane 1). Addition of HrdB to core RNAP was not sufficient to activate 
transcription from the RbpA-dependent promoter (Fig. 5.16, lane 2). When 
RbpAw/t was added, transcription was activated (Fig. 5.16, lane 3 & 4). 
However, when RbpAM85A was added, transcription was only partially activated 
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compared to RbpAw/t (Fig. 5.16, lane 5 & 6). RbpA2RA did not activate 
transcription initiation (Fig. 5.16, lane 7 & 8). As expected, RbpA did not 
stimulate transcription in the absence of added HrdB, (Fig. 5.16, lanes 9-14) 
further verifying that RbpA stimulates transcription in a HrdB-dependent manner. 
The slight increase in transcription caused by the addition of RbpAw/t is probably 
the result of contaminating HrdB in the core RNAP preparation. 
 
 
Figure 5.16: In vitro transcription assays showing transcription activation 
in the presence of RbpAw/t, RbpAM85A, and RbpA2RA.  
The samples were loaded on the urea gel and separated at 600 V, 50 W at 
55°C for 1 h. Lane 1: RNAP core only, Lane 2: RNAP and HrdB, Lane 3: RNAP, 
HrdB and RbpAw/t (1x), Lane 4: RNAP, 
HrdB and RbpAw/t (5x), Lane 5: RNAP, 
HrdB and RbpAM85A (1x), Lane 6: RNAP, 
HrdB and RbpAM85A (5x), Lane 7: 
RNAP, HrdB and RbpA2RA (1x), Lane 8: RNAP, 
HrdB and RbpA2RA (5x), Lane 9: 
RNAP and RbpAw/t (1x), Lane 10: RNAP and RbpAw/t (5x), Lane 11: RNAP and 
RbpAM85A (1x), Lane 12: RNAP and RbpAM85A (5x), Lane 13: RNAP and 
RbpA2RA (1x), Lane 14: RNAP and RbpA2RA (5x). 
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5.7 Discussion 
 
5.7.1 The C-terminal region of RbpA 
The C-terminal region of RbpA was shown to interact with HrdB (Section 5.1.1) 
and thus, it contains the HrdB-binding region. It is possible that other regions of 
RbpA might be important in vivo, however, based on the assays in the chapter, 
the C-terminal region appears to be the region involved in HrdB interaction. To 
identify possible residues that may be involved in this protein-protein interaction, 
specific residues were selected and mutated. The C-terminal region of RbpA is 
composed of Helix 1 and Helix 2, which are connected by the ERR motif. Helix 
1 is present in all the RbpA and RbpB homologues with a highly conserved 
sequence. However, this sequence conservation differs in the RbpA and RbpB 
homologues (Fig. 3.1 & 3.2). In addition, the ERR motif is completely conserved 
amongst all the RbpA and RbpB homologues (Fig. 3.1 & 3.2). Helix 2 is also 
present in the RbpA and RbpB homologues, with few leucine, arginine and 
glutamate residues being well conserved amongst the RbpA and RbpB 
homologues. Helix 2 is amphipathic in RbpA homologues but this is not the 
case in the RbpB homologues. Therefore, all the residues within Helix 1 and the 
ERR motif were selected for mutagenesis, whereas, in Helix 2, the conserved 
glutamate residues and arginine residues were selected for mutagenesis.  
 
5.7.2 R80 and M85 are important in RbpA functionality 
Site-directed mutagenesis studies of RbpA Helix 1 identified two key residues, 
R80 and M85, which seem to be indispensible for the full role of RbpA. When 
alanine was substituted for R80 and M85 and introduced into S. coelicolor 
∆rbpA strain, they partially complemented the rbpA phenotype (Section 
5.2.2.1). The effect of R80A and M85A was further confirmed by determining 
the growth curve of these mutants, which were shown to rescue the growth 
relative to the mutant but still less than that of the wild-type (Section 5.2.2.2). 
The mutants did not fully restore the full functionality of RbpA showing that both 
these residues are necessary for its correct functioning. 
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Despite the inability of the R80A and M85A mutants to complement the ∆rbpA 
phenotype, each protein interacted with HrdB (Fig. 5.10 & Fig. 5.13). Alignment 
of RbpA and Crl showed that R80 and M85 were not conserved in these 
proteins (Fig. A3- Appendices), suggesting that the possible interaction with 
domain 2 of HrdB might be by other residues. Therefore, how do these mutants 
exert their effect? They might bind to HrdB and sequester it, preventing its 
binding to core RNAP. Alternatively, they might trap RNAP in an inactive 
complex, perhaps blocking closed complex formation or open complex 
formation. Further analysis is required to investigate these possibilities. 
 
It was considered that a mutant RbpA that could bind the essential sigma factor, 
HrdB, but not activate transcription, might be a dominant-negative mutant. 
rbpAR80A did not cause such an effect. The reason why R80A did not cause this 
effect is not known. It is possible that it cannot compete with RbpAw/t due to a 
lower affinity or that the protein is unstable in vivo and gets degraded. However, 
rbpAM85A was a dominant mutation, which when induced in wild-type S. 
coelicolor strains, inhibited growth (Fig. 5.15B & C). Therefore, the M85A 
mutant protein might compete with RbpAw/t for interaction with 
HrdB thereby 
affecting transcription. 
  
In vitro transcription assays performed on RbpAM85A revealed that the mutant 
protein partially activates transcription initiation (Fig. 5.16) showing that the 
mutant protein can interact productively with HrdB and stimulate transcription to 
some extent. 
 
5.7.3 The ERR motif of RbpA is essential for HrdB interaction 
Generating mutations in the ERR motif of RbpA revealed that R89 and R90 are 
important residues for maintaining the functional role of RbpA. When alanine 
was substituted for both R89 and R90 (2RA) and introduced into S. coelicolor 
∆rbpA strain, it did not complement the phenotype of the deletant (Section 
5.2.3.1). However, when the alanine substitutions for R89 or R90 were 
generated individually and introduced into S. coelicolor ∆rbpA strain, it 
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appeared that the presence of either R89 or R90 was sufficient to restore RbpA 
functionality to some extent in vivo (Section 5.2.3.1).  
 
The ERR motif is very highly conserved amongst all the RbpA and RbpB 
homologues in the Actinobacteria (Fig. 3.1 & 3.2). Hence, it was not surprising 
when R89 and R90 (2RA) were shown to be necessary for HrdB interaction 
(Section 5.3.2 & 5.4.2). This is consistent with the in vitro transcription assays 
which showed that RbpA2RA protein did not activate transcription (Fig. 5.16). On 
the other hand, RbpAR89A and RbpAR90A were shown to interact with 
HrdB using 
BACTH assays (Section 5.3.2). However, it was observed that the interaction 
between these mutant proteins and HrdB was weak as the -galactosidase 
activity fold decreased from 57 for RbpAw/t to about 26 and 16 for RbpAR90A and 
RbpAR89A, respectively. The in vitro pull down assays showed that RbpAR89A 
and RbpAR90A did not to interact with 
HrdB (Section 5.4.2), which is possibly due 
to a weak interaction between the two proteins as observed in BACTH (see 
above). Thus, R89 and R90 may also form specific interactions with residues in 
HrdB.   
 
Alternatively, R89 and R90 may be structurally important in maintaining the C-
terminal region of RbpA. Nevertheless, when the two arginines were replaced 
with two alanines and the secondary structure analysed by PSIPRED, it was 
predicted that the secondary structure of the C-terminal region of RbpA would 
not be disrupted (data not shown). This can only be verified when the structure 
of RbpA-HrdB(2) is solved (Section 6.5).  
 
5.7.4 Helix 2 of RbpA is involved in interaction with HrdB 
Mapping the region where RbpA binds to HrdB revealed that RbpA construct 
containing the C-terminal region only (RbpA∆) interacted with 
HrdB, whereas 
RbpA construct lacking Helix 2 but containing the ERR motif (RbpA∆H2) did not 
bind to the sigma factor (Section 5.1.1). This provides evidence that Helix 2 is 
required for the interaction with HrdB.  
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However, the mutation of the conserved glutamate and arginine residues 
located in Helix 2, did not have any effect on the S. coelicolor phenotype 
(Section 5.2.4) and the mutant proteins were shown to interact with HrdB 
(Section 5.3.3). This demonstrates that these residues do not individually play a 
critical role in mediating RbpA function. However, they may operate collectively 
with the conserved hydrophobic residues (L & V) in Helix 2 to mediate RbpA-
HrdB interactions and possibly RbpA-RNAP interactions. It is also worth noting 
that introducing a charge reversal, from glutamate (-ve) to argininie or lysine (+), 
or a hydrophobic side group (L & V), may produce a significant effect on RbpA. 
However, these hydrophobic residues have not been analysed yet.   
 
Even though the C-terminal region of RbpA was shown to be important for 
RbpA functionality, the N-terminal region of RbpA might also be important in 
vivo. The N-terminal region appears to be involved in maintaining the structural 
integrity of RbpA (Chapter 6).   
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6- Structural analysis of Rv2050/RbpA 
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6.0 Overview 
The structure of RbpA has not yet been solved and there is no available 
structure for any RbpA homologue. It was hoped that a structure of RbpA or one 
of its orthologues (e.g. Rv2050) would help us to better understand the 
biological function of these proteins and so X-ray crystallographic and nuclear 
magnetic resonance (NMR) approaches were used to try to solve RbpA/Rv2050 
structure. The secondary structure prediction of RbpA suggested that RbpA 
might have four -strands interconnected by loops in the N-terminal region 
followed by two -helices in the C-terminal region (Section 3.1.1). This section 
focuses on determining whether this prediction is true. Also, as RbpA/Rv2050 
were shown to interact with HrdB/A at domain 2 (Section 4.2 & 4.3.2), 
approaches were used to purify the RbpA/Rv2050-Sigma complex for structural 
studies. This complex would reveal important residues in the interaction of 
RbpA with its sigma factor.  
 
6.1 X-ray crystallography of Rv2050 
Initially, X-ray crystallography was used to try to solve the structure of Rv2050, 
the orthologue of RbpA in M. tuberculosis. Native Rv2050 (Section 4.3.2.2) was 
over-expressed and purified by anion-exchange purification (data not shown) 
followed by gel filtration (data not shown) to obtain a final concentration of 8.62 
mg/ml. This was then used for setting up crystal trials.  
 
A pre-crystallization test (PCT) was performed to determine the appropriate 
concentration of Rv2050 to use for the crystal trials (Qiagen: EasyXtal® and 
NeXtal® Protein Crystallization Handbook) using the Pre-Screen Assay Suite 
(Qiagen: EasyXtal and Nextal products). These solutions were placed into 24-
well plate and the “hanging drop vapour diffusion” method (Section 2.3.7) was 
used with two different concentrations of Rv2050 (3 mg/ml and 6 mg/ml). It was 
left at 4°C and after a few days, the Rv2050 6 mg/ml was chosen to be the 
appropriate concentration for further trials as it produced very small crystals at 
some buffer conditions.  
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Crystallization trials were then performed using the “Structure Screen 2 MD1-
02” from Molecular Dimensions and “PACT premierTM box 1 of 2 and box 2 of 2 
MD1-29” from Molecular dimensions. The “hanging drop vapour diffusion” was 
performed and after few weeks, very small rod-like crystals were seen in few 
wells. However, when X-ray beams were passed through them, they did not 
diffract well. The crystals were either poor or small crystals of Rv2050 or they 
were salt precipitates.  
 
At this point it was decided to temporarily abandon the X-ray crystallisation 
approach in favour of a nuclear magnetic resonance-based approach. Although, 
the crystallisation approach had not been exhaustive, the small size of 
RbpA/Rv2050 is suitable for NMR-based studies.  
 
6.2 NMR spectroscopy of Rv2050 
Unlike X-ray crystallization, NMR is performed in solution. It relies on the nuclei 
possessing a small electromagnetic charge called spin. Any element that has a 
nuclear spin can give an NMR signal. 13C and 15N are isotopes used for protein 
labelling since they have a net nuclear spin of 1/2. This makes them suitable for 
NMR spectroscopy studies. Pulses of electromagnetic energy are sent to the 
sample, which generates multiple resonance frequencies that are used to 
assign chemical shifts. The structure calculations are determined using the 
chemical shifts and the distance restraints. Labelled 13C 15N Rv2050 was over-
produced in minimal medium, purified by anion exchange-chromatography 
followed by gel filtration and sent to the laboratory of Professor Stephen 
Matthews in Imperial College London for NMR analysis. 
 
6.2.1 Native 13C &15N Rv2050 over-expression   
E. coli BL21 (pLysS) (pET20b::Rv2050) was grown in 200 ml LB media to an 
OD600 of 3-5. The cells were harvested by centrifugation, and then re-
suspended in optimized high-cell density IPTG-induction minimal medium 
(Section 2.1.4.1). This minimal medium included 13C-glucose as carbon source 
and 15N-NH4Cl as nitrogen source, thereby labelling Rv2050. The culture was 
equilibrated in minimal media for 1.5-2 h, then induced with IPTG and the cells 
harvested (Section 2.3.1.2) (Sivashanmugam et al., 2009). 
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6.2.2 Purification of 13C 15N Rv2050 
 
6.2.2.1 Anion-exchange - QFF column  
The first anion-exchange step was performed using a low resolution Hi-Trap 
QFF column. Following the preparation of the cleared cell lysate (Section 
2.3.2.1) using the anion-exchange binding buffer (Section 2.1.6.2), Rv2050 was 
loaded onto the column then eluted using a 10 ml gradient of 0 to100% elution 
buffer (Section 2.3.2.5). Rv2050 eluted at ~ 40% elution buffer i.e 0.4 M NaCl 
(4-9 ml; Fig. 6.1A).  
 
6.2.2.2 Anion-exchange - Mono Q column 
Fractions 4 to 8 (Fig. 6.1A) were dialysed into anion-exchange binding buffer 
then further purified by anion-exchange using a Mono Q column 5/50 GL 
column. The gradient was set at 0 to 80% for 20 ml followed by 80 to 100% for 
5 ml (Section 2.3.2.5). Rv2050 eluted between fractions 15 to 17 (~ 0.4-0.5 M 
NaCl). However, fraction 16 was the most pure fraction (Fig. 6.1B). 
 
6.2.2.3 Gel filtration  
Fraction 16 (Fig. 6.1B) was dialysed into gel filtration buffer (using 20 mM Tris 
pH 7.9, 50 mM NaCl, 5% (v/v) glycerol, 5 mM -mercaptoethanol) at 4°C 
overnight, filtered, and passed through a pre-equilibrated gel filtration column 
(HiLoadTM 16/60 SuperdexTM 200 column) (Section 2.3.2.6). Eluates were 
collected as 1 ml fractions and Rv2050 eluted at around 65 to 72 ml. When 
these fractions were analysed by SDS polyacrylamide gel, the fractions were 
considered sufficiently pure for NMR analysis (Fig. 6.1C).  
 
Fractions 67 to 78 ml (Fig. 6.1C) were concentrated to 42 mg/ml in a volume of 
500 l and then dialysed into a standard NMR buffer (Section 2.1.6.2) overnight, 
snap frozen in liquid nitrogen after the addition of 0.02% sodium azide, and 
finally sent for NMR spectroscopy.  
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Figure 6.1: The purification of 13C 15N Rv2050.  
The samples were assessed by separating the proteins on 4-15% Bis-Tris 
polyacrylamide gel at 200 V for 70 min and visualized by Coomassie Blue 
staining. The Marker used was SeeBlue®Plus2. (A) QFF anion-exchange 
chromatography. 10 µl of the whole cell lysate (WCL), cleared cell lysate (CCL), 
supernatant flow-through (SF) and 15 µl of different 1 ml fractions were loaded 
on the gel. (B) Mono Q anion-exchange purification. 5 l of injected Rv2050 (Inj) 
together with 10 µl of different 1 ml fractions loaded on gel. (C) Gel filtration 
purification of 13C 15N Rv2050. The same volumes of samples loaded as in B.  
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6.2.3 NMR structure of Rv2050 
NMR was performed in collaboration with Professor Stephen Matthews 
(Imperial College London). The analysis of the backbone and allocation of the 
side chains was performed by Marie-Laure Parsy and Dr. Peter Simpson, and 
are briefly described here. Initially, unlabelled Rv2050 was assessed by one-
dimensional (1D) 1H magnetic spectrum, which revealed that it was structured 
and could be analyzed for NMR. The 2-dimensional 15N-1H Heteronuclear 
Single Quantum Coherence Spectrum of labelled Rv2050 showed the H-N 
correlations of the protein and produced dispersed peaks that would allow for 
assignment of 13C, 13C, and 13C’ resonance. The backbone resonance, 
chemical shift Index Script and side chain resonance were then obtained. 
Rv2050 structure was then calculated and validated (M.L. Parsy, P. Simpson, & 
S. Matthews- unpublished observations). Rv2050 was not aggregated and was 
free of contaminants but appeared to have only 40 to 60 structured residues 
(Fig. 6.2: Bold with light grey shading).  
 
It was noticed that the C-terminus of Rv2050 was very dynamic and its structure 
could not be solved. However, the N-terminal region of Rv2050 was solved and 
was analysed and visualized using PyMOL software. The N-terminal region of 
Rv2050 backbone structure, charge surface, and cartoon illustrations were 
generated using PyMOL (Fig. 6.3 & 6.4). The N-terminal region of Rv2050 has 
four -strands that run anti-parallel and are interconnected by loops (Fig. 6.4- 
Right). The -strands of Rv2050 are located at the exact regions as denoted by 
the predicted secondary structure software - PSIPRED (Section 3.1.1).  
 
MADRVLRGSRLGAVSYETDRNHDLAPRQIARYRTDNGEEFEVPFADDAEIPG
TWLCRNGMEGTLIEGDLPEPKKVKPPRTHWDMLLERRSIEELEELLKERLELI
RSRRRG 
Figure 6.2: The amino acid sequence of Rv2050 indicating its structured 
region.  
The amino acid residues with bold grey shading represent the structured region 
of Rv2050. 
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Figure 6.3: Backbone structure of N-terminus of Rv2050.  
Left - Using PyMOL software to show the carbon (C), Nitrogen (N) and 
Oxygen (O) backbone of the N-terminal region of Rv2050 excluding the 
hydogens and side chains. Right - including the side chains (right). Residues of 
Rv2050 included are: PRQIARYRTDNGEEFEVPFADDAEIPGTWLCR 
NGMEGTLIEGDLPE. 
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Figure 6.4: The surface charge and the cartoon representation of the N-
terminus of Rv2050.  
Left - Surface charge: The red regions denotes the negative charge, the blue 
regions represent the positive charge, whilst the white regions denote the neutral 
charge amino acids. Right - Cartoon representation: The blue arrows represent the 
-stands whilst the grey lines represent the loops connecting the -strands. PyMOL 
software was used to generate these images. Residues of Rv2050 included are: 
PRQIARYRTDNGEEFEVPFADDAEIPGTWLCRNGMEGTLIEGDLPE.  
 
 
6.2.4 Homology search of Rv2050 
Using the pdb file of the N-terminal region of Rv2050, a DALI search was performed. 
Most of the proteins in the search belonged to ribosomal proteins: 50S Ribosomal 
proteins (Table 13). The top hit was a Peptide Chain Release Factor subunit 1 (RF1) 
(Section 6.6.1). 
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Table 13: DALI Search hits using the N-terminal region of Rv2050.  
Protein Z Score 
Peptide Chain Release factor Subunit 1: PDB entry 3IR9 4.2 
50S Ribosomal Protein L27: PDB entry 2Y0Z 4.1 
50S Ribosomal Protein L1: PDB entry 3KIR 3.9 
50S Ribosomal protein L2: PDB entry 3I1N 3.4 
Desulfoferrodoxin: PDB entry 1Y07  2.8 
Replicase polyprotein 1AB: PDB entry 2FE8 2.8 
Aminomethyltransferase: PDB entry 3A8I 2.8 
Prokaryotic transcription elongation factor GreA/GreB: PDB entry 2PN0 2.2 
The Z-score is a measure of the accuracy of the prediction, values < 2 are false. 
 
 
6.3 Rv2050 is not a Zn metalloprotein 
As mentioned in Section 3.1.1, RbpA homologues exist in the Zn and non-Zn form. It 
was shown that S. coelicolor RbpA is a Zn-binding protein with its Zn coordinated by 
three cysteine residues (C34, C56 & C59) and probably one histidine residue (H38) 
(Fig. 3.1) (P. Doughty & M. Paget, personal communication). However, Rv2050 only 
has a single cysteine and two histidine residues, neither of which is equivalent to 
RbpA H38 (Fig. 3.1), which suggests that this protein does not coordinate a metal. 
Therefore, inductively coupled plasma mass spectrometry (ICP-MS) was used to 
analyse the presence of trace metals in Rv2050.  
 
6.3.1 ICP-MS analysis of Rv2050 
A pure fraction of 0.5 mg Rv2050 purified by anion-exchange chromatography was 
sent for ICP-MS (University of Sussex). For a 1:1 stoichiometry of Rv2050 
complexed with Zn, Mg, or Mn, the concentrations would be 946 ppb, 352 ppb, and 
795 ppb, respectively. However, the sample contained Zn, Mg and Mn at 34.25 ppb, 
5.814 ppb and 0.03938 ppb, respectively (Table 14), indicating that Rv2050 is not a 
metalloprotein.  
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Table 14: ICP-MS data for Zn, Mg and Mn trace metals of Rv2050.  
 
File 
001_ 
STD.D 
 
002_ 
STD.D 
 
003 
SMPL.D 
 
004 
SMPL.D 
 
005 
SMPL.D 
 
Sample 
0 
ppb 
 
1000 
Ppb 
 
rinse 
blank 
 
Buffer 
 
 
Rv2050 
sample 
 Dilution 1 
 
1 
 
1 
 
1 
 
1 
 
 
conc. 
(ppb) 
% 
RSD 
conc. 
(ppb) 
% 
RSD 
conc. 
(ppb) 
% 
RSD 
conc. 
(ppb) 
% 
RSD 
conc. 
(ppb) 
% 
RSD 
Zn / 66 -6.7E-08 >100 1000 0.64 7.383 4.11 3.168 8.84 34.25 0.6 
Mg / 24 1.8E-07 >100 1000 0.94 0.2267 78.12 2.332 1.27 5.814 0.66 
Mn / 55 1.7E-09 >100 1000 0.5 0.4237 34.25 -0.1494 3.15 0.03938 22.06 
“Buffer” represents concentration of metals present in the solution Rv2050 was dialysed in. 
“RV2050 Sample” represents the concentration of the different metals present in 0.5 mg 
Rv2050. 
 
6.3.2 Key residues that maintain the structural integrity of Rv2050 
The alignment in Fig. 3.1 revealed that the predicted Zn-ligands in RbpA (C34, H38, 
C56 and C59) are “replaced” by the following conserved residues in Rv2050: T34, 
E38, C56 and N58. Strikingly, these residues appear to play an important role in 
maintaining the structural fold. For example, there appears to be a hydrogen/salt 
bridge formed between the glutamate (E38) and asparagine (N58). Furthermore, the 
PyMOL program predicted a hydrogen bond between E38 and T34 (Fig. 6.5). It 
follows that the proximity of T34, E38, C56 and N58 side chains in Rv2050 suggests 
that the equivalent residues in RbpA ligate Zn, as predicted. 
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Figure 6.5: Residues in Rv2050 that are thought to be interacting instead of co-
ordinating Zn.  
This illustration was generated using PyMOL software. Broken lines represent 
hydrogen bonds and/or salt bridges forming between GLU 38 and THR 34, and GLU 
38 and ASN 58 together with the distance of the bonds (black).  
 
 
6.4 Attempts to solve the structure of RbpA using NMR  
The overall structure of Rv2050 could not be solved due to the flexible/degraded C-
terminal region. Therefore, it was decided to repeat the experiments using S. 
coelicolor RbpA, which is likely to have a virtually identical fold. Initially, native RbpA 
labelled with 15N was over-produced, purified by anion-exchange chromatography 
followed by gel filtration, and sent for NMR analysis to determine if the protein was 
structured. RbpA produced dispersed peaks showing that it was structured, possibly 
more so than Rv2050, and therefore RbpA was produced labelled with 13C and 15N. 
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Following purification using anion-exchange chromatography and gel filtration, 13C 
15N RbpA was dialysed into phosphate buffer and sent for NMR spectroscopy. 
 
6.4.1 Over-expression of 13C 15N RbpA 
E. coli BL21 (pLysS) (pET20b::rbpA) was grown in 500 ml LB media to an OD600 of 
3-5. The culture was harvested by centrifugation and the pellet re-suspended in 
optimized high-cell density IPTG-induction minimal media containing 13C-glucose 
and 15N-NH4Cl (Section 2.1.4.1). The cultures were cold shocked, 0.03 mM ZnSO4 
added as RbpA is a Zn metalloprotein, and RbpA expression was induced with 
IPTG. The cultures were induced at 30ºC with vigorous shaking for 3 h (Section 
2.3.1.2).  
 
6.4.2 Purification of 13C 15N RbpA 
 
6.4.2.1 Anion-exchange - QFF column 
Anion-exchange chromatography was performed as described in Section 6.2.2.1, 
with some minor modifications. RbpA was also eluted at ~0.4 M NaCl (21-27 ml). A 
lower band appeared beneath the RbpA band suggesting that RbpA was degrading 
during the steps of purification (Fig. 6.6A).  
 
6.4.2.2 Anion-exchange - Mono Q column  
Fractions 21 to 25 (Fig. 6.6A) were dialysed into anion-exchange binding buffer then 
further purified by anion-exchange using a Mono Q column 5/50 GL column. The 
gradient was set at 0 to 40% for 30 ml followed by 40 to 100% for 5 ml. RbpA eluted 
between fractions 15 to 19 (~0.4 M NaCl) (Fig. 6.6B). However, fraction 15 was the 
most pure fraction lacking the lower degraded band (Fig. 6.6B). 
 
6.4.2.3 Gel filtration  
Gel filtration chromatography was used as the final step of purification of 13C 15N 
RbpA. Fraction 15 (Fig. 6.6B) was dialysed into gel filtration buffer (see above - 100 
mM NaCl) at 4ºC overnight, filtered, and passed through a pre-equilibrated gel 
filtration column (HiLoadTM 16/60 SuperdexTM 200 column) (Section 2.3.2.6). Eluates 
were collected as 1 ml fractions and RbpA was concentrated up (Fig. 6.6C). The 
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concentration of 13C 15N RbpA was low due to its gradual degradation (the lower 
band that appeared below RbpA- Fig. 6.6C). Therefore, an overall of 2 L of native 
13C 15N RbpA was expressed and purified (see above) to obtain 13.18 mg/ml in a 
final volume of 200 l. 13C 15N RbpA was then dialysed into a standard NMR buffer 
(Section 2.1.6.2) overnight, snap-frozen in liquid nitrogen after the addition of 0.02% 
sodium azide, and finally sent for NMR spectroscopy.  
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B 
  
C 
 
Figure 6.6: The purification of 13C 15N RbpA.  
The samples were assessed by separating the proteins on 4-12% Bis-Tris 
polyacrylamide gel at 120 V for 80 min and visualized by Coomassie Blue staining. 
The Marker used was SeeBlue®Plus2. (A) QFF anion-exchange chromatography. 10 
µl of the cleared cell lysate (CCL), supernatant flow-through (SF) and different 1 ml 
fractions were loaded on the gel. (B) Mono Q anion-exchange purification. 10 l of 
injected Rv2050 (Inj) and different 1 ml fractions loaded on gel. (C) Gel filtration 
purification of 13C 15N Rv2050. The same volumes of samples loaded as in B.  
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6.4.3 The C-terminal region  
Throughout the purification of RbpA a common problem faced was the presence of a 
band below RbpA that might be a degradation product of RbpA (e.g. Fig. 6.6). To 
confirm this, the two separate bands were excised separately from an SDS 
polyacrylamide gel and analysed by mass spectroscopy following digestion with 
trypsin (L. Bowler, University of Sussex). The results indicated that the upper band 
contained fragments that covered the whole length of RbpA, whilst the lower band 
lacked fragments from the C-terminal region of RbpA (data not shown). This 
suggests that the lower band was RbpA lacking its C-terminal region. This provides 
further evidence that the C-terminal region is critical for interaction with sigma, as the 
lower band that is RbpA protein lacking C-terminal region did not interact with HrdB 
(Fig. 4.7). 
 
6.4.4 NMR analysis  
As with Rv2050, the C-terminal region of 13C 15N RbpA was not visible by NMR, 
probably due to degradation. However, the N-terminal region contained 50 amino 
acids in the structured region ranging from residues 21 to 71 (Fig. 6.7). The grey 
highlighted residues were successfully assigned (K. O’Dwyer, P. Simpson and S. 
Matthews, personal communication). However, a constant problem faced was the 
continued degradation of RbpA during the acquisition of the NMR data.  
 
 
MSERALRGTRLVVTSYETDRGIDLAPRQAVEYACEKGHRFEMPFSVEAEIPPEWE
CKVCGAQALLVDGDGPEEKKAKPARTHWDMLMERRTREELEEVLEERLAVLRSG
AMNIAVHPRDSRKSA 
Figure 6.7: The amino acid sequence of RbpA indicating its structured region.  
The amino acid sequence of RbpA showing the structured region (in bold) and the 
residues that have been assigned (in grey highlight). 
 
 
The structure of RbpA was observed to be highly similar to that of Rv2050, as 
predicted by PSIPRED (Section 3.1.1). RbpA contains four -strands interconnected 
by loops at the N-terminal region (S. Matthews, personal communication). RbpA was 
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also shown to co-ordinate a metal. Using 1D NMR, it was noticed that the addition of 
EDTA to the RbpA solution showed a reduction in the intensity of the structured 
region and a rise in the flexibility of this region. Therefore, as expected, the bound Zn 
is likely to be important for maintaining the structural integrity of RbpA (K. O’Dwyer, 
P. Simpson and S. Matthews, personal communication). 
 
Similar to Rv2050, it was impossible to obtain the complete structure of RbpA due to 
the rapid degradation of the C-terminal region. To test whether a faster purification 
would help obtain intact/full length RbpA, His-tagged RbpA which is partially soluble, 
was purified at Imperial College London to be analysed immediately by NMR (K. 
O’Dwyer and S. Matthews, ICL). Following nickel-affinity chromatography, the 
protein was purified by gel filtration chromatography. Also, to minimise degradation, 
the purification was done at 4°C. High yield of pure His-tagged 13C 15N RbpA is in the 
process of being purified together with further NMR analysis (R. Lewis, M. Paget, P. 
Simpson, and S. Matthews, Work in progress). 
 
6.5 Attempts to solve the structure of an RbpA/Rv2050-sigma complex 
The structure obtained so far of Rv2050 only contained the N-terminal region but not 
the C-terminal region. NMR and mass spectrometry analysis of RbpA also showed 
that the C-teminal region was missing. It is possible that the C-terminal region is 
flexible and that this enhances its susceptibility to degradation. It was shown in 
Chapter 5, that this is the key region that interacts with the principal sigma factor. It 
therefore follows that sigma might stabilise the C-terminal region in a complex 
between the two proteins, thereby allowing the structure to be solved.  
 
6.5.1 Isolation of Rv2050-A(2) 
Rv2050 was shown to interact with A(2) using BACTH (Section 4.3.2.1). It was 
important to show that this interaction occurs in vitro, which would allow the complex 
to be purified before further structural studies. Different approaches were taken to 
obtain this complex. The first attempt was to over-express and purify Rv2050 and 
A(2) seperately and then mixed together to check for interaction. Another approach 
was to clone Rv2050 and A(2) together into the same expression vector, pET15b, 
allowing their co-expression and co-purification.  
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sigA(2) was amplified using sigA(2) primers introducing an NdeI site at the start codon 
and a BamHI site downstream of a newly introduced stop codon (Table 7- Section 
2.1.5.3). This amplified fragment was cloned into pBluescript II SK+, sequenced, 
then sub-cloned into pET15b and pET20b (Table 1- Section 2.1.2). Using E. coli 
BL21 (pLysS) (pET20b::sigA(2)), A(2) was not detected in both soluble and insoluble 
fractions (data not shown). A(2) was highly expressed from E. coli BL21 (pLysS) 
(pET15b::sigA(2)), but unfortunately was absent from a cleared cell lysate (data not 
shown), indicating that it is insoluble.  
 
It was decided to follow published methods to solubilise A(2). The first approach was 
by performing Ni-affinity purification using 6 M Urea buffers (Section 2.1.6.2 & 
2.3.2.2), followed by step dialysis, involving the gradual removal of urea, allowing the 
protein to re-nature slowly. However, A(2) precipitated out during the removal of 
urea. Another approach, adapted from Ignatova and co-workers (Ignatova & 
Gierasch, 2006, Fisher, 2006), involved over-expressing A(2) in the presence of high 
salt and proline, which is an osmoprotectant. However, A(2) remained insoluble 
showing that proline has no effect on A(2) solubility.  
 
A different approach was then taken by co-expressing A(2) and Rv2050 in pET15b. 
Rv2050 was isolated from pET20b::Rv2050 as a HindIII/BglII fragment and cloned 
into HindIII/BamHI-digested pET15b::sigA(2). E. coli BL21 (pLysS) competent cells 
were transformed with the resulting plasmid, pET15b::sigA(2)-Rv2050. Rv2050 and 
A(2) were both over-expressed and soluble as both proteins were present in the 
cleared cell lysate fraction (CCL). When the CCL was passed through the Ni-NTA 
column, both proteins bound to the column and were co-eluted, even though Rv2050 
was not His-tagged. This further indicates that Rv2050 and A(2) interact with each 
other (Fig. 6.8). 
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Figure 6.8: The expression, solubility and interaction of Rv2050 and A(2).   
13 l of the whole cell lysate (WCL), cleared cell lysate (CCL), supernatant flow-
through (SF), first wash (W1), second wash (W2), first elution (E1) and second 
elution (E2) were assessed by separating the proteins on 4-12% Bis-Tris 
polyacrylamide gel at 120 V for 80 min. The protein was visualized by staining with 
Coomassie Blue. The marker (M) used was SeeBlue®Plus2. 
 
 
Unfortunately, when the Rv2050 and A(2) elution fractions were dialysed into gel 
filtration buffer (Section 2.1.6.2) for a final purification step, the proteins precipitated 
out of solution. Further work is ongoing to try to maintain protein solubility. Following 
this, the complex will be sent for NMR analysis or for X-ray crystallography (R. 
Lewis, and M. Paget, work in progress). 
 
6.5.2 Isolation of RbpA-HrdB(2) 
In Section 4.3.2.1, HrdB(2) was shown to interact both with RbpA and its orthologue, 
Rv2050 in M. tuberculosis. Since HrdB(2) appears to be more soluble than the 
equivalent fragment in A, it was decided to attempt to study the structure of a 
complex between HrdB(2) and RbpA. Hence, HrdB(2) was purified by Ni-affinity 
chromatography followed by gel filtration (Fig. 6.9) and the appropriate buffer 
conditions were identified to keep the protein in solution.  
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Figure 6.9: Gel filtration purification of HrdB(2).  
13 l of the fraction injected into gel filtration column (Inj) together with the different 1 
ml fractions collected from the AKTA purifier were assessed by separating the 
protein samples on 5-15% Bis-Tris polyacrylamide gel at 200 V for 70 min. The 
protein bands were visualised using Coomassie Blue staining. The Marker (M) used 
was SeeBlue®Plus2. 
 
 
Pure HrdB(2) (fractions 87 to 97, Fig. 6.9) was concentrated to 1.6 mg/ml, sodium 
azide added and then snap frozen in liquid nitrogen in 200 l aliquots. In 
collaboration (K. O’Dwyer, P. Simpson, and S. Matthews, ICL), HrdB(2) was titrated 
into 15N-labelled RbpA. Preliminary data obtained also suggested an interaction 
between the C-terminal flexible/degradable region of RbpA and HrdB(2) due to 
observed peak broadening followed by peak disappearance (Section 5.1.1) (K. 
O’Dwyer, P. Simpson, and S. Matthews, unpublished observations). 
 
Further work is ongoing to express high yields of labelled HrdB(2), labelled RbpA, and 
unlabelled RbpA. These will then be titrated into each other to start assigning 
residues within the two proteins and thus, obtain the overall structure of RbpA-HrdB(2) 
complex (R. Lewis, M. Paget, P. Simpson and S. Matthews, personal 
communications).   
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6.6 Discussion 
Solving the structure of Rv2050 using X-ray crystallography failed as Rv2050 
produced poor crystals that did not diffract. However, using NMR spectroscopy, the 
structure of the N-terminal region of Rv2050 has been solved and this region is 
composed of four anti-parallel -strands interconnected by flexible loops. The C-
terminal region of Rv2050 appeared to be flexible and/or degradable. The structure 
of RbpA is also underway to be solved and its N-terminal region is likely to be very 
similar to that of Rv2050, however, RbpA co-ordinates a Zn (II) ion. The C-terminal 
region of RbpA also appeared to be flexible and/or degradable and since this region 
is involved in the interaction with the sigma factor (Section 5.1.1), methods have 
been developed to allow the purification of a complex (RbpA-HrdB(2) and/or Rv2050-
A(2)), which will allow the structure of the complex to be solved in the future.  
 
6.6.1 Protein homology of the N-terminal region of Rv2050 
NMR spectroscopy revealed that the N-terminal region of Rv2050 is composed of 
four anti-parallel -strands interconnected by loops (Fig. 6.4 - Right). Using the DALI 
server, the N-terminal region of Rv2050 was shown to share protein homology with 
the C-terminal domain of Peptide Chain Release Factor subunit 1 (RF1) from the 
archaebacterium, Methanosarcina mazei (Fig. 6.10), and some small ribosomal 
proteins (Table 13). RF1 was shown to co-ordinate Zn using four cysteine residues 
located at either end of the monomers by the-strands (Fig. 6.10). 
 
The N-terminal region of Rv2050 is similar to the C-terminal domain of RF1 as they 
both have anti-parallel -strands inter-connected by flexible loops (Fig. 6.4- Right & 
6.10). Interestingly, whereas Rv2050 lacks Zn, RbpA contains Zn (Section 6.3). The 
Zn (II) ion present in RF1 appears to be in an equivalent place as the predicted Zn 
(II) ion co-ordinated in RbpA. Apart from the structural similarity of these regions, 
Rv2050/RbpA has no apparent functional relation with RF1 or any of the DALI 
search hits (Table 13).  
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Figure 6.10: The X-ray crystal structure of the C-terminal domain of the peptide 
chain release factor 1 (RF1) dimer from Methanosarcina mazei overlayed with 
Rv2050 N-terminal region.  
Left- The structure of the C-terminal domain of RF1 dimer from Methanosarcina 
mazei overlayed with Rv2050 N-terminal region. The red ribbons denotes the -
strands of RF1 and the blue ribbons denote the -strands of Rv2050. RF1 crystal 
structure was obtained from the RSCB PDB database no. 3IR9 (Osipiuk et al., to be 
published). Right- The overlay region of RF1 and Rv2050. The red ribbons denote 
-strands of RF1 whilst the blue ribbons denote the -strands of Rv2050. PyMOL 
software was used and alignment done using cealign. The RMSD value is 2.67 (a 
value of 0 means perfect alignment) and alignment is over 40 residues. 
 
 
6.6.2 Zn metal as a structural component of RbpA 
Zn is an essential metal required in all living organisms and can play a structural, 
catalytic, regulatory or substrate role (Andreini et al., 2011). However, excess Zn in 
cells can be toxic. Zn (II) ions, co-ordinated by four amino acid residues, are 
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frequently found to play structural roles in protein folding. The most common 
occurring Zn co-ordinating residues are cysteine (80%) and histidine (19%), with the 
few rare exceptions being aspartate, glutamate and serine (Andreini et al., 2011). 
Also, most proteins that co-ordinate Zn for proper folding have at least two cysteine 
residues. Cysteine is favoured above other amino acid residues as it makes stronger 
bonds with the Zn (II) ion due to its ability to transmit negative charge to the Zn (II) 
ion (Andreini et al., 2011). Many structural Zn-clusters exist as “Zinc ribbons” with 
two -strands parallel to two other -strands and the Zn (II) ion present in the middle 
(Andreini et al., 2011).  
 
RbpA appears to co-ordinate a Zn metal in its N-terminal region using its three 
cysteine residues and one histidine residue (Section 3.1.1). This arrangement is 
consistent with the role of Zn in RbpA being structural. Also, from the PSIPRED 
RbpA secondary structure prediction (Section 3.1.1) and initial NMR analysis data 
(Section 6.4.4), RbpA was shown to have a “Zn ribbon”, which contains the amino 
acid residues co-ordinating the Zn (II) ion. There is no data that suggests that RbpA 
is a redox-sensing protein and it is thought that the Zn plays a purely structural role. 
The paralogue of RbpA in S. coelicolor, RbpB, also has the three cysteine residues 
(C35, C57 and C60) and the one histidine (H39) residue, which suggests that RbpB 
may also be a Zn-binding protein. However, Rv2050, the orthologue of RbpA in M. 
tuberculosis, does not co-ordinate any metal and two of the three cysteine ligands 
and the histidine ligand are absent (Section 6.3). Genome sequencing is revealing 
increasing numbers of examples where homologous proteins occur in alternative Zn-
binding or Zn-free forms, depending on lineage.  
 
6.6.3 Protein homologues that exist in Zn and non-Zn form 
 
6.6.3.1 Ribosomal proteins 
Ribosomal proteins stabilise rRNA and may play a functional role in the ribosomes. 
S. coelicolor has seven ribosomal proteins (S14, S18, L28, L31, L32, L33 and L36), 
which exist in both the Zn and non-Zn form (Owen et al., 2007). In most cases the Zn 
(II) ion is co-ordinated by four cysteine residues and has a structural role (Owen et 
al., 2007), whereas, the non-Zn form has apparently lost its “Zn ribbon” (Makarova et 
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al., 2001). It was shown that L31 can partly replace the Zn form of L31 in S. 
coelicolor (Owen et al., 2007). However, other organisms have only the non-Zn form 
of L31 implying that this form is fully functional. 
 
The reason why organisms might evolve Zn-free forms of r-proteins became clear 
when the regulation of these genes was studied. The non-Zn forms of these 
ribosomal proteins were induced during Zn limitation, on account of their control by 
the Zn regulator Zur (Panina et al., 2003, Owen et al., 2007). It is hypothesised that 
this reduces cellular demand for Zn, and possibly stimulates the release of the Zn (II) 
from Zn-binding r-proteins, which may be incorporated by other Zn metalloproteins 
(Owen et al., 2007). 
 
6.6.3.2 DksA 
DksA, an RNAP binding protein, was shown to coordinate Zn using four cysteine 
residues (Section 1.2.6.1). The Zn (II) ion is chelated by two cysteine residues in the 
globular domain and two cysteine residues in the coiled-coil domain. The role of Zn 
in DksA is to ensure proper folding of the globular domain and is essential for DksA 
functionality (Blaby-Haas et al., 2011). DksA was shown to exist in both the Zn and 
non-Zn (DksA2) form in P. aeruginosa (Blaby-Haas et al., 2011).  
 
DksA2, the paralogue of DksA, is fully functional and behaves in a similar manner to 
DksA inhibiting open complex formation (Section 1.2.6.1). DksA2 is thought to be 
expressed in poor Zn conditions and repressed in conditions of Zn availability and 
this regulation is controlled by Zur (Blaby-Haas et al., 2011).   
 
P. aeruginosa is a common pathogen that infects and causes death in many cystic 
fibrosis patients. Calprotectin, a neutrophil protein that sequesters Zn, is present in 
high levels in cystic fibrosis sputum. Thus, this protein leads to a low Zn environment 
in the sputum thereby expression of DksA2 is stimulated, which aids the survival of 
the bacterium in such conditions (Blaby-Haas et al., 2011). 
 
6.6.3.3 Superoxide dismutase (SodC) 
Superoxide dismutase co-ordinate metals and catalyse the dismutation of 
superoxide radicals (O2
-) into molecular oxygen (O2) and hydrogen peroxide (H2O2) 
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(Spagnolo et al., 2004). sodC encodes a Cu-, Zn-dependent superoxide dismutase. 
The Zn metal present in sodC-encoded enzyme is coordinated by three histidine 
residues and one aspartate residue and is important to maintain the structural 
integrity of the protein. However, in M. tuberculosis the sodC-encoded superoxide 
dismutase exists in the non-Zn form yet is fully functional (Spagnolo et al., 2004).  
 
SodC is required during M. tuberculosis infection. When the bacterium invades the 
macrophages, sodC expression is stimulated and is involved in the defence against 
the host-derived superoxide (Spagnolo et al., 2004). It was proposed that Zn might 
be limiting in the host which might account for the evolution of this Zn-free form of 
SodC (Spagnolo et al., 2004, Riccardi et al., 2008). An analogous explanation can 
be proposed for the apparent evolution of Rv2050, which is an essential protein in M. 
tuberculosis, to a Zn-free form. The RbpA orthologue in M. smegmatis also lacks Zn 
suggesting that the lost of Zn may have evolved to aid these microorganisms in Zn 
limiting conditions and gives them a competitive advantage against others.   
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7- General Discussions and Summary 
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7.0 Overview 
RbpA, an RNAP binding protein, was discovered when it co-eluted with RNAP during 
gel filtration and is partially regulated by R (Paget et al., 2001b). S. coelicolor ∆rbpA 
strains grow slowly producing smaller sized colonies than wild-type and overproduce 
the antibiotic actinorhodin (Newell et al., 2006). These strains were also shown to be 
sensitive to the antibiotic rifampicin (Newell et al., 2006), however, it is not thought 
that RbpA confers rifampicin resistance. RbpA was shown to interact with HrdB, the 
principal sigma factor in S. coelicolor, and to activate HrdB-dependent transcription 
(P. Doughty and M. Paget, unpublished observations). It was shown in this thesis 
that RbpA specifically interacts with domain 2 of HrdB using its C-terminal region. 
Furthermore, the orthologue of RbpA in M. tuberculosis, Rv2050, was also shown to 
interact in a similar manner to RbpA by binding to domain 2 of its principal sigma 
factor, A. 
 
Previous work showed that RbpA appears to be involved in an early stage of 
transcription initiation (P. Doughty and M. Paget, personal communication). 
However, the exact mechanism of action of RbpA has not yet been determined. 
Work done in this thesis suggests that RbpA is not involved in holoenzyme 
formation, but may be involved at some point within closed-open complex formation.  
 
Using NMR spectroscopy, the N-terminal region of Rv2050 has been solved and the 
equivalent region in RbpA is also underway to be solved. The C-terminal region 
appeared to be flexible and susceptible to degradation therefore, as this region 
interacts with sigma, the underlying work of obtaining a soluble sigma fragment that 
interacts with RbpA and its purification was completed. The overall structure of 
RbpA-HrdB(2) is currently subject to investigation (In collaboration with R. Lewis and 
M. Paget, work in progress).  
 
7.1 The RbpA family 
The RbpA family is present in only the Actinobacteria and is divided into three 
distinct classes. Two of these classes are likely to include orthologous proteins that 
differ by the presence or absence of putative Zn ligands e.g. RbpA in S. coelicolor, 
which co-ordinates Zn (II) using its three cysteine residues (C34, C56 and C59) and 
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possibly one histidine residue (H38), and Rv2050 in M. tuberculosis that lacks the 
putative Zn ligands (C34, C59 and H38). The third class are the RbpA paralogues, 
designated RbpB, which are less conserved amongst the Actinobacteria but are 
present in all of the Streptomyces and most of the Frankia genomes sequenced to 
date. Each RbpB orthologue has putative Zn ligands (C35, H39, C57, and C60 in S. 
coelicolor RbpB) suggesting that each co-ordinates Zn.  
 
7.1.1 Why is RbpA only present within the Actinobacteria? 
There appears to be no orthologous or even analogous proteins to RbpA outside of 
the Actinobacteria, raising the important question of why these proteins are required 
in this family. There is no clear answer to this question at present, but there are 
several possibilities. For example, the Actinobacteria contain a high G+C content, 
and therefore RbpA might aid in the melting of DNA during transcription initiation. 
However, this hypothesis is probably not true as RbpA is absent from some 
Actinobacteria containing a high G+C content (e.g Conexibacter woesie, 72.7% 
G+C, Pukall et al., 2009) yet present in others with a lower G+C content  (e.g. M. 
leprae, 57.8% G+C content, Cole et al., 2001). Nonetheless, a detailed analysis of 
G+C content at transcription initiation sites is yet to be performed, and so it is not 
clear whether the overall high G+C content is reflected by local high G+C content in 
promoter regions. 
 
Another possibility why RbpA is only found within the Actinobacteria might be due to 
the presence of some difference in the principal sigma factors or other subunits of 
the RNAP of the Actinobacteria that causes a requirement for RbpA. Multiple 
sequence alignment of HrdB with other HrdB-like sigma factors in the Actinobacteria 
containing and lacking RbpA did not show any evident dissimilarity. Many HrdB-like 
sigma factors have a strong positive (Lysine, K-rich) and negative (Aspartate, D- and 
Glutamate, E-rich) region 1.1 followed by well conserved domains 2-4 (Fig.A2- 
Appendices). However, some organisms lacked the highly basic region (Lysine, K).  
 
RbpA is not the only protein to be conserved and limited to the Actinobacteria. Other 
proteins (233 proteins) have been identified to be specific for the Actinobacteria (Gao 
et al., 2006). However, 29 of these proteins are found in most of the Actinobacteria 
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with some of these proteins absent within R. xylanophilus and/or T. whipplei (Gao et 
al., 2006), which is similar to the RbpA proteins (Table A1- Appendices). Is it 
possible that RbpA interacts with one of these proteins that are specific to the 
Actinobacteria and functions through this? This might explain why RbpA is 
conserved only within the Actinobacteria. 
 
7.1.2 Is the RbpA family essential in the Actinobacteria? 
RbpA is essential for the normal growth of S. coelicolor, whilst RbpB is non-essential 
and appears to be important only in the absence of RbpA (Newell et al., 2006). Since 
the construction of a S. coelicolor rbpA rbpB double mutant has not been 
successful, it is thought that RbpA and RbpB are partially redundant and rbpB is able 
to compensate for the absence of rbpA. In support of this, the overexpression of 
rbpB in a rbpA strain partially suppresses the slow-growth phenotype. Therefore, 
the combined function of RbpA and RbpB may be essential for the survival of S. 
coelicolor.  
 
The application of global transposon mutagenesis and microarray-based analysis of 
mutant libraries first provided some evidence that Rv2050, the homologue of RbpA 
in M. tuberculosis, might be a core gene required for optimal growth in vitro (Sassetti 
et al., 2003, Marmiesse et al., 2004). This was confirmed recently by the construction 
of a conditional mutant in M. tuberculosis (Forti et al., 2011).  
 
The importance of RbpA is further suggested by its presence in the highly reduced 
genome of M. leprae (Cole et al., 2001). It was shown here that Rv2050 interacts 
with the principal sigma factor of M. tuberculosis and therefore, is likely to play a key 
role in transcription initiation in this organism. Therefore, Rv2050 may be a possible 
target for drug design in the combat against mycobacterial infections such as 
tuberculosis, which is a persistent infection claiming millions of lives.   
 
7.2 RbpA as a distinct transcriptional activator  
RbpA stimulates transcription initiation although the mechanism involved is unclear. 
The evidence presented in this thesis suggests that this activation occurs through an 
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interaction with the principal sigma factor, although the additional interaction with one 
or more other subunits of RNAP cannot be discounted. 
 
Most of the described activators in the literature have been shown to interact with 
DNA in addition to a subunit of the RNAP holoenzyme. Activators that bind close to 
or overlapping the -35 promoter region often interact with the sigma factor, while 
those binding further upstream tend to interact with the  subunit (Rhodius & Busby, 
1998). Some activators can interact with several sites on RNAP. For example, the 
most studied transcriptional activator in the last few decades is the E. coli catabolite 
activator protein (CAP). CAP activates transcription from different classes of 
promoters differently. At some promoters CAP binds upstream from the RNAP DNA 
binding site (e.g. lac operon) and contacts the -CTD of RNAP stabilising closed 
complex (Igarashi & Ishihama, 1991, Busby & Ebright, 1999). At other promoters 
CAP overlaps the -35 region and contacts the -CTD and -NTD using distinct 
activating regions (Niu et al., 1996). At this position, it is also thought to contact the 
sigma factor domain 4 (Rhodius & Busby, 2000). The interaction with the -CTD 
stimulate RNAP holoenzyme to bind to promoters forming closed complex, whilst the 
interaction with the -NTD leads to isomerisation from closed to open complex (Niu 
et al., 1996).  
 
A particularly well-studied example of an activator that interacts with sigma is the cI 
repressor that activates its own expression, while repressing rightward lytic gene 
expression. cI was shown to make specific contacts with the C-terminal region of E. 
coli 70(4) (Li et al., 1994, Dove et al., 2000). From the structure of 70(4) and cI it 
was shown that residues in 70(4) interact with cI, thereby stabilising the interaction 
of 70 region 4 with the -35 element (Nickels et al., 2002). 
 
More unusual examples of activators interacting with other subunits of RNAP 
include: DnaA, which in addition to its role in DNA replication in E. coli, is also 
involved in transcription activation through interactions with the -subunit of RNAP at 
the PR promoter of bacteriophage  (Szalewska-Palasz et al., 1998); N4SSB, encoded 
by the bacteriophage N4, which activates transcription of the N4 late promoter by 
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interacting with the C-terminal region of the ’ subunit of RNAP-70 (Miller et al., 
1997).  
 
RbpA, however, is distinct from the above transcriptional activators in two key ways. 
Firstly, it does not appear to interact with DNA. Secondly, it specifically interacts with 
domain 2 of HrdB (Section 4.2). This is particularly unusual because most other 
described proteins that interact with sigma domain 2 are anti-sigma factors that have 
a negative effect on transcription. Some of the common examples include: FlgM-28 
in Salmonella typhimurium (Section 1.2.7), Rsd-70 in E. coli (Section 1.2.7.1), and 
SpoIIAB-F in B. subtilis (Campbell & Darst, 2000). These sigma factors appear to 
block sigma from associating with core RNAP (Rsd; Jishage & Ishihama, 1999, and 
SpoIIAB; Campbell & Darst, 2000) or destabilise the holoenzyme (FlgM; Chadsey et 
al., 1998) as it binds to domain 2, which make major interactions with core RNAP. 
Clearly, RbpA must interact with this region in a distinct way that does not block core 
interactions. 
 
Recently, Crl has been described as a transcriptional activator that interacts with 
sigma factor but does not interact with DNA (Section 1.2.9.1). It directly binds to the 
stationary phase sigma factor, S and increases S-dependent transcription in E. coli 
(Gaal et al., 2006). Furthermore, Crl was shown to also interact with domain 2 of S 
in Salmonella enteric Typhi with a 1:1 stoichiometry (England et al., 2008, Monteil et 
al., 2010b). The addition of Crl to S prior to core RNAP increased transcription 
activity showing that Crl might act by facilitating RNAP-S holoenzyme formation 
(Gaal et al., 2006). Crl was also shown to increase the affinity of S for RNAP by 7- 
fold (England et al., 2008), thereby giving S an advantage to bind to core RNAP 
during sigma competition (Typas et al., 2007).  
 
 7.3 The role of RbpA in transcription initiation 
RbpA appears to be involved in an early stage of transcription initiation as shown by 
its stimulation of transcription in single-round in vitro transcription assays and the 
formation of open-complexes (P. Doughty and M. Paget, personal communications). 
However, its exact mechanism of action is yet to be determined. As mentioned 
above, RbpA interacts with domain 2 of HrdB, which is composed of sub-regions: 
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1.2, 2.1, 2.2, 2.3 and 2.4. These regions are well conserved amongst the 70-like 
sigma factors and the regions are involved in forming major interactions with ’-
coiled-coil subunit of RNAP (region 1.2, 2.1 and 2.2) (Malhotra et al., 1996, Zenkin et 
al., 2007), melting of the -10 element to form the transcription bubble (region 2.3) 
(Feklistov & Darst, 2011), and the -10 element promoter recognition (region 2.4) 
(Murakami & Darst, 2003). In addition, the 1.2 region was recently shown to interact 
with the “discriminator region” (Haugen et al., 2008). 
 
Formation of an active holoenzyme can be seen as the first step in initiation and is 
the step at which Crl is thought to act (see above). A possible role of RbpA in RNAP-
HrdB formation was tested using in vivo pull-down assays (Section 3.2.4). However, 
the level of HrdB in affinity purified RNAP fractions was similar in wild-type and rbpA 
mutant backgrounds. In addition, preliminary results obtained using surface plasmon 
resonance assays in vitro suggest that RbpA does not stimulate holoenzyme 
formation (P. Doughty and M. Paget, personal communication). A possible role of 
RbpA in formation of the closed complex at HrdB-dependent promoters has been 
difficult to test because of the natural affinity of HrdB for non-specific DNA, probably 
due to its positively charged repeat region. 
 
RbpA might alternatively play a role in isomerisation from closed to open complex. 
Preliminary data obtained from KMnO4 assays suggested that RbpA stimulates open 
complex formation although the stage at which it acts could not be defined (P. 
Doughty and M. Paget, personal communication). If RbpA was involved in 
isomerisation it might aid in the melting of the -10 element directing it to transcription 
start site or it might stabilise the transcription bubble. For example, RbpA might bind 
to HrdB within the RNAP holoenzyme and affect the conformation of the sigma factor 
exposing region 2.3, hence, allowing initiation of DNA melting of the non-template -
10 element (Feklistov & Darst, 2011) and/or positioning region 2.4 to make specific 
interactions with bases in the non-template -10 element (Feklistov & Darst, 2011), 
thereby shifting the equilibrium towards the formation of the open complex.  
 
An example of a transcriptional activator that increases the rate of isomerisation from 
closed to open complex is cI (Hawley & McClure, 1982). It was proposed that cI 
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stabilises the binding of 70(4) to the -35 element leading to formation of a stable 
intermediate, which directs the equilibrium towards the open complex formation 
(Dove et al., 2000). However, as RbpA interacts with domain 2 instead of domain 4 
its mechanism of action would be quite distinct. Interestingly, Crl also showed an 
increase in promoter melting using KMnO4 assay suggesting a possible role for Crl in 
transcription bubble formation during open complex (England et al., 2008). 
 
7.4 RbpA structure and region function 
RbpA appears to be divided into two distinct regions: the N-terminal region and the 
C-terminal region. The structure of the N-terminal region of Rv2050 has been solved 
using NMR spectroscopy (Section 6.2) and is composed of four anti-parallel -
strands interconnected by loops. Determination of the structure of RbpA is also 
underway, and from an initial assessment, the N-terminal region was noted to be 
virtually identical to that of its homologue, Rv2050, as predicted by the PSIPRED 
(Section 3.1.1). This region of RbpA appears to be involved in maintaining the 
structural integrity of the protein by co-ordinating a Zn (II) ion using its three cysteine 
residues (C34, C56 and C59) and possibly one histidine (H38). As mentioned 
previously, Rv2050, however, lacks Zn and is a non-metalloprotein (Section 6.3).  
 
The C-terminal region of RbpA was not solved by NMR as this region appears to be 
susceptible to degradation and also possibly flexible. However, from the PSIPRED 
prediction, the C-terminal region of RbpA seems to be composed of two -helices, 
which are connected by a very short turn (ERR motif). Both helices together with the 
ERR motif were shown to be highly conserved amongst the RbpA homologues. Both 
helices in the C-terminal region play a key role in the interaction of RbpA with HrdB 
(Section 5.1).  
 
Site-directed mutagenesis studies on the C-terminal region of RbpA revealed that 
the arginine residues in the ERR motif are essential for the interaction with HrdB and 
when mutated the RbpA2RA is non-functional in S. coelicolor. Another interesting 
mutation within Helix 1 of RbpA appeared to be M85. An RbpA M85 mutant protein 
still interacted with HrdB, however, only retained partial function both in vivo (Section 
5.2.2) and in vitro (Section 5.6). The expression of the M85A allele in a wild-type 
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background revealed that it is a dominant negative mutation. Presumably, this is 
because it interacts with the essential HrdB and either prevents its association with 
core RNAP, or somehow blocks transcription initiation at a later stage. The future 
analysis of this allele and other dominant mutations is likely to play a key role in the 
dissection of RbpA function.  
 
Another group has shown that the RbpA homologue in M. smegmatis is involved in 
interacting with RNAP -subunit using cross-linking experiments (Dey et al., 2010). 
However, it should be noted that cross-linking reactions could generate non-specific 
products, which might account for the results. A recent paper showed that RbpA 
homologue in M. tuberculosis interacts with the -subunit of RNAP at the ‘sandwich-
barrel-hybrid motif’ that is located outside the active site cleft of RNAP (Hu et al., 
2012). This is distint from the interaction predicted by Dey et al., 2010.  While our 
data indicate that sigma is a major binding partner for RbpA, they do not rule out an 
additional interaction with other subunits. For example, it might be possible that 
RbpA interacts with core subunits via its N-terminal region.  
 
7.5 Future directions 
RbpA is thought to be a general positive regulator activating HrdB-dependent 
promoters. Is RbpA specific towards a particular promoter sequence or does it 
activate all HrdB-dependent genes? Using global approaches such as ChIP-Seq, it 
may be possible to identify whether RbpA might act as a promoter specific activator. 
However, since RbpA is partly expressed by stress (Paget et al., 2001b), it might be 
possible that it reprogram’s transcription and not act as a RNAP subunit but rather as 
a modulator.  
 
Rv2050 was shown to be essential for M. tuberculosis (Forti et al., 2011) and thus, 
the notion that RbpA together with RbpB are essential in S. coelicolor needs to be 
tested. As RbpA is predicted to be involved in transcription initiation, determining at 
what stage RbpA is involved in is crucial in understanding transcription in the 
medically and industrially important Actinobacteria. Biochemical assays together with 
the structure of the complex: RbpA-HrdB(2) would shed light into the role of RbpA. 
The overall structure of RbpA within the holoenzyme is a major goal, which might 
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answer many questions regarding the mechanism of action of RbpA. RNAP is a 
major proven target for anti-tuberculosis drugs, therefore novel essential 
components of RNAP such as Rv2050 that interact with RNAP and is present in M. 
tuberculosis can be potential drug targets to combat such diseases. 
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Table A1: The level of conservation of RbpA and RbpB in the Actinobacteria.  
Actinobacteria  RbpA RbpB  
Acidimicrobium ferrooxidans  
  Acidothermus cellulolyticus  P 
 Actinomyces coleocanis  P 
 Actinosynnema mirum P P 
Aeromicrobium marinum P P 
Agreia sp.  P 
 Amycolatopsis mediterranei  P P 
Arcanobacterium haemolyticum  P 
 Arthrobacter arilaitensis  P 
 Atopobium parvulum  
  Beutenbergia cavernae  P 
 Bifidobacterium adolescentis P 
 Brachybacterium faecium  P 
 Brevibacterium linens  P 
 Catenulispora acidiphila  P 
 Cellulomonas flavigena  P 
 Clavibacter michiganensis michiganensis  P 
 Collinsella aerofaciens  
  Conexibacter woesei  
  Corynebacterium diphtheriae gravis  P 
 Cryptobacterium curtum  
  Dermacoccus sp.  P 
 Dietzia cinnamea  P 
 Eggerthella lenta  
  Frankia alni ACN14a P P 
Gardnerella vaginalis  P 
 Geodermatophilus obscurus  P P 
Gordonia bronchialis  P 
 Intrasporangium calvum P 
 Janibacter sp.  P 
 Jonesia denitrificans  P 
 Kineococcus radiotolerans  P P 
Kocuria rhizophila P 
 Kribbella flavida  P P 
Kytococcus sedentarius  P P 
Leifsonia xyli xyli P 
 Micrococcus luteus Fleming  P 
 Micromonospora aurantiaca  P P 
Mobiluncus curtisii  P 
 Mycobacterium tuberculosis H37Rv  P 
 Nakamurella multipartita  P P 
Nocardia farcinica  P 
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Actinobacteria  RbpA RbpB  
Nocardioides sp.  P P 
Nocardiopsis dassonvillei  P P 
Olsenella uli VPI 
  Parascardovia denticolens  P 
 Propionibacterium acnes  P P 
Pseudonocardia sp. P P 
Renibacterium salmoninarum  P 
 Rhodococcus equi  P 
 Rothia dentocariosa  P 
 Rubrobacter xylanophilus 
  Saccharomonospora viridis  P P 
Saccharopolyspora erythraea  P P 
Salinispora arenicola  P 
 Sanguibacter keddieii  P 
 Scardovia inopinata  P 
 Segniliparus rotundus  P 
 Slackia heliotrinireducens RHS 1 
  Stackebrandtia nassauensis  P P 
Streptomyces coelicolor A3(2) P P 
Streptosporangium roseum  P 
 Thermobifida fusca  P P 
Thermobispora bispora  P P 
Thermomonospora curvata P P 
Tropheryma whipplei  
  Verrucosispora maris P 
 Tsukamurella paurometabola P 
 Xylanimonas cellulosilytica P P 
The list of the Actinobacteria only includes a single representative of the species. RbpA and 
RbpB are either present (P) in all or absent in all.   
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Figure A1: A graph representation of the growth curve of J1981 and S129. 
Samples were taken at early exponential phase and then at 2 h intervals until 
stationary phase and the dry weights were measured. The error bars shown 
represent the standard deviation of triplicate samples. The graph was plotted using 
SigmaPlot. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
236 
 
Table A2: Genes that are downregulated in S. coelicolor ∆rbpA strain, S101, 
relative to wild-type strain, J1915.  
Gene 
Name 
Log2 Average 
Cond1/Cond2 
inv. 
Log Description 
SCO0527 -1.079 0.47 cold shock protein 
SCO0753 -2.686 0.16 hypothetical protein 
SCO1086 -1.488 0.36 hypothetical protein 
SCO1139 -0.764 0.59 integral membrane protein 
SCO1341 -0.995 0.50 Lipoprotein 
SCO1421 -1.363 0.39 rbpA gene 
SCO1578 -1.185 0.44 acetylglutamate kinase 
SCO1579 -1.002 0.50 
bifunctional ornithine acetyltransferase/N-acetylglutamate 
synthase protein  
SCO2628 -0.831 0.56 amino acid permease 
SCO2698 -0.210 0.87 small hydrophilic protein 
SCO2779 -0.690 0.63 acyl-CoA dehydrogenase 
SCO2920 -0.761 0.59 secreted protease 
SCO2968 -0.727 0.60 cell division protein 
SCO3483 -0.714 0.61 integral membrane transport protein 
SCO3484 -0.777 0.58 secreted sugar-binding protein 
SCO3527 -0.375 0.77 hypothetical protein 
SCO3553 -0.588 0.67 small membrane protein 
SCO3661 -0.738 0.60 ATP-dependent protease ATP-binding subunit 
SCO3662 -0.923 0.53 hypothetical protein 
SCO3663 -0.861 0.55 hypothetical protein 
SCO3731 -0.989 0.50 cold-shock protein 
SCO3781 -0.751 0.59 secreted protein 
SCO3795 -1.103 0.47 aspartyl-tRNA synthetase 
SCO3897 -0.721 0.61 hypothetical protein 
SCO3961 -1.243 0.42 seryl-tRNA synthetase 
SCO4078 -1.017 0.49 phosphoribosyl formylglycinamidine synthase I 
SCO4079 -0.692 0.62 phosphoribosylformylglycinamidine synthase subunit II 
SCO4089 -0.761 0.59 valine dehydrogenase 
SCO4178 -1.079 0.47 small membrane protein 
SCO4179 -0.801 0.57 hypothetical protein 
SCO4614 -0.724 0.61 nucleotide-binding protein 
SCO4652 -0.430 0.74 50S ribosomal protein L10 
SCO4660 -0.789 0.58 30S ribosomal protein S7 
SCO4716 -0.514 0.70 30S ribosomal protein S8 
SCO4717 -0.392 0.76 50S ribosomal protein L6 
SCO4718 -0.466 0.72 50S ribosomal protein L18 
SCO4719 -0.541 0.69 30S ribosomal protein S5 
SCO4720 -0.430 0.74 50S ribosomal protein L30 
SCO4721 -0.460 0.73 50S ribosomal protein L15 
SCO4945 -1.150 0.45 Dehydrogenase 
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Gene 
Name 
Log2 Average 
Cond1/Cond2 
inv. 
Log Description 
SCO5049 -0.682 0.62 hypothetical protein 
SCO5189 -0.833 0.56 hypothetical protein  
SCO5190 -1.351 0.39 DNA-binding protein 
SCO5191 -1.035 0.49 hypothetical protein  
SCO5209 -1.028 0.49 tetR-family transcriptional regulator 
SCO5272 0.126 0.92 hypothetical protein  
SCO5519 -0.821 0.57 hypothetical protein 
SCO5520 -0.757 0.59 delta-1-pyrroline-5-carboxylate dehydrogenase 
SCO5537 -0.660 0.63 ATP/GTP binding protein 
SCO5680 -0.806 0.57 cytidine deaminase 
SCO6592 -0.663 0.63 secreted protein 
SCO6624 -0.842 0.56 hypothetical protein 
SCO7036 -0.909 0.53 argininosuccinate synthase 
SCO7209 -1.089 0.47 hypothetical protein 
SCO7463 -0.654 0.64 sensor histidine kinase 
SCO7464 -0.505 0.71 hypothetical protein 
SCO7708 -0.911 0.53 hypothetical protein 
SCO7793 -1.366 0.39 hypothetical protein 
All these genes had a pfp value < 0.15. Hence, there is > 95 % probability that the differene 
in expression has not occurred by chance. 
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Table A3: Genes that are upregulated in S. coelicolor ∆rbpA strain, S101, 
relative to wild-type strain, J1915.  
Gene 
Name 
Log2 Average 
Cond1/Cond2 
inv. 
Log Description 
SCO0049 3.595 12.08 hypothetical protein 
SCO0168 1.006 2.00 regulator protein 
SCO0169 0.975 1.96 hypothetical protein 
SCO0190 0.787 1.73 Methyltransferase 
SCO0201 0.864 1.82 integral membrane protein SCJ1213c 
SCO0204 1.019 2.03 luxR family two-component response regulator 
SCO0212 1.305 2.47 hypothetical protein 
SCO0226 0.684 1.61 hypothetical protein 
SCO0231 1.400 2.64 small hydrophobic hypothetical protein 
SCO0409 1.204 2.30 spore-associated protein precursor 
SCO0426 0.750 1.68 hypothetical protein 
SCO0596 1.114 2.17 DNA-binding protein 
SCO0600 0.712 1.64 RNA polymerase sigma factor sig8 
SCO0608 0.921 1.89 regulatory protein 
SCO0650 0.891 1.85 gas vesicle synthesis-like protein 
SCO0678 2.111 4.32 hypothetical protein 
SCO0694 2.270 4.83 hypothetical protein 
SCO0736 1.739 3.34 secreted protein 
SCO0761 1.171 2.25 hypothetical protein 
SCO0779 0.743 1.67 hypothetical protein 
SCO0931 0.780 1.72 secreted proline-rich protein 
SCO0973 0.898 1.86 integral membrane protein 
SCO0999 1.281 2.43 superoxide dismutase 
SCO1023 0.981 1.97 hypothetical protein 
SCO1236 1.268 2.41 urease gamma subunit 
SCO1364 1.247 2.37 hypothetical protein 
SCO1385 1.081 2.12 hypothetical protein 
SCO1550 2.212 4.63 small membrane protein 
SCO1603 1.120 2.17 Transposase 
SCO1604 1.261 2.40 hypothetical protein 
SCO1605 0.895 1.86 hypothetical protein 
SCO1627 1.257 2.39 ATP-GTP binding protein 
SCO1659 1.079 2.11 glycerol uptake facilitator protein 
SCO1660 0.774 1.71 glycerol kinase 
SCO1661 0.702 1.63 glycerol-3-phosphate dehydrogenase 
SCO1674 1.059 2.08 secreted protein 
SCO1675 2.867 7.30 small membrane protein 
SCO1695 1.340 2.53 hypothetical protein 
SCO1700 3.094 8.54 hypothetical protein 
SCO1793 0.748 1.68 secreted protein 
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Gene 
Name 
Log2 Average 
Cond1/Cond2 
inv. 
Log Description 
SCO1800 2.107 4.31 small secreted protein 
SCO1839 0.925 1.89 transcriptional regulator 
SCO1865 0.855 1.81 diaminobutyrate--2-oxoglutarate aminotransferase 
SCO1866 2.129 4.38 L-ectoine synthase 
SCO1867 1.536 2.90 Hydroxylase 
SCO1875 1.147 2.22 secreted penicillin binding protein 
SCO1993 0.728 1.66 hypothetical protein 
SCO1995 1.136 2.19 hypothetical protein 
SCO2113 1.160 2.24 bacterioferritin: iron storage protein 
SCO2367 0.859 1.81 hypothetical protein 
SCO2582 1.343 2.54 hypothetical protein 
SCO2633 1.931 3.81 superoxide dismutase [Fe-Zn] 
SCO2717 1.992 3.98 small membrane protein 
SCO2718 0.787 1.72 secreted protein 
SCO2760 0.741 1.67 membrane protein 
SCO2807 0.955 1.94 integral membrane protein 
SCO2828 0.718 1.64 
probable amino acid ABC transporter protein,  
solute-binding component 
SCO2912 1.119 2.17 hypothetical protein 
SCO3009 0.767 1.70 hypothetical protein 
SCO3034 1.336 2.53 sporulation regulatory protein 
SCO3082 1.740 3.34 hypothetical protein 
SCO3089 2.249 4.75 ABC transporter ATP-binding protein 
SCO3090 1.326 2.51 ABC transporter integral membrane protein 
SCO3098 0.975 1.97 secreted protein 
SCO3110 0.710 1.64 ABC transport system integral membrane protein 
SCO3111 1.552 2.93 ABC transport system ATP-binding protein 
SCO3202 1.180 2.27 RNA polymerase sigma factor, hrdD 
SCO3218 0.748 1.68 small conserved hypothetical protein 
SCO3323 0.965 1.95 RNA polymerase sigma protein, bldN 
SCO3324 1.023 2.03 hypothetical protein 
SCO3396 0.897 1.86 hypothetical protein 
SCO3397 0.738 1.67 integral membrane lysyl-tRNA synthetase 
SCO3561 0.720 1.65 secreted protein 
SCO3660 0.688 1.61 hypothetical protein 
SCO3814 1.196 2.29 DNA-binding protein 
SCO3855 1.259 2.39 hypothetical protein 
SCO3857 0.740 1.67 regulatory protein 
SCO3862 1.508 2.84 hypothetical protein 
SCO3924 0.799 1.74 hypothetical protein 
SCO3929 0.915 1.88 hypothetical protein 
SCO3937 0.917 1.89 integrase /recombinase 
SCO3945 1.646 3.13 cytochrome oxidase subunit I 
SCO3946 1.119 2.17 cytochrome oxidase subunit II 
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Gene 
Name 
Log2 Average 
Cond1/Cond2 
inv. 
Log Description 
SCO3956 2.978 7.88 ABC transporter ATP-binding protein 
SCO3957 1.941 3.84 integral membrane protein 
SCO3958 2.671 6.37 ABC transporter ATP-binding protein 
SCO3992 0.754 1.68 hypothetical protein 
SCO3993 1.002 2.00 hypothetical protein 
SCO4004 1.652 3.14 small membrane protein 
SCO4063 0.875 1.83 secreted protein 
SCO4080 1.156 2.23 hypothetical protein 
SCO4148 0.704 1.63 ABC transport system ATP-binding protein 
SCO4174 3.140 8.81 integral membrane protein 
SCO4187 1.357 2.56 hypothetical protein 
SCO4198 0.758 1.69 DNA-binding protein 
SCO4226 0.933 1.91 hypothetical protein 
SCO4247 0.793 1.73 hypothetical protein 
SCO4248 0.911 1.88 hypothetical protein 
SCO4251 1.183 2.27 secreted protein 
SCO4252 1.076 2.11 hypothetical protein 
SCO4253 1.012 2.02 hypothetical protein 
SCO4257 1.057 2.08 hydrolytic protein 
SCO4258 1.188 2.28 hydrolytic protein 
SCO4261 0.988 1.98 response regulator 
SCO4277 0.802 1.74 tellurium resistance protein: responds to bacterial stress 
SCO4317 2.312 4.97 hypothetical protein 
SCO4347 1.590 3.01 hypothetical protein 
SCO4350 0.964 1.95 Integrase 
SCO4471 1.125 2.18 secreted protein 
SCO4562 0.865 1.82 NADH dehydrogenase alpha subunit 
SCO4584 1.481 2.79 hypothetical protein 
SCO4585 0.823 1.77 ABC transporter ATP-binding protein 
SCO4610 1.348 2.55 integral membrane protein 
SCO4635 0.771 1.71 50S ribosomal protein L33 
SCO4636 1.412 2.66 hypothetical protein 
SCO4675 0.920 1.89 hypothetical protein 
SCO4767 1.314 2.49 regulatory protein 
SCO4807 0.984 1.98 hypothetical protein 
SCO4861 1.163 2.24 hypothetical protein 
SCO4934 0.901 1.87 Lipoprotein 
SCO4994 1.582 3.00 hypothetical protein 2SCK3617 
SCO5071 1.469 2.77 hydroxylacyl-CoA dehydrogenase 
SCO5074 2.262 4.80 Dehydratase 
SCO5075 1.253 2.38 Oxidoreductase 
SCO5077 0.985 1.98 hypothetical protein 
SCO5078 1.275 2.42 hypothetical protein 
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Gene 
Name 
Log2 Average 
Cond1/Cond2 
inv. 
Log Description 
SCO5079 1.033 2.05 hypothetical protein 
SCO5080 1.028 2.04 hydrolase: in actinorhodin cluster 
SCO5084 1.127 2.18 hypothetical protein: in actinorhodin cluster 
SCO5085 2.048 4.14 actinorhodin cluster activator protein, actII0RFIV 
SCO5086 0.824 1.77 ketoacyl reductase: in actinorhodin cluster 
SCO5088 1.473 2.78 
actinorhodin polyketide beta-ketoacyl synthase beta 
subunit: in actinorhodin cluster 
SCO5091 0.885 1.85 cyclase: in actinorhodin cluster 
SCO5130 0.944 1.92 ABC transporter integral membrane protein 
SCO5145 0.692 1.62 hypothetical protein 
SCO5174 0.910 1.88 Transferase 
SCO5198 0.699 1.62 hypothetical protein 
SCO5204 1.205 2.31 integral membrane protein 
SCO5496 0.741 1.67 small membrane hydrophobic protein 
SCO5590 1.411 2.66 hypothetical protein 
SCO5644 0.787 1.73 hypothetical protein 
SCO5741 1.179 2.26 hypothetical protein 
SCO5790 0.967 1.96 hypothetical protein 
SCO5826 1.117 2.17 hypothetical protein 
SCO5862 1.014 2.02 two-component regulator CutR 
SCO5877 1.078 2.11 transcriptional regulator RedD: in RED cluster 
SCO5885 1.503 2.83 hypothetical protein: in RED cluster 
SCO5890 1.236 2.36 8-amino-7-oxononanoate synthase 
SCO5897 1.210 2.31 Oxidase 
SCO5898 1.328 2.51 probable membrane protein 
SCO6073 0.894 1.86 Cyclase 
SCO6239 1.117 2.17 sigma factor 
SCO6282 0.946 1.93 3-oxoacyl-[acyl-carrier protein] reductase 
SCO6377 0.932 1.91 Lipoprotein 
SCO6380 0.944 1.92 hypothetical protein 
SCO6382 0.783 1.72 secreted protein 
SCO6394 1.276 2.42 IS element ATP binding protein 
SCO6400 0.999 2.00 IS117 transposase 
SCO6401 0.936 1.91 hypothetical protein 
SCO6402 1.349 2.55 hypothetical protein 
SCO6404 0.837 1.79 hypothetical protein 
SCO6499 4.066 16.75 gas vesicle synthesis protein 
SCO6500 0.784 1.72 gas vesicle synthesis-like protein 
SCO6501 0.815 1.76 gas vesicle synthesis protein 
SCO6502 1.603 3.04 gas vesicle synthesis protein 
SCO6509 3.416 10.67 hydrophobic protein 
SCO6682 0.947 1.93 hypothetical protein 
SCO6708 0.873 1.83 hypothetical protein 
SCO6766 0.801 1.74 hypothetical protein 
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Gene 
Name 
Log2 Average 
Cond1/Cond2 
inv. 
Log Description 
SCO6776 1.140 2.20 hypothetical protein 
SCO6814 2.113 4.33 ABC transporter ATP-binding protein 
SCO6815 0.812 1.76 ABC transporter permease protein 
SCO6816 1.574 2.98 ABC transporter binding lipoprotein 
SCO6817 1.557 2.94 hypothetical protein 
SCO6818 1.124 2.18 Phosphoglyceromutase 
SCO6819 0.888 1.85 3-phosphoshikimate 1-carboxyvinyltransferase 
SCO6820 1.123 2.18 Oxidoreductase 
SCO6821 2.153 4.45 hypothetical protein 
SCO6831 0.850 1.80 hypothetical protein 
SCO6925 1.003 2.01 hypothetical protein (membrane protein) 
SCO6931 0.997 1.99 hypothetical protein 
SCO6932 2.696 6.48 hypothetical protein 
SCO6935 1.090 2.13 hypothetical protein 
SCO6939 0.832 1.78 hypothetical protein 
SCO6941 0.768 1.70 hypothetical protein 
SCO6978 0.767 1.70 carbohydrate kinase 
SCO6983 0.877 1.84 hypothetical protein 
SCO7018 0.922 1.89 hypothetical protein 
SCO7092 0.870 1.83 secreted protein 
SCO7108 0.819 1.77 hypothetical protein 
SCO7210 1.078 2.11 hypothetical protein 
SCO7278 0.797 1.74 RNA polymerase sigma factor 
SCO7325 0.897 1.86 
Stage II sporulation protein: belongs to anti-sigma factor 
antagonist 
SCO7330 0.898 1.86 membrane protein 
SCO7383 0.239 1.18 hypothetical protein 
SCO7405 0.771 1.71 acetyltransferase (fragment) 
SCO7536 1.025 2.04 integral membrane protein 
SCO7646 1.829 3.55 hypothetical protein 
SCO7657 1.242 2.37 secreted protein 
SCO7658 1.429 2.69 hypothetical protein 
SCO7756 1.715 3.28 hypothetical protein 
SCO7781 0.681 1.60 pseudo gene 
SCO7805 0.548 1.46 hypothetical protein 
SCO7820 0.696 1.62 hypothetical protein 
The genes had a pfp value < 0.15. Hence there is > 95% probability that the differene in 
expression has not occurred by chance. 
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Sig_Rx    1 ------------------------------------------------------------ 
Sig_Af    1 ------------------------------------------------------------ 
Sig_Cc    1 ---MAAASRTSTT----------------------------------------------- 
Sig_Ap    1 ---MAAKKANDEV----------------------------------------------- 
Sig_El    1 ---MAQASSKQAQ----------------------------------------------- 
Sig_Se    1 ------------------------------------------------------------ 
Sig_Ou    1 ---MTTNKAASDL----------------------------------------------- 
Sig_Mt    1 ---MAATKASTATDEPVKRTATKSP----------------------------------- 
Sig_Cd    1 MANAGEASSATVKKAAKKTAAKKTARK--------------------------------- 
Sig_Am    1 ---MAAAKTTQAAKADAEETPKATS----------------------------------- 
Sig_Sv    1 ---MDETATPETKSSGRKTAAKKAP----------------------------------- 
Sig_Kf    1 ---MSSSSSENLPAESARAV---------------------------------------- 
Sig_Ac    1 ---MAQNGGKEISVAVAKTTKKSGKVSEVEAPEVLAES---------------------- 
Sig_Sc    1 ---MSASTSRTLPPEIAESVSVMALIERGKAEGQIAGDDVRRAFEADQIPATQWKNVLRS 
Sig_Fa    1 ----MPRNLGRSR----------------------------------------------- 
HrdA      1 ------------------------------------------------------------ 
HrdC      1 ------------------------------------------------------------ 
HrdD      1 ------------------------------------------------------------ 
 
 
Sig_Rx    1 -------------MAAEDTMMLADRAYELLSKGRSQGFLSAEDVADLVREGDLSPDEAEE 
Sig_Af    1 -------------------------------------------------MRAVLRGSAPH 
Sig_Cc   11 ---------------EKVPGKD--------GSSQPDEEIQNQAASDSEDSVDLEDLEAPD 
Sig_Ap   11 ---------------KLSDELTKIVDDLV-SSSKSNGSISEDDIQVAIRDIDVNDDELSD 
Sig_El   11 ---------------ERNNAAV--------ASIEAEDILEEDALDDEPDVVDAGDGLDDD 
Sig_Se    1 ------------------------------MDIEEG-ALNEESLGDD---LAAEDGKD-- 
Sig_Ou   11 ---------------EFSDELQVVVTKLIRSASSSDSSITEDDIQVAIAEMDVDDDELSD 
Sig_Mt   23 -------------AASASGAKTGAKRTAAKSASGSPPA------------KRATKPAARS 
Sig_Cd   28 ------------VARKVTAVKVAATPTVTSSAESATAEPAIELPSSEPVKKAAKKTAKKT 
Sig_Am   23 -------------ARKAPVRKPAAKTAAAGKTTARAPR------------KTAAKAAAGS 
Sig_Sv   23 -------------AKSAKTTRTRKTTTKSDKAKTTTRS------------KASKSTSKAK 
Sig_Kf   18 ---------------AATARSTAPRTSARVPDP-------AAKKATVKKAAPAAKKAAVS 
Sig_Ac   36 ------------LAEEKPAKKTATKKKAPAKKAAEATDEVAEKPKRTRKTKATESTEATA 
Sig_Sc   58 LNQILEEEGVTLMVSAAEPKRTRKSVAAKSPAKRTATKAVAAKPVTSRKATAPAAPAAPA 
Sig_Fa   10 ---------------EGSDEIP----------PMSPTVLPREAQVDEVKDLITRGKEIG- 
HrdA      1 ---------------------------VRGGQRRASRLRPPTYRRRPPPAASILEVAPVQ 
HrdC      1 -------------------------------------------------MAPTARTPTAR 
HrdD      1 ----------------------------------------------------MATRAVAR 
 
 
Sig_Rx   48 LY-----------------------------------------ATLEEEDITLVDEELEG 
Sig_Af   12 RF-----------------------------------------VHPASQESSGGGE---- 
Sig_Cc   48 TVG-------------------VPDIS-------------DDAIAGDKPEAESEEDLLEG 
Sig_Ap   55 LYD-------------------SLRVKGIEITTASEATVSFAIEDDAAEDDFSSDDDLDN 
Sig_El   48 ------------------------------------------KLESPLSDDSDDEDLLEG 
Sig_Se   25 -------------------------------------------VDANLSD----EELLEG 
Sig_Ou   56 IYE-------------------AVRARGVSIVASGESQPVSAVDDEDGLDALEADG-KAA 
Sig_Mt   58 VKPASAPQDTTTSTIPKRKTRAAAKSAAAKAPSARGHATKPRAPKDAQHEAATDPEDALD 
Sig_Cd   76 AK-----------KVAKKAAKKTAKKTTAKKSTRKSAKKVAAPVPEEATQSSEESEDELE 
Sig_Am   58 PK--------------------AKKAGEGDEP--------------EEIEGAPGDEDLVD 
Sig_Sv   58 SK----------------------KSAELDEG-----------FDSPELEDVDLSDLDVD 
Sig_Kf   56 TK----------------EDGIPAKKAAAKKAP----------AKKAVSEAGLAIDPKTG 
Sig_Ac   84 EA----------------TEEKPKKKRAPRKKK----------AEEEVASETPAPEADAE 
Sig_Sc  118 TEP------------AAVEEEAPAKKAAAKKTT----------AKKATAKKTTAKKAAAK 
Sig_Fa   44 -----------------------------------------FLTTEDVTVAIQAAELPPE 
HrdA     34 TQ-----------------------------------------TLTQTDTAAGGAEPDAE 
HrdC     12 -------------------------------------------TRDDRRATTRTAR---- 
HrdD      9 -------------------------------------------RKSAAGETSGSAT---- 
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Sig_Rx   67 AAEVTPER---------------------------------------------------- 
Sig_Af   27 ------------------------------------------------------------ 
Sig_Cc   76 IPE------------EELKAS--SSVSLP------------------------------- 
Sig_Ap   96 SSDFEDEDDEDFDVVNEAREVKEALRSVS------------------------------- 
Sig_El   66 IPE------------EELKAT--VEVQLP------------------------------- 
Sig_Se   38 IPE------------NELKAASTSEINLP------------------------------- 
Sig_Ou   96 LDDEDDEDDEISKARKEARVANEVLRSVP------------------------------- 
Sig_Mt  118 SVEELDAEPDLDVEPGEDLDLDAADLNLDDLEDDVAPDADDDLDSGDDEDHEDLEAEAAV 
Sig_Cd  125 SLAGEDSDEDYDPHLDEFDDDDE------------------------------------- 
Sig_Am   84 EVELIDEP--VEEEPAE------------------------------------------- 
Sig_Sv   85 AVEVDVVDATVTEDTDES------------------------------------------ 
Sig_Kf   90 KPRALDE-----VDEADFQP---------------------------------------- 
Sig_Ac  118 EIEDRHDDELAEPDEFADEEDLDLDLDVD------------------------------- 
Sig_Sc  156 KTTAKKEDGELLEDEATEEP---------------------------------------- 
Sig_Fa   63 QAET---------VLQVLNDEGIEVLEAG------------------------------- 
HrdA     53 RGVLLAMPAQPGAGAALPHP---------------------------------------- 
HrdC     25 ------------------------------------------------------------ 
HrdD     22 ------------------------------------------------------------ 
 
 
Sig_Rx   75 -------------------------------------------AAGREGDNPASQLAHAV 
Sig_Af   27 ---------------------------------------------------LVTKERQER 
Sig_Cc   91 ------------------------------------KVTASKSRIRQSSRSRAADTSITM 
Sig_Ap  125 ------------------------------------KAKVSKPKRSSRARARRSDTTTVM 
Sig_El   81 ------------------------------------KVAGK-SKVRSVRKRNADAS-VTM 
Sig_Se   55 ------------------------------------KLSS--SRASKVRRRSSDGSSAVM 
Sig_Ou  125 ------------------------------------KPKGRK--RSSRARAHKLDSSAVM 
Sig_Mt  178 APGQTADDDEEIAEPTEKD---------------KASGDFVWDEDESEALRQARKDAELT 
Sig_Cd  148 --MHTDELGEDDSSDDDSD---------------EDEGSSVWDEDESAALRQARKDAELS 
Sig_Am   99 ---------EENAKPGE--------------------GDFVWDEEESEALRQARKDAELT 
Sig_Sv  103 ---------DEESDAND--------------------PDFVWDEEESEALRQARKDAELT 
Sig_Kf  105 ---DAVKPLEKELTEDQ--------------------GFIVSEADETDEP--EQQVMVAG 
Sig_Ac  147 --DDLEEDLESDDDEDSEGARRGKPDAEETQAVVKTGGFVVSEFDDTDEP--VQKVTVAG 
Sig_Sc  176 ---KAAT-EEPEGTENA--------------------GFVLSDEDEDDAP--AQQVAAAG 
Sig_Fa   83 ------------------------------------GENPDEADLLARRRREEEELALKA 
HrdA     73 --------------------------------------GAPVDVPEHPEPPPPTRTESGG 
HrdC     25 ---------------------------------------------------LRTRIPEPD 
HrdD     22 ---------------------------------------------------SVRANGGEL 
 
 
Sig_Rx   92 ATGDSIRMYLAEIGRVPLLTHADEIRLAKAISRG-------------------------- 
Sig_Af   36 EDEDLVRLYLGDIGSHELLTKDDEAELGRRMDR---ARDAQRQLDAG------VKEPAR- 
Sig_Cc  115 LTGDPVRMYLKEIGKVPLLTAAEEIDLAMKIEAGVEAGEQLEAAEADN-----AEELSRR 
Sig_Ap  149 LTGDPVRMYLKEIGKVDLLTASEEVHLAMKIEAGTAASQKLEDFEDG------LIELNRA 
Sig_El  103 LTGDPVRMYLKEIGKVPLLTAAEEIDLAMKIEAGVAAMEELEKAEDE------GIELERR 
Sig_Se   77 LTGDPVRMYLKEIGKVPLLTAAEEIDLAMKIEAGVAATAELERAEDE------GIELNRR 
Sig_Ou  147 LTGDPVRMYLKEIGKVDLLTASEEVHLAMKIEAGTEATERLEAADRG------EIELTRA 
Sig_Mt  223 ASADSVRAYLKQIGKVALLNAEEEVELAKRIEAGLYATQLMTELSE------RGEKLPAA 
Sig_Cd  191 ASADSVRAYLKQIGKVALLNAEQEVSLAKRIEAGLYATYRMEQMEEAFNNGDKEAKLTPA 
Sig_Am  130 ASADSVRAYLKQIGKVALLNAEEEVELAKRIEAGLYAAERLRRAED------ESEKLTPQ 
Sig_Sv  134 ASADSVRAYLKQIGKVALLNAEEEVELAKRIEAGLYAAERLRIAEE------EGEKLSTQ 
Sig_Kf  140 ATADPVKDYLKQIGKVPLLNAEQEVELAKRIEAGLFAEEQLSDESA---------KLKDK 
Sig_Ac  203 ATTDPVKDYLKQIGKVSLLTAADEVDLARRIEAGLYAEHKIKTEGD---------ELPSK 
Sig_Sc  210 ATADPVKDYLKQIGKVPLLNAEQEVELAKRIEAGLFAEDKLAN-SD---------KLAPK 
Sig_Fa  107 PTSDPVRMYLKEIGKVPLLTAEEEVDLAKRIEAGLFASEKLAVATKK---------TSPQ 
HrdA     95 PSSDLFRQYLREIGRIPLLSAAEEVDLARRVEAGLFAEEKLRCSPGL------DDRLAL- 
HrdC     34 EEPDLLGQYLTQIGATPLLTAEDEVRLATRIEAGVRAREELETADTG------EPAPTPR 
HrdD     31 ADRDLVGMYLDEIARTPLLDAAKEVELSQTIEAGVFARQVLEGYEET------GADAT-- 
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Sig_Rx  126 -----------CKRSKDKLVEANLRLVVSIAKKYRNRGVSFLDLIQEGNIGLIRAAEKFD 
Sig_Af   86 -RAELEELVRQGEEAKRAFIQANLRLVVSIAKRYQASGLPLLDLIQEGNMGLIHAVEKFD 
Sig_Cc  170 EHRRLTRIEAVGLDAKQQLIEANLRLVVSIAKRYVGRGMLFLDLIQEGNLGLIRAVEKFD 
Sig_Ap  203 EQRRLMRIESVGLDAKQQLISANLRLVVSIAKRYVGRGMLFLDLIQEGNLGLIRAVEKFD 
Sig_El  157 EKRRLGRIEQVGIDAKQQLIEANLRLVVSIAKRYVGRGMLFLDLIQEGNLGLIRAVEKFD 
Sig_Se  131 DKRRLTRVEAVGLDAKQQLIEANLRLVVSIAKRYVGRGMLFLDLIQEGNLGLIRAVEKFD 
Sig_Ou  201 EQRRLMRIEQVGLEAKQALISANLRLTVSIAKRYVGRGMLFLDLIQEGNLGLIRAVEKFD 
Sig_Mt  277 QRRDMMWICRDGDRAKNHLLEANLRLVVSLAKRYTGRGMAFLDLIQEGNLGLIRAVEKFD 
Sig_Cd  251 VKRDLRAIARDGRKAKNHLLEANLRLVVSLAKRYTGRGMAFLDLIQEGNLGLIRAVEKFD 
Sig_Am  184 MRRDLRWIVRDGERAKNHLLEANLRLVVSLAKRYTGRGMAFLDLIQEGNLGLIRAVEKFD 
Sig_Sv  188 MRRDLKWIVRDGERAKSHLLEANLRLVVSLAKRYTGRGMAFLDLIQEGNLGLIRAVEKFD 
Sig_Kf  191 VRDEYDWISEDGRRAKNHLLEANLRLVVSLAKRYTGRGMLFLDLIQEGNLGLIRAVEKFD 
Sig_Ac  254 LRRELQILVHDGQLSKNHLLEANLRLVVSLAKRYTGRGMLFLDLIQEGNLGLIRAVEKFD 
Sig_Sc  260 LKRELEIIAEDGRRAKNHLLEANLRLVVSLAKRYTGRGMLFLDLIQEGNLGLIRAVEKFD 
Sig_Fa  158 MRRDLEAIERDGQIAKRKLVEANLRLVVSIAKRYVGRGMLFLDLIQEGNLGLIRAVEKFD 
HrdA    148 ---DLDRLVVLGRLAKRRLIEANLRLVVSVAKRYVGRGLTMLDLVQEGNLGLIRAVEKFD 
HrdC     88 RRRTLEETVHDGQEAKDHMVRANLRLVVSMAKRHAHRGLPLLDVIQEGNLGLIRAVEKFD 
HrdD     83 -REELQALIDESERAKDVFIRSNLRLVVAVARRYPRSGLPLLDLIQEGNAGLVRAVEKFD 
 
 
Sig_Rx  175 YRKGFKFSTYATWWIRQAITRAIADKGRTIRIPVHMVEKVNKYHRTQRRMTQALGREPTD 
Sig_Af  145 WRKGFKFSTYATWWIRQAITRGIANTGRTIRLPVHAGDSLSRVQRAQVQLEVRLGRAPTV 
Sig_Cc  230 YTKGFKFSTYATWWIRQAITRAIADQARTIRIPVHMVETINKLVRIQRQLLQELGREPTP 
Sig_Ap  263 YTKGFKFSTYATWWIRQAITRAIADQARTIRIPVHMVETINKLIRVQRQLLQDFGRDPTP 
Sig_El  217 YTKGFKFSTYATWWIRQAITRAIADQARTIRIPVHMVETINKLVRIQRQLLQELGREPSP 
Sig_Se  191 YTKGFKFSTYATWWIRQAITRAIADQARTIRIPVHMVETINKLVRIQRQLLQDLNRDPTP 
Sig_Ou  261 YTKGFKFSTYATWWIRQAITRAIADQARTIRIPVHMVETINKLVRVQRQLLQDLGRDPTP 
Sig_Mt  337 YTKGYKFSTYATWWIRQAITRAMADQARTIRIPVHMVEVINKLGRIQRELLQDLGREPTP 
Sig_Cd  311 YTKGYKFSTYATWWIRQAITRAMADQARTIRIPVHMVEVINKLGRIQRELLQDLGREPTP 
Sig_Am  244 YTKGYKFSTYATWWIRQAITRAMADQARTIRIPVHMVEVINKLGRIQRELLQDLGREPTP 
Sig_Sv  248 YTKGFKFSTYATWWIRQAITRAMADQARTIRIPVHMVEVINKLGRIQRELLQDLGREPTP 
Sig_Kf  251 YTKGYKFSTYATWWIRQAITRAMADQARTIRIPVHMVEVINKLARVQRQMLQDLGREPTP 
Sig_Ac  314 YTKGYKFSTYATWWIRQAITRAMADQARTIRIPVHMVEVINKLARVQRQMLQDLGREPTP 
Sig_Sc  320 YTKGYKFSTYATWWIRQAITRAMADQARTIRIPVHMVEVINKLARVQRQMLQDLGREPTP 
Sig_Fa  218 YTKGYKFSTYATWWIRQAITRAIADQARTIRIPVHMVETINKLIRIQRQLLQDLGREPSP 
HrdA    205 YARGYKFSTYATWWIRQAMSRALADQARTIRVPVHVVELINRVVRVQRRMLQERGCEPTP 
HrdC    148 HTKGFKFSTYATWWIRQAIERGLATHARTVRLPVHVVEQLQKLAKVERKLRAGLDREPTT 
HrdD    142 YRKGFKFSTYATWWIRQAITRSIADQSRTIRLPVHLVEELGRIRRVQREFNREHGREPEP 
 
 
Sig_Rx  235 EEVAEELGVPVEEVLRLQEISQRSISLETPVGDDESSSLGDFLEDASAVTPTDAVSESLL 
Sig_Af  205 RELAAEVDLPYDKLVEALRFRAEPVSLSEPLRDDGDAELGDVVEDSQSATPFDVAAEHLL 
Sig_Cc  290 EEIAEEMDLTPDRVREIQKISQEPVSLETPIGEEEDSQLGDFIEDDAAVVPPDAASFSML 
Sig_Ap  323 EEIGSEMGMSPDRVREIQKISQEPVSLETPIGEEEDSQLGDFIEDSTAVAPPDAASDSML 
Sig_El  277 EEIGKEMGLPAERVREIQKISQEPVSLETPIGEEEDSQLGDFIEDDAAVVPPDAASFSML 
Sig_Se  251 EEIGEKMGLSAERVREIQKISQEPVSLETPIGEEEDSQLGDFIEDDSAVVPPDAASFSML 
Sig_Ou  321 EEIGAEMGISADRVREIQKISQEPVSLETPIGEEEDSSLGDFIEDSSAVAPPEAASDSML 
Sig_Mt  397 EELAKEMDITPEKVLEIQQYAREPISLDQTIGDEGDSQLGDFIEDSEAVVAVDAVSFTLL 
Sig_Cd  371 QELAKEMDITEEKVLEIQQYAREPISLDQTIGDEGDSQLGDFIEDSEAVIAVDAVSFTLL 
Sig_Am  304 EELAKEMDITPEKVLEIQQYAREPISLDQTIGDEGDSQLGDFIEDSEAVVAVDAVSFTLL 
Sig_Sv  308 EELAKEMDISPEKVLEIQQYAREPISLDQTIGDEGDSQLGDFIEDSEAVVAVDAVSFTLL 
Sig_Kf  311 EELAKELDMTPEKVIEVQKYGREPISLHTPLGEDGDSEFGDLIEDSEAIVPAEAVSFTLL 
Sig_Ac  374 EELAKELDMTPEKVVEVQKYGREPISLHTPLGEDGDSEFGDLIEDSEAIVPTDAVSFTLL 
Sig_Sc  380 EELAKELDMTPEKVIEVQKYGREPISLHTPLGEDGDSEFGDLIEDSEAVVPADAVSFTLL 
Sig_Fa  278 EEIAKEMDLTPDKVREILKVSQEPVSLETPIGEEEDSHLGDFIEDCDAVVPVDAASFILL 
HrdA    265 QEVAAHLDLAPERVGEVLRLAQEPVSLHAPVGEEDDVALGDLIEDGDAASPVESAAFLLL 
HrdC    208 EEVAAESGIDVDKVVWLRRVGRDAVSLDTPVDETGDTVVGDLIPDTEVLRAPEVAEFQAL 
HrdD    202 AEIAAELGSTPERVTDVLDWARDPVSLNMSVDDEGETQFGDLLEDTSAVSPEQSVLTLLR 
246 
 
Sig_Rx  295 KLHLREALDELPERERQIIEMRFGMKDDRPRTLEEVGREFDITRERVRQIQMKTLNLLRE 
Sig_Af  265 PSEVSRLLAPLDGREREILRLRYGLDRGEPRTLEEVGEYFHLTRERIRQIEARAMSKLRH 
Sig_Cc  350 QEQLTKVLDGLAERERKVISLRFGLEDGHPRTLEEVGREFGVTRERIRQIESKTLAKLRH 
Sig_Ap  383 REQLEQVLDSLADRERKVIKFRFGLEDGHPRTLEEVGKEFGVTRERIRQIESKTLAKLRH 
Sig_El  337 QEQLSKVLDGLAERERKVISLRFGLEDGHPRTLEEVGREFGVTRERIRQIESKTLAKLRH 
Sig_Se  311 QEQLSKVLDGLAERERKVISLRFGLEDGHPHTLEEVGREFGVTRERIRQIESKTLAKLRH 
Sig_Ou  381 REQLEQVLDSLADRERKVIKFRFGLEDGHPRTLEEVGREFGVTRERIRQIESKTLAKLRH 
Sig_Mt  457 QDQLQSVLDTLSEREAGVVRLRFGLTDGQPRTLDEIGQVYGVTRERIRQIESKTMSKLRH 
Sig_Cd  431 QDQLQDVLHTLSEREAGVVKLRFGLTDGMPRTLDEIGQVYGVTRERIRQIESKTMSKLRH 
Sig_Am  364 QDQLQSVLATLSEREAGVVRLRFGLTDGQPRTLDEIGQVYGVTRERIRQIESKTMSKLRH 
Sig_Sv  368 QDQLQSVLQTLSEREAGVVRLRFGLTDGQPRTLDEIGQVYGVTRERIRQIESKTMSKLRH 
Sig_Kf  371 QEQLHAVLDTLSEREAGVVSMRFGLTDGQPKTLDEIGKVYGVTRERIRQIESKTMSKLRH 
Sig_Ac  434 QEQLHKVLDTLSEREAGVVSMRFGLGDGQPKTLDEIGKVYGVTRERIRQIESKTMSKLRH 
Sig_Sc  440 QEQLHSVLDTLSEREAGVVSMRFGLTDGQPKTLDEIGKVYGVTRERIRQIESKTMSKLRH 
Sig_Fa  338 QEQLDSVLHTLSDREKKVIQLRFGLTDGHPRTLEEVGREFGVTRERIRQIESKTLSKLRH 
HrdA    325 RQHLEAVLSTLGERERKVVQLRYGLADGRPRTLEEIGRLFGVTRERIRQIESKTLSKLRD 
HrdC    268 AAELREAVGTLAPRESLILSLRYGLHDGRPRTLQQVAQHVGLTRERVRQLEKESLAHLRA 
HrdD    262 SEELDDLIGRLDPRTASIIKMRYGIDDGRERTLTEVGKEHGLTRERIRQIEKHALLELKK 
 
 
Sig_Rx  355 QRRTQNLREYLH- 
Sig_Af  325 PSADIGARDLLTG 
Sig_Cc  410 PSRSSKLKDYLED 
Sig_Ap  443 PSRSGRLKDYMEE 
Sig_El  397 PSRSSKLKDYLED 
Sig_Se  371 PSRSSKLKDYLED 
Sig_Ou  441 PSRSGRLKDYMED 
Sig_Mt  517 PSRSQVLRDYLD- 
Sig_Cd  491 PSRSQVLRDYLD- 
Sig_Am  424 PSRSQVLRDYLD- 
Sig_Sv  428 PSRSQVLRDYLD- 
Sig_Kf  431 PSRSQVLRDYLD- 
Sig_Ac  494 PSRSQVLRDYLD- 
Sig_Sc  500 PSRSQVLRDYLD- 
Sig_Fa  398 PSRSQKLRDYLE- 
HrdA    385 HAYADQLRGYLD- 
HrdC    328 PENRERLLDWAS- 
HrdD    322 LA-RDTGFEAAA- 
 
Figure A2: Multiple sequence alignment of HrdB between RbpA and Non-RbpA 
containing Actinobacteria together with HrdA, HrdC and HrdD.  
The Clustal W2 multiple sequence alignment tool and the BOXSHADE 3.21 server 
were used. Amino acid residues shown in white font with black highlight showed 
identical residues whilst the amino acid residues in white font with grey highlight 
showed similar residues. The homology was tested to the 0.5 fraction that must 
agree for shading.The first seven HrdB amino acid sequences are from strains 
lacking RbpA: Sig_Rx: Rubrobacter xylanophilus DSM 9941, Sig_Af: Acidimicrobium 
ferrooxidans ICP, DSM 10331,Sig_Cc:Cryptobacterium curtum 12-3, DSM 15641, 
Sig_Ap: Atopobium parvulum IPP 1246, DSM 20469, Sig_El: Eggerthella lenta VPI 
0255, DSM 2243, Sig_Se: Slackia exigua ATCC 700122 and Sig_Ou: Olsenella uli 
VPI, DSM 7084. The following eight HrdB sequences are from strains containing 
RbpA: Sig_Mt: Mycobacterium tuberculosis H37Rv (lab strain), Sig_Cd: 
Corynebacterium diphtheriae gravis NCTC 13129, Sig_Am: Actinosynnema mirum 
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DSM 43827, Sig_Sv: Saccharomonospora viridis DSM 43017, Sig_Kf: Kribbella 
flavida DSM 17836, Sig_Ac: Actinomyces coleocanis DSM 15436 contig00038, 
Sig_Sc: Streptomyces coelicolor A3 (2), and Sig_Fa: Frankia alni ACN14a. The 
sequences of HrdA, HrdC and HrdD of Streptomyces coelicolor A3 (2) were also 
aligned.  
 
 
RbpA    1 MSERALRGTRLVVTSYETDRGIDLAPRQAVEYACEKGHRFEMPFSVEAEIPPEWECKVCG 
Crl     1 MTLPSGHPKSRLIKKFT-----ALGP-YIREGQCEDNRFFFDCLAVCVNVKPAPEKREFW 
 
 
RbpA   61 AQALLVDGDGP-----EEKKAKPARTHWDML--MERRTREELEEVLEERLAVLRSG--AM 
Crl    55 GWWMELEAQEKRFTYRYQFGLFDKEGNWTVVPINETEVVERLEYTLREFHEKLRDLLISM 
 
 
RbpA  112 NIAVHPRDSRKSA------ 
Crl   115 ELALEPSDDFNDEPVKLSA 
Figure A3: Alignment of RbpA and Crl amino acid sequences.  
The amino acids in white fonts and black highlights show identical residues whilst 
amino acids in white font and grey highlights show similar residues. The homology 
was tested to the 0.6 fraction that must agree for shading.This shows some 
conserved residues between RbpA and Crl. 
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Figure A4: The vector map of pSETΩ::rbpA.  
Spec; Spectinomycin resistance gene, RbpA; gene of interest including its promoter 
region, restriction enzyme sites mapped around the vector shown in black, red, 
purple and blue. The vector map was generated using pDRAW32 software.  
 
 
 
 
 
 
 
 
pSETomega::rbpA
7821 bp
PvuI - 323 - CG_AT'CG
PvuII - 352 - CAG'CTG
HindIII - 443 - A'AGCT_T
XbaI - 464 - T'CTAG_A
HindIII - 482 - A'AGCT_T
XbaI - 502 - T'CTAG_A
BamHI - 508 - G'GATC_C
XhoI - 514 - C'TCGA_G
BamHI - 520 - G'GATC_C
XhoI - 835 - C'TCGA_G
SacI - 1123 - G_AGCT'C
NdeI - 1133 - CA'TA_TG
EcoRV - 1298 - GAT'ATC
EcoRI - 1302 - G'AATT_C
PvuII - 1481 - CAG'CTG
EcoRI - 2538 - G'AATT_C
BamHI - 2548 - G'GATC_C
HindIII - 2569 - A'AGCT_T
PvuI - 3358 - CG_AT'CG
HindIII - 4575 - A'AGCT_T
BamHI - 4596 - G'GATC_C
EcoRI - 4606 - G'AATT_C
EcoRI - 6031 - G'AATT_C
HindIII - 6572 - A'AGCT_T
HindIII - 7541 - A'AGCT_T
RbpA
P
ro
m
o
te
r
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